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ABSTRACT OF THESIS
The morphology and function of the human Graafian follicle and
corpus luteum, together with the factors which may control follicular
development, ovulation and luteal regression, are reviewed.
Intact ovaries or ovarian wedge biopsies, endometria and
peripheral blood samples were obtained from women (aged 21-52 years)
who were at varying stages of the menstrual cycle and undergoing
hysterectomy for various gynaecological conditions. Intact Graafian
follicles were dissected from the ovarian specimens; the follicular
fluid was aspirated for hormone assay and the granulosa cell3
harvested for culturing in vitro. The concentrations of follicle-
stimulating hormone (FSH), luteinizing hormone (LH) the tX. and
{3 subunits of LH (LHo(and LHp), prolactin, progesterone, oe3tradiol-17p
and androstenedione in peripheral plasma and follicular fluid were
determined by various specific radioimmunoassays. In addition, the
concentration of testosterone was measured in follicular fluid.
Histological sections were prepared from Graafian follicles and
corpora lutea at differing stages of the menstrual cycle. The
steroidogenic potential, mitotic activity and viability of granulosa
cells were examined after they were cultured in media containing
varying amounts of pituitary hormone, the subunits of LH, oestradiol,
Q
prostaglandins NJf o - dibutryl adenosine 3',5* cyclic monophosphate
(DBC) or serum from patients with Addison's disease and premature
ovarian failure.
From these procedures, it was possible to investigate the
relationship between the concentrations of pituitary and 3teroid
hormone in follicular fluid and relate them to concentrations in
plasma, follicle size, stage of the menstrual cycle and the sterodogenic
xviii
potential of granulosa cells in tissue culture.
The results suggest that a precise sequence of hormonal changes
occur within the microenvironment of the developing Graafian follicle:
the order in which they occur may be of considerable importance for
the growth of that follicle and the secretory activity of granulosa
cells both before and after ovulation. These results suggest that
the early appearance of FSH in follicular fluid i3 critical for the
growth of that follicle: subsequent exposure to high levels of both
FSH and oestradiol stimulates the mitotic activity of the granulosa
cells and enhances their biosynthetic capacity. The final entry of
significant amounts of LH into the follicle Just before ovulation
inhibits further mitotic activity and, together with prolactin,
initiates the secretion of jrogesterone which can only be sustained
in the presence of low physiological concentrations of FSH, LH and
prolactin.
Serum from seme patients with idiopathic Addison's disease and
premature ovarian failure contained antibodies which together
with complement were cytotoxic to granulosa cells in culture. It
is suggested that in vivo, these cytotoxic antibodies may cross the
blood-follicle barrier and may at least be partially responsible for
the persistence of amenorrhoea in some patients with idiopathic
Addison's disease and premature ovarian failure.
j rostaglandin F2c< , either alone car in combination with LH and
F3H, inhibited the production of progesterone over a wide range of
concentrations (1-8000 ng/ml) without affecting cell viability.
By contrast I GE2 over a similar range of concentrations markedly
stimulated the production of progesterone by granulosa cells, and
this was not prevented by the addition of - G?2o(. The degree of
OTlV
inhibition by I GF2* or stimulation by PGE2 was related to the
biosynthetic capacity, that the cells had achieved prior to tissue
culture.
Finally two hypotheses are proposed, the first of which may
explain why only one follicle is selected for ovulation, and





The discovery of the ovary and its functions
Contemporary anatomists still refer to the human ovary as a rather
uninteresting structure averaging about 35 mm in length, 20 mm in
depth and 15 mm in thickness and weighing between 2 and 10 g.
(Corner, 1947; Mossman & Duke, 1973a). It is not surprising
therefore, to discover that the ancient anatomists were completely
mystified as to its function since they did not appreciate that the
female mammal produced eggs (Corner, 1947). In fact, it took almost
3O0 years from the time Andreas Versalius of Brussels first described
the ovarian follicle (Versalius, 1555) until von Baer (1827) first
described the mammalian egg as a very small speck inside the follicle,
too small to be seen with the naked eye. Paradoxically however,
it is Hegnier de Graaf (1672) who gave his name to the ovarian follicle,
although he and many others for years to come thought that the whole
follicle was an egg. Nevertheless, de Graaf did provide the first
accurate and detailed descriptions of the preovulatory follicle and
the corpus luteum, which he correctly attributed to a consequence of
coitus in the rabbit. Furthermore, he suggested that the number of
corpora lutea provided an index of the number of embryos present.
It was probably Malpighi (1697) who first suggested that the Graafian
follicle never left the ovary, but served to protect the true ovum
that lay within it. He also noted that the corpus luteum was
glandular in nature, although he failed to appreciate that it was
formed from the ruptured follicle. By the beginning of the 19th
century the corpus luteum was thought to be scar tissue formed
after ovulation (Prevost & Dumas, 1824) and another 70 years passed
before Prenant, (1898) suggested that the corpus luteum was a gland
of internal secretion releasing its products directly into the
2.
circulation. About the same time Lataste (1886-1887) 3howed that
changes in the vaginal epithelium of rodents correlated with the
stage of follicular development.
Although I'ott (1775) gave the first accurate clinical
description of the consequences of ovariectomy in women and the first
evidence to show that menstruation is under ovarian control, the
inter-relationship between menstruation and ovarian function was not
fully appreciated until the end of the 19th century (see review by
Short, 1975). Thus by the beginning of the 20th century it was
generally understood that both the Graafian follicle and the corpus
luteum were capable of secreting substances which could influence
menstruation and the vaginal epithelium.
During the early part of the 20th century, considerable debate
arose as to the actual time in the menstrual cycle when ovulation
takes place. Raciborski (1834) noted that girls who were married soon
after a menstrual period became pregnant without menstruating again
while those who married twelve or more days after menstruation
invariably menstruated once more before becoming pregnant. However
Pouchet (1842; 1847) thought that pregnancy could only occur if
intercourse took place during or immediately after menstruation; thus
his "safe period" actually coincided with the time of ovulation.
Even though people slowly began to appreciate how menstruation was
related in time to ovulation, it was not until the 1930*s that it
was realised that menstruation marked the end of a cycle, rather than
a sign of the next impending ovulation (see review by Short, 1975).
In 1911, Leo Loeb, the father of American endocrinology,
provided convincing experimental evidence to support an earlier
suggestion by Beard (1897) that the corpus luteum controlled the time
of ovulation; Loeb showed that enucleation of corpora lutea from
ovaries of guinea-pigs hastened the onset of the next oestrus. Not
long after this discovery Stockard & Papanicolaou (1917) and Long
& Evans (1922) some 30 years after Lataste's original observations
showed that the changing cytology of vaginal smears from rodents
provided a sensitive indicator of ovarian activity. These studies
quickly led to the development of a suitable bio-assay system in
which extracts of ovarian tissue were tested for their ability to
alter the vaginal cytology of rats and mice (Allen & Doisey, 1923).
In 1924, Doisey, Halls, Allen & Johnston isolated and purified a
substance from follicular fluid in sows which produced vaginal
cornification when injected into rats and mice. They named this
substance 'theelin' from the Greek 'thelys' meaning female, although
it was later called oe3trin (see review by i arkes, I960). Before
long oestradiol-17p, was isolated and purified from a pool of
follicular fluid which had been obtained from four tons of sow's
ovaries (MacCorquodale, Thayer & Doisoy, 1937). A few years earlier
Doisey in St. Louis, Butenandt in Gottingen, Laqueur in Amsterdam
and Marrian in London had isolated and characterised oestrone and
oestriol (see reviews by Marrian, 1966; Parkes, 1966; Short, 1975).
In 1929, Corner & Allen prepared an ethanolic extract of pig corpora
lutea which produced a progesterone proliferation of the endometrium
in the rabbit, and in the following year, they found that the extract
successfully maintained pregnancy in rabbits up to term, even after
the animals had been ovariectomized only eighteen hours after mating
(Allen & Corner, 1930). The speed at which endocrinology was
proceeding continued unabated when in 1934 progesterone was isolated in
crystalline form from luteal tissue and its structure elucidated by
four independent groups (Allen & Wintersteiner, 1934; Slotta,
Rusching & Pels, 1934; Butenandt, Westphal & Coblar, 1934;
Hartmann & Wettstein, 1934). In retrospect however, perhaps the most
significant endocrinological discovery of these exciting years
was by Makepeace, Weinstein & Friedman (1937) because they found
that the administration of progesterone to rabbits inhibited
ovulation. This discovery was to be of immense importance to
social medicine. However sixteen years were to pass before
Pincus & Chang (1953) put theory to practice and provided a method
for controlling fertility, and thus "The i ill" was born.
Conceptually the endocrine control of menstruation wa3 a
problem which concerned many researchers during the early part of
the 20th century. Although it was known that the regression of the
corpus luteum was followed by the onset of menstruation the
difficulty was to explain how menstruation could occur in the primate
in the absence of a corpus luteum (Corner, 1923). Allan (1927)
found that menstruation could be induced in castrated rhesus monkeys
following a period of oestrogen treatment and later it was shown
that progesterone could prevent oestrogen withdrawal bleeding
£Imith & Engle, 1932; Engle, Smith & Shelesnyak, 1935; Hisaw, 1935).
Finally the problem was solved when it was conclusively demonstrated
that menstruation occurred normally after the regression of the corpus
luteum but, if no corpus luteura was present, menstruation could still
occur in response to a declining secretion of oestrogen (Zuckerman,
1937; Hisaw & Greep, 1938).
The control of the life span of the corpus luteum is still a
problem which remains with us today and especially so in women (see
review by Short, 1972). Loeb (1923; 1927) showed that hysterectomy
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in the guinea-pig could prolong the life of the corpu3 luteum
and he went on to postulate that uterine secretions may be responsible
for terminating normal corpus luteum function. However almost 70 years
were to pass before prostaglandin F2<* wa3 identified as the uterine
luteolytic hormone in sheep (see review by Goding, 1974).
Another equally important era of research began at the
beginning of the 20th century; this was the relationship between
the anterior pituitary and the ovary. Research in this area
proceeded at considerable speed following the experiments of
Carmichael & Marshall (1908) who showed that unilateral ovariectomy
led to compensatory hypertrophy of the centralateral gland. In
1927, Smith at Columbia University, New York, showed that after rats
were hypophysectoralsed, there was a marked increase in their ovarian
weights after they had received implants of pituitary extract.
During the following year Evans & Simpson (1928) found that alkaline
extracts of pituitaries induced luteinization. These studies led to
the postulate that two separate gonadotrophic factors controlled
ovarian activity (see review by Chester-Jones fa Ball, 1962; Greep,
1967). About the same time, two fractions of the anterior lobe of
the pituitary were prepared, one with follicle-stimulating and the
other with luteinizing properties (Fevold, Hisaw fa Leonard, 1931;
van Dyke & Walien-Lawrence, 1933; Evans, Korpi Pencharz fa Simpson,
1936). Using the very latest techniques in protein chemistry Greep,
van Dyke & Chow (1942) in a classic series of experiments isolated
some very highly purified preparations of F3H and LH. They then
found that the administration of a highly purified FSH preparation
to hypophysectomizod rats enhanced follicular development but that the
uterus remained atrophic as in the untreated animals. Thus it appeared
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that in the absence of LH, oestrogen secretion did not occur despite
the development of large follicles. These findings provided
convincing evidence to suggest that pituitary hormones acted in
concert (see review by Greep, 1967).
In 1941, Astwood suggested that a third gonadotrophin,
luteotrophin, activated corpus luteum function in rats; this
hormone was later to be known as prolactin. However, in man there
was no evidence before 1961 to suggest that pituitary prolactin
existed. The initial experimental evidence for the separate
existence of prolactin came from in vitro cultures of human
pituitaries, which in the absence of the hypothalamus produced large
amounts of a substance which was distinct from growth hormone but
similar to the pigeon crop-stimulating substance, i.e. prolactin
(see review by I asteels, 1973). Antibodies raised in rabbits to
this substance neutralised the pigeon crop-stimulating activity
of human blood collected from either lactating women or women with
amenorrhoea and galactorrhoea. Finally the separate existence of
human prolactin was confirmed when Lewis, Singh and Seavey (1972)
successfully extracted it from human pituitary glands.
By the 1950's despite the lack of knowledge about the role
of prolactin in man it was clear that the follicular phase of the
ovarian cycle is dominated by the growth of Graafian follicles which
secretes oestrogen and that follicular growth and secretion is
controlled by the gonadotropins. It wa3 also clear that the luteal
phase is dominated by the corpus luteum which secretes progesterone under
the influence of LH and also prolactin in some species (Rothchild, 1965).
The way was then open to explore how the follicle prepared
itself for the transition from an oestrogen to a progesterone
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secreting gland following follicular rupture. Investigators began
to examine the cell types of the follicle to examine whether
steroid secretion originated from a specific cell type. Hi3tologists
had for many years postulated that the theca interna cells might
produce oestrogens but the first direct evidence to support this
concept came from the elegant studies of Falck (1959). He
transplanted granulosa and theca interna cells into the anterior chamber
of the rat*s eye, together with a piece of vagina to serve as an
indicator of oestrogen secretion. He observed that the granulosa
cells by themselves alway3 grew into luteal cells and failed to
cornify the vaginal transplant, whilst the theca cells produced
cornification provided some granulosa cells were also present. He
suggested that the production of oestrogen was dependent on an
interplay between the theca interna and the granulosa cells. A few
years later Short (1962a; 1964a) after studying the ovarian cell
types of the mare advanced the concept that the theca interna cells
possessed all the enzyme systems necessary for oestrogen secretion by
the follicle, and that the luteinized granulosa cells produced mainly
progesterone because of their relatively inactive 17- hydroxylase and
desmolase enzyme systems. Further evidence from the mare to support
the earlier concept proposed by Short came from studies of Younglai
k Short (1970); they found that the rate of progesterone released
from follicular fluid was very slow. This ob3ewition suggested
that progesterone produced by the granulosa cells was unlikely to be
a suitable substrate for the theca interna cells. In addition this
study drew attention to the possible importance of follicular fluid
as an endocrine microenvironment in which granulosa cells could be
•programmed* for their subsequent secretory activity in the corpus luteum
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However at the present time the factors influencing the maturation
and biosynthetic potential of the granulosa cells within the
developing Graafian follicle, and the granulo3a-derived lutein cells
of the corpus luteum remain obscure.
The morphology of the ovarian follicle
The changes in morphology of the follicle during its growth
has been extensively reviewed (Corner, 1947; Brambell, 1956;
Harrison, 1962; Mauleem, 1969; Perry, 1971; Baker, 1972a;
Hertig & Barton, 1973; Mossman & Duke, 1973a, b; Peters, 1973;
Schwartz, 1973; Zamboni, 1974). The system of nomenclature used
here to define the various stages ctf follicular growth is that
described by Baker (1972a, b).
The PRIMOkPIAL FOLLICLE (Plate 1) is the most immature stage.
This follicle is separated from the surrounding stroma by a basement
membrane and contains a primary oocyte in prophase of the first
meiotic division (Baker, 1972b) together with a 3ingle layer of
spindle shaped cells which are the undifferentiated granulosa cells.
The oocyte originates from the primordial germ cells which migrated
into the embryonic gonad from the yolk sac stalk near to the
developing allantois (Vfit3chi, 1948). However, the origin of the
granulosa cells is much less certain. It has been suggested that
they are derived from the embryonic cells of the stroma (3ee review
by Mossman & Duke, 1973b) and also the rete ovarii (Byskov &
Lintern-Moore, 1973; Byskov & Rusraussen, 1973). Ohno & Smith (1964)
have suggested that the presence of follicular cells determined the
fate of the oocyte; without these cells, oocytes are unable to
enter meiosis. It has also been suggested that the granulosa cells
inhibit the final stages of meiosis in the oocyte (Foot & Thibault,
1969). A functional interrelationship seem3 to persist between the
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Plate 1. Human primordial follicle. Note the lack of
orientation of the cells beyond the 'flattened'
epithelial cells which are positioned around the
circumference of the oocyte. Mag. X 580.
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(Lacassagne, Duplan, Marcovich & Raynaud, 1962; Short, 1971)
Most follicles in the adult ovary are quiescent primordial
follicles (Peters, Byskov & Faber, 1973a) within the cortex.
When the flat, spindle-shaped cells inside the basement membrane
become cuboidal (Plate 2), the follicle is then defined as a
PRIMARY FOLLICLE. .Successive mitotic divisions of these cuboidal
cells gives rise to a multilayered lining of granulosa cells
(plate 3)and the oocyte is separated from the granulosa cells by
the zona pellucida (3ee Plates 3 and 4). Protoplasmic processes
from the adjacent granulosa cells traverse the zona pellucida and
interdigitate with microvilli arising from the oocyte (see reviews.
Baker, 1972a; Zamboni, 1974). Presumably the transfer of nutrients
to the oocyte occurs by diffusion (Zamboni, 1974) or by pinocytosis
of granulosa cell projections (Hope, 1965; Baker, 1372c).
Coincident with proliferation of the granulosa cells, adjacent
stromal cells outside the basement membrane become orientated in
concentric perifollicular layers (Plate 2 and 3). It is suggested
that these changes are induced by the proliferating granulosa cells
(Dubreuil, 1957). At the time of antrum formation the concentric
layers of 'compressed' stromal cells differentiate into theca interna
and theca externa. The theca interna cells assume a cuboidal 3hape
and develop a vacuolated cytoplasm and vesicular nuclei (Harrison,
1962). Unlike the granulosa cells which are avascular the theca
interna cells in the growing follicle are surrounded by an extensive
capillary and lymphatic network which terminates at the basement
membrane (see review, Reynolds, 1973). With continued proliferation
of the membrane, granulosa a confluent fluid filled space within the
follicle develops which is called the ANTRUM. The follicle is now
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Plate 2. Human primary follicle. Note the single layer of
cuboidal epithelial cells (granulosa) around the
circumference of the oocyte. The cells adjacent to
the granulosa are beginning to align themselves
concentrically to the oocyte. Mag. X 580.
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. late 3. A primary follicle with 4-5 layers of granulosa cells
around the oocyte. Note the well defined concentric
layer of theca (T) cells surrounding the granulosa (G)
cell layers and the prominent blood vessels (B).
Mag, X 580.
13
-a '' ?'»%v '•* ;*/"V
Plate 4. Section through a human Graafian follicle showing the
oocyte (O), antrum (A), granulosa (G) and the cumulus
oophorua cells (CO). Note the zona pellucida
('arrowed') around the oocyte. Wag. X 380.
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defined as the GRAAFIAN FOLLICLE (Plate 5) and is visible to the
naked eye. The antral fluid is presumed to consist of transudates
of plasma and secretory products of the granulosa cells (T erloff,
Gchultz, Farris & Balin, 1955; Caravaglios & Cilotti, 1957; Shivers,
Metz & Lutwak-iVann, 1964; 0e3jardins, Kirton & Hafs, 1966;
Manarang & Menge, 1971; Kdwards, 1974). By the time the antrum has
appeared, the oocyte has enlarged to its final 'resting' size which,
in the human female, is "80^ni in diameter (Green & kuckerman, 1951;
Baker, 1972a). Proliferation of the granulosa in the mouse i3 said
to be greatly increased after the formation of the antrum (Bullough,
1942). Peak mitotic activity appears to occur during the mid to
late follicular phase of the human menstrual cycle when there are rising
concentrations of oestradiol in peripheral plasma (Dyrenfurth, Ferin,
Jewelewicz, Warren, kizkallah & Mikhail, 1970; Delforge, Thomas,
Koux, Carneiro de Siqueira & Ferin, 1972). Granulosa cells show
little sign of secretory activity during the period of intense
mitotic activity; they are small and cuboidal and contain a granular
cytoplasm and a densely stained nucleus (Harrison, 1962). Mitotic
activity of the granulosa cell3 falls abruptly during the late
follicular phase when there are rising concentrations ftf luteinizing
hormone (LH) in peripheral plasma; this has been attributed to high
concentrations of LH and/or progesterone (Delforge et al.. 1972).
The theca cells in the developing human Graafian follicle show a
marked degree of hypertrophy (Solomons & Gatenby, 1924;
Harrison, 1962) and an increase in histochemical activity (aicKay &
Robinson, 1947) indicating secretory activity. Little information
however, is available on the temporal relationships between the
morphology of theca cells in human Graafian follicles and their
rlate 5. Human Graafian follicle. Note the size of the
follicular cavity (F) in relation to the cells of
the follicle. Mag. X 72.
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secretory activity (Baird, Baker, McNatty & Neal, 1975).
The cells attached to the oocyte (Plate 4) remain
morphologically indistinguishable from the granulosa cells until
just prior to ovulation when they become columnar in shape and are
called the corona radiata or cumulus oophorous cells. After
ovulation these cells remain attached to the oocyte for 2 to 3 days
(Harrison, 1962; Baker, 1972a); degenerative changes in these
cells are a strong indication that the oocyte is atretic (Baker,
1972b).
In women it is not known how long it takes for a primordial
follicle to develop into a mature preovulatory follicle whereas
it takes 10 - 11 days in the guinea pig (Bland & Donovan, 1968)
and rabbit (Desaive, 1947, 1948), but 26 days in the mouse (Pedersen,
1969). However, follicular development and ovulation can be
induced in anovulatory women (whose ovaries previously contained no
visible antral follicles) with exogenous gonadotropins administered
over a period not exceeding the follicular phase of the spontaneous
ovulatory cycle (see review, Ross & Vande Wiele, 1974). Therefore,
it is reasonable to assume that complete follicle maturation,
beginning with a primary or a small antral follicle can be completed
within 10 - 15 days, which i3 similar to the time taken from the
primary follicle stage in the mouse (i edersen, 1969), There is a
2 to 4 hundred-fold increase in follicle diameter (i.e. from 0.05
to 10-20 mm) and the follicle prior to rupture contains up to 4 mis
of antral fluid. Similarly, the oocyte Increases 4 to 5 fold in
diameter from 30-40^10 in the primordial follicle to lSO^m in a
mature preovulatory follicle (Baker, 1963; Ross & Vande Wiele, 1974).
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The morphology of the preovulatory follicle
The human preovulatory follicle averages 15 mm in diameter and
occupies up to 20% of the entire volume of the ovary. Little is
known however about the changes which occur prior to rupture although
extensive studies have been made in the following species: rodents
(Blandau & Rumery, 1963; Blandau, 1955; Byakov, 1969); rabbit
(Bjersing & Cajander, 1974a, b, c; Espey, 1967, 1971a, 1971b;
Espey h Lipner, 1963, 1965; Espey & Rondell, 1968; Lipner, 1973;
ewe (Bjersing, Hay, Kann, Moor, Naftolin, Scaramuzzi, Short &
Younglai, 1972; Moor, Hay & Seamark, 1975) and the mare (Short,
1964 a) .
In women, following the mid-cycle peak of LH in plasma, the
abrupt fall in mitotic activity of the granulosa cells is
accompanied by morphological changes consistent with luteinization.
(Hertig, 1967; Delforge et al., 1972). Furthermore the electron
microscope reveals an increase in these cells of the amount of smooth
endoplasmic reticulum and mitochondia (Delforge et al., 1972;
Crisp, Dessouky & Denys, 1970) and histochemically, the present of
3p-ol steroid dehydrogenase can be demonstrated (Friedrich, Breitenecker,
Sulzer & Holzner, 1974). Changes in the viscosity of follicular fluid
occur as the mucopolysaccharides become depolymerised (Jensen &
Za chariae, 1958). The fluid is highly viscous in preovulatory
follicles in women and rhesus monkeys (Koering, 1969; Steptoe &
Edwards, 1970; Butler, 1971). A general haemorrhagic appearance has
been described in some human preovulatory follicles, and in those
of macaques (Steptoe & Edwards, 1970; Jewett & Dukelow, 1972).
There is a marked increase in capillary flow to the developing human
follicle (Gillet, Kovitke, P»Iuller & Juliens, 1968) and in the ewe
a 2-fold increase in blood flow occurs some 12 to 18h before ovulation
(Moor et al., 1975). Burr & Davies (1951) have suggested that
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the follicle destined to ovulate not only receives the largest
volume of blood in absolute terms (ml/min) but also has
capillaries which are more permeable than those in other follicles.
The high levels of oestrogen and LH during the preovulatory period
probably have an important role in increasing the rate of blood
flow to follicles (Moor et al.. 1975).
The morphological changes occurring in human theca cells before
ovulation are not clear although the levels of oestradiol
fall in plasma and probably in follicular fluid (Edwards, 1974;
Baird et al., 1975). Presumably degenerative changes occur as is the
case in the sheep (Moor et al.. 1975), rabbit (Bjersing & Cajander,
1974a) and rat (Byskov, 1969),
A number of hypotheses have been proposed to explain the
mechanism of follicular rupture (see review, Lipner, 1973). The most
recent is that based on studies in the rabbit (Lipner, 1973) and is
possibly the most attractive since it integrates the many diverse
changes which take place in and around the follicle following the
mid-cycle 'surge' of LH. This hypothesis relates the increased rate
of steroidogenesis (which will be discussed more fully elsewhere),
blood flow and prostaglandins (Bjersing & Cajander, 1975) to the
production of proteolytic enzymes, theca cell degeneration and
increased distensibility of the follicle wall. Lipner (1973) then
suggests that ovulation occurs when at constant intrafollicular
pressure, the modulus of elasticity of the follicle wall approaches
a minimal value, and, as the antral volume increases, wall stress
achieves rupture stress.
The dynamics of follicular growth
Follicular growth from the time of completion of meiosis is a
continuous process uninterrupted by pregnancy or other periods of
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anovulation. follicles grow sequentially and continue to grow until
they either become atretic or ovulate (Peters, Byskov, Himelstein-Braw
& Faber, 1975).
Most available evidence, based on studies in rodents, suggests
that the initiation of follicular growth is independent of
gonadotrophins (Pfeiffer & Hooker, 1942; Fainstat, 1968; Mauleon,
1969; Eshkol, Lunenfeld & Peters, 1970; Eshkol & Lunenfeld, 1971;
Odor & Blandau, 1971; Peters & Braathen, 1973; Peters et al.. 1973a)
The rate at which follicles leave the non-growing pool of primordial
follicles also appears to be independent of gonadotrophins (Peters,
Byskov, Lintern-Moore, Faber & Andersen, 1973b). It i3 postulated
that the order in which follicles begin to grow is related to the
time of first contact with the cells of the rete ovarii (Byskov &
Lintern Moore, 1973; Byskov, 1975). This may or may not be consistent
with the earlier hypothesis of Henderson Pa Edwards (1968) which
suggests that oocytes develop in the order in which they are formed
in foetal life.
Intra-ovarian mechanisms are thought to regulate the number of
antral follicles present in the ovary (Vande Wiele, Bogmumil,
Dyrenfurth, Ferin, Jewelwicz, ,/arren, Rizkallah & Mikhail, 1970;
Short, 1971; Peters et al.. 1973a; Taylor & Short, 1973) since a
reduction in the pool of non-growing follicles reduces the number
beginning growth (Krarup, Pedersen & Faber, 1969; Peters orenson,
Byskov, Pedersen & Krarup, 1970). It has also been suggested that
antral fluid from degenerating follicles may reduce the number of
follicles leaving the pool (Peters et al., 1973a).
Follicular development in the absence of gonadotrophins is
retarded and disorganised (Eshkol et al.t 1970} Eshkol & Lunenfeld,
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1971; Baker & Neal, 1973) suggesting that pituitary gonadotropins
are obligatory for the maturation of follicles at all stages of
growth (see reviews by Baker, 1972b; Riggers & Scheutz, 1972;
Schwartz, 1973; Yoshinnga, 1973; Rosa % Vande iele, 1974). In
addition th© gonadotrophins regulate the proportion of follicles
that will mature and the number that will ovulate (Baker, 1972a;
etera, et al.. 1975). This has been demonstrated moat dramatically
by the incidence of multiple births following exogenous gonadotropin
treatment in anovulatory women (Gemzell, 1965; Brown, Evans, Adey,
Taft « Toamsend, 1969; Brown, 1971; see Baird, 1974a, for review).
The distribution and size of Graafian follicles fluctuates throughout
the menstrual cycle, with the largest follicles occurring at raid-
cycle and again during the aid to late luteal phase (Block, 1951a).
This variation appears to be related temporally to the cyclic changes
in the concentrations of the pituitary hormones (doss & Vande «iele,
1974).
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At birth the human female ha3 2 X 10 oocytes (follicles) and
this polulatlon declines throughout life until at menopause it is
almost totally depleted (Hertlg, 1944; Block, 1931b; Baker, 1973).
During the period from oenarche to menopause ("-15 to 50 y) only
a maximum of *■ 130 follicles will ovulate. Clearly the fate of
most follicles is atresia. Conversely the process of selecting a
follicle for ovulation must be very precise and depend on the
interplay of several mechanisms which lie partly outside the ovary
and partly within it.
Steroid secrotlcn by the Graafian follicle
The human ovary probably secretes most of the steroids in the
bisaynthetic pathway from pregnenolone to oestradiol (Baird, 1971).
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It has conclusively been demonstrated that the concentrations of
progesterone, 17o(-hydroxyproge3terone, androstenedione, oestrone,
and oestradiol-17p are higher in the vein draining the ovary
containing a large Graafian follicle than in the contralateral vein
during the follicular phase (Mikhail, 1970; Baird, 1971; Lobotsky,
Baird, McCracken, Weisz, Pupkin, Zanartu & Puga, 1971; Baird,
Burger, Heavon-Jones & Scararauzzi, 1974). Neither dehyroepiandrosterone
nor testosterone seem to be major secretory products of the Graafian
follicle (danJang et al.. 1974), although their concentrations are
higher in ovarian than peripheral venous plasma (Norton, Komanoff &
Walker, 1966; Kivarola, 3aez, Jones, Jones 8s Migeon, 1967).
The changing concentration of oestradiol*-17|3 in peripheral
plasma during the follicular phase of the menstrual cycle provides an
index of follicular growth (Baird, 1971), since more than 9® of this
steroid is derived solely from actively growing follicles (Baird,
1972; Baird St Fraser, 1974a). These actively secreting follicles
also contain high concentrations of oestradiol (.-.mith, 1960; Short
& London, 1961; Giorgi, 1965; Edwards, Steptoe, Abraham, Walters,
Purdy & Fotherby, 1972; Baird & Fraser, 1974b; Sanyal, Berger,
Thompson, Taymor & Horne, 1974). Furthermore, during the immediate
preovulatory phase there is an increase in the concentration of
progesterone in follicular fluid (Edwards et al., 1972; Sanyal et al.,
1974) which is also reflected in ovarian (Lloyd et al.; de Jong, 1974)
and peripheral venous pla3ma (Johansson & Wide, 1969; Yussman &
Taymor, 1970). The high correlation between ovarian venous
concentrations of oestradiol and oestrone or androstenedione suggests
that these steroids arise largely from the same structures (Baird et al..
1974; de Jong et al., 1974) and perhapa even the same cell type
CYounglai & Short, 1970).
The tneca cells of the human Graafian follicle can apparently
synthesise de novo the complete range of ovarian steroids when
incubated in vitro, whereas the granulosa cells do not appear to
have the biosynthetic capacity to make oestradiol (Ryan & t'etro,
1966; Ryan, 1-etro & Kaiser, 1968; Channing, 1969a). In addition
when theca cells are cultured in vitro, they secreted quantitatively
more oestradiol than progesterone while granulosa cells secreted
more progesterone than oestradiol (Channing, 1969a). It is
difficult however to conclude from this study that the granulosa
cells actually secrete oestradiol 3ince high concentrations of this
steroid are present in follicular fluid, a trace of which may have
been transferred with the cells into culture medium. Studies in
the mare have shown that granulosa cells have extremely low
desmola3e and aromatase activity in vivo (Younglai & Short, 1970)
thus it is unlikely that these cells have the capacity to secrete
significant amounts of androstenedione and oestradiol-17p. These
studies are consistent with the 'two-cell-type" theory proposed
earlier by Short (1962a).
The synthesis of steroids by human granulosa and theca cells
in vitro is increased when both cell types are Incubated together,
as compared to each cell type alonff (Ryan et al.. 1966) however
this could not be confirmed by Channing (1969a). It is of interest
to note that in Channlng's study the cells were obtained from an
ovary during the mid-proliferative phase whilst those from Ryan's study
were obtained from a preovulatory follicle. These studies perhaps
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highlight the importance of the "two-cell-types" in steroid
secretion from the preovulatory follicle and corpus luteura rather
than from the small immature Graafian follicle since in women and
rhesus monkeys, the avascular granulosa cells of Graafian follicles
show netther histological, hi3tochemical nor ultrastructural
indications of steroidogenic activity until just prior to rupture
(Harrison, 1932; Hope, 1965; Hertig & Adams, 1967; Christensen &
Gillim, 1969; Crisp & Channlng, 1972; Delforge ct al.. 1972;
-Hriedrich, Dreitenecker, Sulzer Holzner, 1971). The evidence
obtained from a number of species including vfomen strongly suggests
that oe3tradiol-17|3 is secreted by the theca cells and pr-ogesterone
by t e luteinising granulosa cells (Falck, 1953; Peane, Lobel &
omnoy, 1962; Short, 1964a; Younglai & Short, 1970; ie mark, Moor
& Mcintosh, 1974).
thy don't the granulosa cells in small Graafian follicles which
are not preovulatory secrete progesterone in vivo? There is
substantial evidence to suggest that granulosa cell3 harvested from
these follicles are capable of secreting some progesterone in Vitro
(Channing, 1969a, 1970a, 1972). It has been assumed that granulosa
cells from these follicles are inhibited from expressing their
biosynthetic potential in vivo or that they are deprived of an
essential nutrient or pituitary hormone. One hypothesis was that
the oocyte exert3 the 'inhibitory influence* which can be overcame
by luteinising hormone (LF!) (21-Fouly, Cook, Hekola & Nalbandov, 1970).
It is difficult to interpret the results of experiments involving
surgical removal of an oocyte from a Graafian follicle in vivo
('ovectoray'), 3ince it is impossible to avoid damaging the basement
membrane, with the consequent haemorrhage into the follicular cavity
and the development of follicular cysts (Hunter & Baker, 1975).
This hypothesis of oocyte inhibition has not been confirmed in
in vitro experiments since 'ovectomy' has no effect on the production
of progesterone by murine Graafian follicles (! indner, Tsafriri, Lleberman,
Zor, Koch, Bauminger & Barnea, 1974). In addition, granulosa cells
harvested from small iramoture Graafian follicles of women, rhesus monkeys
and mares when cultured in the absence of the oocyte will still secrete
only low amounts of progesterone even in the presence of LH (see
review Channing, 1970a), and the find structure of these cells is
not consistent with functional or structural luteinization (Crisp
St Channing, 1972). It is likely therefore that granulosa cells from
small follicles do not secrete large amounts of progesterone because
they do not have the biosynthetic capacity (Channing, 1970a) and are
devoid of receptors for LH (Channing, 1972, 1975; Channing &
Karamerman, 1973a; Zeleznik, Midgely fc Reichert, 1974). It is
also possible that they may be deprived of LH which is perhaps unable
to cross the blood-follicle barrier in appreciable amounts until the
mid^cycle 'surge'. Human adrenal cortical cells in culture medium
devoid of adrenocorticotropic hormone (ACTH) proliferate actively
and secrete only low amounts of steroid; however, in the presente of
ACTH, increased secretion occurs and cell proliferation is arrested
(O'llare & Munro-Neville, 1973a, b). The measurement of LH in
follicular fluid may help to confirm whether similar changes occur
within the Graafian follicles
The pituitary-ovarian axis in relation to follicular development
During the last decade considerable advances have been made in
our understanding of the interaction between the ovary and the
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pituitary (see reviews by Gemzell, 1965; Rothchild, 1965; Short,
1967, 1972b; Ross, Cargille, Lipsett, Rayford, Marshall, Strott
& Rodbard, 1970; Yande Wiele et al., 1970; McCracken, Baird &
Goding, 1971; Knobil, Dierschke, Yamaji, Karsh, Hotchkiss & Weick,
1972; Baird, 1974a;; Barraclough, 1974; Yoshinaga, 1974).
Since the development and secretory activity of a follicle is
totally dependent on the pituitary gonadotrophin3, the selection
of a developing follicle for ovulation must relate to the changes
in their concentrations throughout the ovarian cycle. In women it
i3 believed that a primary follicle is stimulated to further growth
by rising concentrations of plasma FSH (and to a lesser extent LH)
which occur during the late luteal phase of the previous cycle, when
the secretion of oestradiol and progesterone from the regressing
corpus luteum cease3 (Ross et al.. 1970; Ross & Vande Wiele, 1974).
By the 6th or 7th day following the cmset of menstruation a
significant increase in plasma oestradiol is detectable and the
developing follicle is clearly established as the major source of
tbl3xst&B&ld (Baird & Fraser, 1974a). The rise in the secretion of
oestradiol inhibits FSH by negative feedback, so that the concentration
of this gonadotrophin in peripheral plasma falls progressively
(Midgely & Jaffe, 1968). Despite falling levels of FSH in plasma,
follicular maturation is probably unaffected since the rising
concentrations of oestradiol may enhance the sensitivity of the
follicle to FSH (Bradbury, 1961; Goldenberg, Vaitukaitis & Ross,
1972a). Moreover when the level of FSH in peripheral plasma ia
falling, that of LH is actually rising slightly. The reason for this
is obscure but it may be due to the differential sensitivity of the
hypothalamus and/or the anterior lobe of the pituitary to the
feedback effects of oestrogen. The secretion of FSH is more
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sensitive than that of LH to the negative feedback effect of
oestrogen in both men (Kulin & Reiter, 1972) and women (Cargille,
Vaitukaitis, Bermudez & Ross, 1973). The basal level of LH is
probably important for maintaining the secretion of oestrogen and
androstenedione by the theca cell3 of the follicle. In sheep, LH
is known to stimulate the production Of ©estradiol and androstenedione
by the follicle in vivo (Baird, Goding, Iehikawa & McCracken, 1968;
MeCracken, Uno, Goding, Ichikawa & Baird, 1969), and in vitro
(Moor, 1973). It would seem that a certain minimal concentration
of LH is probably required for steroidogenesis to occur in ovarian
cells.
During the mid to late follicular phase there is a marked
increase in the size of the largest Graafian follicle in both
women (Block, 1951a) and rhesus monkeys (Koering, 1969) at a time
when there is a sharp increase in the concentration of oestradiol
in plasma (Ross & Vande Wiele, 1974). These two events are
probably causally related since the exogenous administration of
oestradiol early in the menstrual cycle elicits a discharge of LH,
which results in either anovulation or a shortened luteal phase
probably because the follicle was not sufficiently mature (Tsai
& Yen, 1971; Vaitukaitis, Bermudez, Cargille, Lipsett & R033, 1971;
Cargille et al.t 1973). Thus as the follicle matures and the
secretion of oestradiol reaches between 200 and SOO^g per day the
cyclic centre in the hypothalamus is stimulated by positive feedback
(Harris & Naftolin, 1970) and the mid-cycle release of LH and FSH
occurs (Knobil, 1973). Although both progesterone (Swerdloff &
Odell, 1969; McCann, Kalra, Donoso, Bishfcp, Schneider, Fawcett &
Krulich, 1972; Leyendecker, Wardlaw & Nocke, 1972) and oestradiol
(Goding, Catt, Brown, Kaltenbach, Cumming & Mole, 1969; Taleisnik,
Caligaris & Astrada, 1969; Knobll et al., 1972; Leyendecker et al.,
1972) can elicit an acute release of LH, progesterone is unlikely to
be involved in the preovulatory 'surge' since its plasma concentrations
do not precede those of LH in women (Neill, Johansson, Datta & Knobil,
1967; Vande Wiele et al. . 1970; Thomas, Hertogh, Pizzaro, van Sxter
& Ferin, 1973), rhesus monkeys (Monroe, Atkinson & Knobil, 1970),
rats (Barraclough, Collu, Mass a • Martini, 1971) or sheep (A. G. Wheeler,
a. Land, D.T. Baird & H.J. Scaram izzi, unpublished observations) .
By contrast, the circulating levels of oestradiol clearly and
consistently rise several days before the initiation of the LH 'surge*
in women (Vande Wiele, et al,, 1970) and in the rhesus monkey
(Hotchkiss, Atkinson 8s Knobil, 1971) and the neutralisation of
circulating oestrogen with antisera to oestradiol effectively blocks
the LH 'surge' in both rats and rhesus monkeys (Ferin, Tempone,
Zimmering & Vande Wiele, 1969; Cowchock, Ferin, Dyrenfurth, Carmel,
Zimmerman, Brinson & Vande Wiele, 1971).
During the LH 'surge' in women the plasma levels of progesterone
rise (Johansson Wide, 1969; Vussman & Taymor, 1970; Thomas
et al., 1973) and this may have a role in facilitating the continued
discharge of LH (Leyendecker et al., 1972). High levels of progesterone
similar to those found during the luteal phase will however inhibit the
positive feedback of oestradiol (sheep, Godlng et al., 1969; monkey,
Diershke, Yamaji, Karsch, Weick, Weiss & Knobil, 1973; women,
Leyendecker et al., 1972). Knowledge is lacking with regard to the
possible effects of other ovarian steroids on the release of gonado-
trophins although preliminary evidence from the ewe suggests that
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androstenedione may influence the release of LH (Martensz,
Scaramuzzi, Van Look & Baird, 1975). The increased secretion
of androgens (Abraham, 1974) at mid cycle and during the luteal
phase may also be important for the maintenance of sexual libido
in primates (Everett & Herbert, 1971).
Although the rapidly maturing follicle dictates the timing
of the gonadotrophin discharge, it is the pituitary which i3 the
final regulator since high levels of LH terminate the secretion
of oestradiol (Moor, 1974) and initiate the production of progesterone
from the granulosa cells which are undergoing hypertrophy at this
time (Delforge et al., 1972).
The action of FSH and LH on the Graafian follicle until
recently remained obscure. studies of the uptake of biologically
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active iddine-labelled ( I) pituitary hormones, and measurement
of the rate of oxygen consumption following exogenous gonadotrophin
stimulation of the rat or pig have produced conflicting results.
Luteinizing hormone does net bind to orcine granulosa cells until
the immediate preovulatory stage (see Channing, 1975 for review)
although it is retained by the plasma membrane of the theca cells
in the rat (Rajaniemi, Hirschfield fe Midge&y, 1974; Hans,
Sajaniemi, Cho, Hirschfield & Midgely, 1974). By contrast, F3H
binds to granulosa cells in the rat but not to theca cells
("idgely, Zeleznik, iiajanierni, Richards & Reichert, 1973;
Zeloznik & Midgely, 1973). Paradoxically however, LH stimulates
oxygen consumption by rat granulosa cells, whilst FSH stimulates
consumption by the theca cells (Ahren, Bamberger & Rubinstein,
1963).
The role of prolactin in the control of follicular growth and
steroidogenesis remains uncertain (Knobil, 1973) although it has
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been known for some time that women with high plasma levels
of prolactin and apparently normal levels of LH and FSH
commonly have araenorrhoea (McNeilly, 1974). The reduction of
these high prolactin levels leads to the restoration of normal
menses; thus the possibility remains that prolactin has a
direct effect on the follicle, although most of the evidence is
against this (^ande Wiele, et al., 1970).
Much is known about the dynamics of follicluar growth and the
levels of hormones in plasma and urine throughout the menstrual
cycle, and yet we know very little about how the gonadotrophins
act on the follicle to prepare it for subsequent luteinization,
or indeed why only one follicle is selected for ovulation. Some
answers to these questions may be provided by examining the role
of the gonadotrophins within the follicular fluid of the developing
and regressing Graafian follicles. Furthermore, by relating the
steroidogenic potential of human granulosa cells in vitro to
a) the hormones which they were previously exposed to in follicular
fluid and b) those in peripheral plasma, it may be possible to
relate the maturation of the follicle to its endocrine environment.
The morphology of the corpus luteum
The corpus luteum is formed as a consequence of follicular
rupture. The newly formed corpus luteum is characterised by marked
vascularization of the granulosa cells and a considerable amount of
haemorrhage into the follicular cavity. Changes suggestive of
luteinization of the membrana granulosa can be demonstrated before
rupture of the follicle in women and these are almost certainly
induced by LH (White, Hertig, Hock & Adams, 1951; Hertig, 1967;
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Delforge et al.. 1972). During follicular rupture, whilst the
granulosa cells are undergoing hypertrophy, the theca cells are
degenerating quickly (Mossman & Duke, 1973a). However, within
three to five day3 the immediately adjacent stromal cells undergo
hypertrophy and form the paraluteal cells (the theca lutein cells
of human corpus luteura; Corner, 1956; Criap, Dessouky &
Denys, 197QS) The fine structure of the granulosa lutein cell
differs from that of the paraluteal cell in that they have a more
homogenous and electron-lucent nuclear matrix with more abundant
mitochondria, isolated Golgi complexes and granular and agranular
endoplasmic reticulum (Crisp et al.. 1970). The paraluteal cells
remain as a definitive cluster of cells around the periphery of the
gland and also in 'folds' or 'streaks* of tissue which have
penetrated deeply into the dispersed layers of granulosa lutein
cells, during follicular rupture. According to Corner (1956)
capillaries invade the granulosa and finally reach the cavity
between Days 2 and 4 after ovulation. A few mitoses are seen in
the granulosa and paraluteal cells before Day 4, but none afterwards.
Haemorrhage into the follicular cavity occurs regularly at ovulation
and again from Day 9 to menstruation. Capillary dilation reaches
a peak on Day 7 and thin walled venules appear along the border
of the antral cavity. By Day 8 the gland has reached its
secretory peak and a definitive connective tissue layer lines the
central cavity.
In 1911, Meyer described the human corpus luteura of the cycle
as 3howing 'full bloom' or maturity between the 8th and loth Day
following ovulation which probably covers the time when the
blastocyst implants (Harrison, 1962). During a non-pregnant cycle,
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cell shrinkage and vacuolation occurs from Days 9 to 12 and
degenerating nuclei are seen from Day 14. The subsequent rate
and degree of cellular degeneration is said to be variable (Corner,
1956). Degeneration of the corpus luteum results in a distinctive
corpus albicans which is composed of a dense 'cottony* ma3s of
very fine collagenous fibres with very few cells. In women the
functioning corpus luteum is red in colour and when regressing
the colour goes to pale yellow and then finally to white (Mossman &
Duke, 1973a).
Whilst there is no doubt as to the origin of the granulosa
lutein cell, there remains some controversy as to whether paraluteal
cells are derived from stromal cells incorporated into the tissue
folds as the follicle collapses following rupture, or whether they
are 'regenerated' theca interna cells which did not regress
completely during or just prior to follicular rupture (see review,
Mossinan & Duke, 1973b). According to Mossman & Duke, new luteal
cells commonly form from the undifferentiated thecal and stromal
cells immediately adjacent to the corpus luteum. These differentiating
cells are said to be the paraluteal cells, which can usually be seen
to be located centrally with the granulosa lutein cells and
peripherally with undifferentiated stromal cells.
The presence of the paraluteal cell in the human corpus luteum
may be of considerable importance since in the ewe (Harrison, 1948)
and cow (Hansel, Concannon & Lukaszewska, 1973) these cells are
much less prominent. This may account for the differences in the
biosynthetic potential of the corpus luteum between women and
sheep (Baird etal,, 1975).
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Steroid secretion by the corpu3 luteum
The human corpus luteum is almost unique amohgst mammals
in synthesizing and secreting androgens and oestrogens as well as
prostagens (Savard, March & Rice, 1965). At least 8 steroids,
pregnenolone, progesterone, 17o(-hydroxyprogesterone, dehydro-
epiandrostenedione, androstenedione, testosterone, oestrone and
oestradiol-17p have all been isolated and characterized as
conversion products following incubations of slices of human
corpora lutea in vitro with radioactively labelled acetate (Huang
& Pearlman, 1963; Savard et al., 1965). Although all eight
steroids have also been found in higher concentrations in ovarian
venous than in peripheral venous blood (Baird, 1971), the most
important secretory products appear to be progesterone,
androstenedione and oestradiol (Mikhail, 1970; Lloyd et al..
1971). The secretion of oestradiol by the corpus luteum is
responsible for the peak concentrations of this hormone in
plasma during the luteal phase of the menstrual cycle (Brown, 1971;
Abraham, 1974; Baird & Eraser, 1974a). As the corpus luteum
develops to full maturity about 8 days after ovulation there is a
marked rise in the secretion of both oestradiol (3 fold) and
progesterone ("* 20 fold) with a smaller ri3e in androstenedione
(1.5 fold) (Abraham, 1974).
The cellular origin of these steroids (paraluteal versus
granulosa lutein cells) is difficult to identify because of the
difficulty in separating these cell types from the intact gland.
Although theca cells from the Graafian follicle synthesize and
secrete virtually every steroid in the biochemical pathway from
pregnenolone to oestradiol in vitro, granulosa cells probably do
not secrete oestradiol (Ryan & Petro, 1966; Ryan et al.. 1968;
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Channing, 1970a); there is compelling evidence to suggest
that when both cell types are recombined there is a marked
quantitative increase in steroidogenesis (Hyan et al., 19G8).
These findings taken together with the 'two-cell-type' hypothesis
proposed by Short (1962a) suggest that the theca (or stroma)
and granulosa derived cells of the corpus luteum may each secrete
the same steroids as the isolated cells of the Graafian follicle
in vitro but there may be marked quantitative differences in
output.
It is of interest to compare the secretory products of the
human corpus luteum to those of the rhesus monkey and the ewe
3ince the mechanism of luteal regression in primates probably
differs from that in other mammals (Neill, Johansson & Knobil,
1969; Baird, 1973). The secretion of oestradiol by the corpus
luteura of the rhesus monkey must be small since there is a
relatively small peak in plasma during the luteal phase
(Hotchkiss et al.. 1971). Nevertheless it is significant that
in the rhesus monkey the concentration of oestradiol in ovarian
venous plasma draining the ovary containing the corpus luteum is
higher than on the contralateral side (Weiss, Dierschke, Karsh,
Hotchkiss, Butler & Knobil, 1973), indicating some secretion by the
corpus luteum. By contrast, the corpus luteum of the sheep does
not have the capacity to synthesise oestrogen when incubated
in vitro (Kaltenbach, Cook, Niswender & Nalbandov, 1967) and in
vitro it secretes only progesterone and 20oC-dlhydroprogesterone
(Short, 1964a; Baird, McCracken & Goding, 1973), It has been
clearly established in the sheep that the secretion of oestradiol
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and androsterti&ione throughout the luteal phase originates from
the Graafian follicles (Baird et al.. 1973). In addition the
secretion of oe3tradiol as measured by cannulating the utero-
ovarian vein in situ is not significantly different in the ovary
containing the corpus luteum to that from the contralateral
ovary (D. T. Baird & ft. J. Scaramuzzi; unpublished results).
Thus the pattern of steroid secretion by the human carpus
luteum i3 clearly different to that of the sheep. In the latter,
oestradiol originates entirely from the Graafian follicle with the
corpus luteum secreting progestins while during the luteal phase
in women the follicle makes insignificant contributions to the
total ovarian secretion ctf oestradiol, over 90& of which originates
from the corpus luteum (Baird & Fraser, 1974a).
Although there are now numerous descriptive accounts of the
changing hormone levels in blood and urine throughout the menstrual
cycle, we still do not really understand which factors are
responsible for the maintenance of the corpus luteum in women. This
is an area of great potential interest for the development of new
forms of contraception. Luteinizing hormone and prolactin together
constitute at least part of the luteotrophin complex necessary for
the maintenance and secretory activity of the corpus luteum in the
rat (vans, Simpson, Lyons & Turpeinen, 1941; A3twood, 1941),
mouse (Kovacic, 1964), rabbit (Spies, Milliard & Sawyer, 1968),
hamster (Greenwald & ftothchild, 1968), ferret (Donovan, 1963),
pig (Du Mensil du Buisson, 1973) and sheep (Denamur, Martinet &
Short, 1973). Recent evidence suggests however, that prolactin
may have little to do with luteal function in women (Dyrenfurth
et al.. 1970; Huang, Guyda & Friesen, 1971; Midgley & Jaffe,
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1972; McNeilly, Evans & Chard, 1973; Robyn, Delvoye, Nokin,
Vekemans, Badawi, Perez-Lopez & L'Hermite, 1973; Tyson &
Friesen, 1973). Perhaps the most convincing argument against
the involvement of prolactin in luteal function is that in
hypophyseCtomized women the corpus luteum can be maintained
with LH alone (Vande Wiele et_al., 1970), Nevertheless in
this 3tudy the levels of prolactin in plasma were not determined
and since it is virtually impossible to remove all the pars
tuberalis in women (Purves, 1966; Daniel & Prichard, 1972)
it is likely that significant levels of prolactin remained in
plasma. Thus it is still possible that prolactin could play
a 'permissive' role as in other species, where alterations in
circulating prolactin levels within limits, have little effect
on luteal activity.
It is also generally assumed that during follicular rupture
and corpus luteum formation, F3H is not required for either the
initiation or maintenance of steroidogenesis (see Nalbandov, 1973
for review). It has been strongly suggested that F5H is involved
in the formation of receptors for LH as the granulosa cells mature
within the developing follicle (Channing, 1975; Zeleznik, Mldgley
& Reichert, 1974) although conclusive evidence is still required.
Nevertheless during a fertile cycle when it is presumed that the
corpus luteum is required to function for longer than 12 days it
is essential that receptors for LH or human chorionic gonadotrophin
(HCG) are maintained. Thus like prolactin FSH may have a 'permissive'
role in luteal maintenance. It is suggested that until conclusive
proof is demonstrated for the integrity of corpus luteum function
in the total absence of a pituitary gonadotrophin it is probably
safer to infer that all three gonadotropins are required, as
has been demonstrated in the hamster (Greenwald & Kothchild, 1968).
The demise of the human corpus luteum during the non-fertile menstrual
cycle.
It is somewhat surprising to find that we still do not know how
the human corpus luteum regresses during a non-fertile menstrual
cycle (see review by Short, 1972a); it is not known whether there is
a luteolytic substance, or indeed how it might act. To have control
over the life-span of the corpus luteum is of considerable interest
since it opens up new possibilities of fertility control.
It has been suggested that the luteolytic substance in women
may well be prostaglandin F2et(PGF2rt) (Baird, 1973; >owell,
Hammarstrom &. Sammuelsson, 1974a) and that it is produced locally
within the corpus luteum rather than in the uterus as is the case in
the ewe (Wiltbank & Casida, 19S6; Goding, 1974), High concentrations
of FGF2cX have in fact been found in the ovaries of rhesus monkeys
(Wilks, Forbes & Norland, 1972). Although women appear to have a
different pattern of venous drainage (Goding, Cumining, Chamley,
Brown, Cain, Cerini, Findlay, O'Shea & Femberton, 1972; Ginther,
Diershke, Walsh & del Campo, 1974) when compared to the sheep
(Dobrowolski & Hafez, 1970) the utero-ovarian vasculature is not
entirely incompatible with a uterine luteolytic substance. Nevertheless
there is convincing evidence to suggest that the luteolytic substance
in women does not originate from the uterus or other mullerian duct
tissue since hysterectomy or the congenital absence of uterus,
Fallopian tubes and vagina does not prolong the life of the corpus
luteum (Whitelaw, 1958; Brown, Keller & Mathew, 1909; Beavis,
Brown & Smith, 1969; MacKae & Mohammedally, 1969; Beling, Marcus &
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Markam, 1970; Doyle, Barclay, Duncan & Kirton, 1971;
Fraser, Baird, Hobson, Wlchie & Hunter, 1973). It is difficult
to imagine how the release of prostaglandins which are present
in high concentrations in the endometrial lining of the uteru3
(Pickles, 1957; Downie, Poyser & Wunderlich, 1974) can continue
to be released into the uterine vein during the late luteal phase
when 'sloughing' of the endometrium is taking place. There is
circumstantial evidence to suggest that oestrogen has an
important role in controlling the life span of the corpus luteum
in women (iiivera & shearman, 1969), wheep (Nalbandov, 1973) and
the rat (Christiansen, Keyes & Armstrong, 1970) since X-irradiation
of the ovary at a dose which destroys Graafian follicles and
perhaps also the theca-lutein cells of the human corpus luteura,
removes the source of oestrogen and prolongs the life of the
corpus luteum. By contrast, implantation of oestrogenic substances
into the ovary containing a corpus luteum in women (Hoffman, 1960)
or to either ovary in the ewe (Cook, Karsch, Foster & Nalbandov,
1973) during the mid-luteal phase significantly shortens the length
of the luteal phase.
It is of interest to examine the experimental data from the
sheep more closely to see how oe3tradiol can influence the life
span of the corpus luteum, because in the ewe, oestradiol originates
from developing follicles but in women during the luteal phase it
originates from the corpus luteum. Oestrogen can release significant
amounts of PGF2«( from the uterus in sheep (Caldwell, Tillson, Brock &
Speroff, 1972; Scaramuzzi, Boyle, Wheeler, Land & Baird, 1974)
although the uterus has to be primed with progesterone before
the maximum effect is seen (Caldwell et al.. 1S72; .^caramuzzi
etal,, 1974). In the ewe there is a 2 to 5 fold increase in the
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concentration of 1 GF2c< in utero-venous plasma on Days 12-13
when Progesterone starts to decline (Baird & aoaramuzzi, 1975);
this prostaglandin secretion is presumably a consequence of
progesterone priming of the uterus. By Days 15 to 16 there is
a dramatic rise in utero-ovarian concentrations of both oestradiol
(5-fold) and PGF2e< (10-fold) and these events appear to be
causally related (Scarainuzzi, et al.. 1974; Baird & Dcaramuzzi,
1975). Although the falling levels of progesterone are
accompanied by some structural changes in luteal cells from Day 13
onwards (Deane, Hay, Moor, Rowson & Short, 1966; Bjersing, Hay,
Moor, Short & Deane, 1970), functional regression can still be
halted by hysterectomy (i.e. removal of PGF2eO as late as Day 15
(Moor, Hay, Short & Rowson, 1970). Thus it appears that
functional regression occurs prior to structural degeneration of
the gland. It is probably the massive amount of FGF2e<, released
as a consequence of rising levels of oestradiol from the developing
Graafian follicles, which induces the final irreversible
morphological and functional demise of the ovine corpus luteum.
Thus in the ewe, the progesterone from the corpus luteum and
oestradiol from the developing follicles influence both the
synthesis and release of uterine prostaglandins which in turn
induces luteal regression. There is convincing experimental
evidence to suggest that in sheep the uterine prostaglandins act
cm the corpus luteum by travelling directly to the ovary via the
utero-ovarian vein and ovarian artery (see review by Baird &
Scaramuzzi, 1975). Transplantation of the ovary in the sheep to
the neck, leaving the uterus in the abdomen results in luteal
maintenance, whilst transplantation of the ovary and uterus
together to the neck results in normal luteal regression
39.
(McCracken, Caldwell, Tiligon, Thorneycroft & icarainuzzi, 1969).
Thi3 suggests that prostaglandins are unlikely to be sufficiently
concentrated and/or able to survive long enough in the peripheral
circulation to exert its effect. The most convincing evidence
to support these results is that peripheral infusion of PGF2<*
even at extremely high doses are unable to cause luteal regression
in sheep (McCracken, 1971). The negative results with systemic
infusions of PGF2<x could therefore be attributed partly to a
dilution effect and partly to the rapid metabolism of PGF2<*
in blood and especially by the lungs (Piper, Vane & Wyllie, 1970;
Granstrom, 1972). It i3 perhaps not surprising therefore to
find that attempts to induce luteal regression in women by short-
term intravenous infusions have been unsuccessful (Hillier, Dutton,
Corker, Singer & Embrey, 1972; Jones & 'Worstz, 1972; Jewelewicz,
Cantor, Dyrenfurth, Warren & Vande ftiele, 1972; Lehraen, Peters,
Breckwoldt & Bettendorf, 1972; Le Maire & Shapiro, 1972; Wentz
& Jones, 1973). It is also possible that the human corpus luteum
is refractory tb the luteolytic effects of PGF2<< during much of
its life as is the case in the pig (C. Polge, personal
communication). Although PGE2 is used as a therapeutic abortifacient
in women (see Csapo, 1974) it i3 unlikely to be the luteolytic
hormone since it has been shown to mimic the actions of trophic
hormones in both primate and non-primate ovarian tissue.
Prostaglandin E2 stimulates the production of progesterone by the
human corpus luteum (March & Le Maire, 1974), bovine corpus luteum
(Speroff & Ramwell, 1970), rat follicle (Lindner et al.. 1974),
mouse follicle (Neal, Baker, McNatty & Scaramuzzi, 1973) and also
monkey and porcine granulosa cells (Charming & Crisp, 1972; Kolena &
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Channing, 1972).
The human and ovine corpora lutea have plasma membrane
receptors for PGF2<* (1 owell et al., 1974a, b), however the human
corpus luteum unlike the 3heep secretes both oestradiol and
progesterone. Thus the most attractive working hypothesis to
explain luteal regression in women is that progesterone and
oestradiol produced within the corpus luteum induces PGF2«'
production by the corpus luteum, which in turn causes luteolysis.
The exact mechanism by which PGF2o< exerts its lytic effect in
non-primates is obscure, although several have been postulated,
including vascular effects. One suggestion wa3 that PGF3°< caused
a constriction of the utero-ovarian vein which reduced the ovarian
flow and thus luteolysis was a consequence of anoxia (Pharris, 1970).
However many experiments have now shown that luteolysis does not
arise as a result of reduced total ovarian Blood flow (Baird,
1974b; Bruce & Hillier, 1974; Jansen, Albrecht & Ahren, 1975) and
Jan3en et al.. (1975) have shown that the observed reduction in
ovarian blood flow following PGF2<*' administration is probably an
artifact resulting from a concomitant fall in systemic arterial
pressure. It has also been suggested that VGP2o( may cause a
vascular redistribution within the ovary, with selective reduction
in blood flow to the corpus luteum and a subsequent increase in
blood flow to the follicles and interstial tissue (Jansen et al., 1975).
Thus i GF2o< would still produce luteolysis by anoxia, although
simultaneously, follicular development would be enhanced by the
increased blood flow. Vascular theories became particularly
attractive when it was found that TGF2X actually stimulated the
secretion of luteal tissue in vitro (Speroff & Hamwell, 1970;
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Behrman, Yoshinaga & Greep, 1971a) thus seeming to rule out the
possibility of a direct luteolytic action on the luteal cell.
Although some kind of vascular effect, such as vascular
redistribution within the ovary still seems plausable, there are
now convincing reports of PGF2e< inhibiting the secretion of
progesterone by luteal tissue in vitro (Caldwell, Auletta,
Gordon & Speroff, 1972; O'Grady, Sohorn, Glass, Caldwell,
Brock & Speroff, 1972).
Granulosa cell3 harvested from large Graafian follicles ju3t
prior to ovulation undergo hypertrophy and secrete large amounts of
progesterone in culture (see Channing, 1970a). Furthermore these
cells display a fine structure similar to the granulosa lutein cells
of the corpus luteum (Crisp & Channing, 1972). By contrast cells
harvested from small Graafian follicles do not secrete much
progesterone (see Channing, 1970a) and retain a fine structure similar
to follicular cells (Crisp & Channing, 1972). Thus human granulosa
cells of differing steroidogenic potentials when cultured in vitro
would provide a simple in vitro biochemical model with which to
examine the effects of PGF2c< and PGE2 on the human corpus luteum.
The mechanism of hormone action in relation to ovarian steroid secretion
The mechanism of hormone action appears to be initiated by the
selective binding of the hormone to a specific receptor in the target
cell, either in the membrane or some other part of the cell. The
binding of pituitary hormones to plasma membrane receptors has been
discussed previously. In terms of ovarian steroid secretion, the
interaction of LH with the granulosa-derived luteal cell is perhaps
the best understood, although our knowledge is far from complete
(Lee & Ryan, 1971; Channing, 1975). Following the preovulatory
surge, LH binds to its plasma membrane receptors on the granulosa
cells (Channing & Kaxomerman, 1973a; Channing, 1975; Channing &
Tsafriri, 1975) which become saturated with this gonadotrophin,
and morphological and functionalluteinization ensue. The
steroidogenic response to LH is mediated indirectly by the
activation of the adenylate cyclase system (Savard et al., 1965;
Dorrington & Kilpatrick, 1967) in the cell membrane to produce the
"second messenger", adenosine 3*, 5' cyclic monophosphate (C-AMP),
an activation system common to many hormones such as ACTH, glucagon,
vasopressin, catecholamines and some prostaglandins, e.g. PGE2;
(Marsh, 1371; Hobison, Butcher & Sutherland, 1971). Although each
of these hormones can activate adenylate cyclase, specificity of
response depends on the existence of a specific plasma membrane
receptor for each hormone, and the final effect produced by the
C-AMP is dependent upon the cell type, i.e. a granulosa lutein cell
will secrete progesterone whereas lipolysis will be induced in
adipose tissue. The morphological changes occurring on luteinization
are probably also mediated by C-AMP, since Channing has shown that
the addition of C-AMF (or the dibutryl derivative, DBC) to cultures
of porcine and monkey granulosa cells stimulates both morphological
luteinization and progesterone secretion (Channing & Seymour, 1970;
Channing, 1970a).
It has been sh$«n that C-AMP interacts with a protein receptor
consisting of two components, (a) a regulatory unit (Ft) to which
C-AMP binds and (b) a catalytic unit (c) which has protein kinase
(P.K.) activity (Garren, Gill, Masui & Walton, 1971), see Fig. la.
Should the stimulation of adenylate cyclase cease, the intracellular
pool of C-AMP will be rapidly depleted, since its conversion to C-AMP
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Fig. 1. A simplified model showing how C-AMP effects protein kinase
activity.
involves a large free energy change due to the highly strained and
unstable ring structure of C-AMP, combined with the fact that
phosphodiesterase activity is limited only by the availability of
substrate. Thus when C-AMF is depleted, protein kinase activity
is also depleted (see Fig. lb).
The C-AMF dependent protein kinases are non-specific
phosphorylators (Krebs, 1972). They can phosphorylote particular
protein components of the nucleoprotein complex, and in so doing
can probably produce a local disruption within the complex which
allows new regions of DNA to be exposed to the transcription
machinery, resulting in new m-RNA, and hence new protein (Langan,
1968). Cyclic-Ain dependent protein kinases can also phosphorylate
many different enzymes and in so doing, modify their activity
(Krebs, 1972). In this respect, the most important enzyme in the
luteal cell is cholesteryl esterase. From studies on the bovine
adrenal cortex a C-AMP dependent protein kinase is capable of
phosphorylating an inactive form of the cholesteryl esterase and
converting it into an active form (Trzeciak & Boyd, 1974). It is
reasonable therefore to assume that the luteal cell cholesteryl
esterase is also capable of being phosphorylated by a C-AM} dependent
protein kinase to produce an active form which will then convert the
cholesterol ester, stored in lipid droplets (Claesson, 1954) into
free cholesterol which on entering the mitochondria is readily
metabolised to progesterone. Should protein kinase activity diminish
due to C-AMP depletion, then a phosphatase enzyme which has been found
in all tissues containing a C-AMP protein kinase (Krebs, 1972), will
reconvert the cholesteryl esterase to its original, non-phosphorylated
inactive form, and the consequence is a rapid reduction in progesterone
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synthesis by the luteal call. However mammalian m-RNA is very
stable (Gelehrter, 1971), and the disappearance of C-AMF will
not immediately effect the production of the new proteins induced by
phosphorylation of the nucleoprotein complex. The biochemical
mechanism of luteinization is suramaried in Fig. 2, where it can be
seen that C-Alfr can also stimulate the conversion of cholesterol
to pregnenolone by inducing the synthesis of a protein with a rapid
turnover rate, which is probably involved in the supply of
cholesterol to the metabolic enzyme systems in the mitochondria
(Hermier, Combarnous & Jutisz, 1971).
The role of FSH in functional or structural luteinization is
largely unknown. This is probably because some difficulty has been
experienced in tagging a radioactive label to FSH without destroying
its biological activity. It appears that K3H is more readily bound
to granulosa cells within small Graafian follicles than to those which
are more mature (Rajaniemi & Vanha- ertulla, 1972). It has also
been suggested that FBH may have a fundamental role in protecting
granulosa cells from undergoing atresia (Peters et al.. 1375)
although the mechanism involved is obscure. The possibility of
FSH involvement in the formation of receptors for LH has been
discussed previously.
There is evidence to suggest that both LH and prolactin control
the ovarian enzymes, cholesterol ester synthetase and esterase
(Behrman « Armstrong, 1969; Behrman, Orczyk, MacDonald & Greep,
1970). These enzymes are maintained by prolactin and the esterase
is activated by LH (3ee Greep, 1971). The implication i3 that
prolactin may have an essential role in ovarian steroidogenesis;



















Fig. 2. The role of C-AMP in structural and functional
luteinization
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Oestrogen enhances the secretion of progesterone by
luteinizing granulosa cells in tissue culture (Goldenberg, Bridsan
& Kohler, 1972b); the stimulatory action is blocked by inhibitors
of protein synthesis. Studies in the rat adrenal suggest that
oestrogen may be involved in the synthesis of enzymes involved in
steroidogenesis (Purvis, Canick, Mason, Estabrook, McCarthy, 1973).
It has been postulated that prostaglandin E2 (PGE2) may mediate
the action of LH on cyclic AMP (Kuehl, Humes, Tarnoff, Cirillo &
Ham, 1970), 3ince prostaglandin antagonists block the actions of
both prostaglandin and LH. However the actions of LH plus PGE2
on luteal tissue, Graafian follicles and isolated granulosa cells
have subsequently been found to be additive; thus it appears
unlikely that prostaglandins play the role of an intermediate between
the membrane effect of LH and C-AMF formation, (Marsh, 1971;
Kolena & Channing, 1972; Jonsson, Shelton & Baggett, 1972; Herlitz
& Rosberg, 1973; Lindner et al.. 1974; Moor et al., 1975).
Nevertheless PGE2 ha3 a specific plasma membrane receptor (Rao, 1973)
and it activates the adenylate cyclase system (Marsh, 1971) yet its
role in the physiological control of ovarian steroidogenesis remains
obscure.
Granulosa cells in tissue culture
Granulosa cells can readily be obtained from Graafian follicles
as a dispersed cell suspension without the need for chemical or
enzymatic treatment. Granulosa cells have been used extensively
in vitro to investigate various aspects of ovarian steroidogenesis
(Bjersing, B62; Bjersing & Carstensen, 1964, 1967; Ryan & Short,
1965, 1966; Channing, 1966, 1969a, b, c, 1970a, b, c, d; Ryan &
Petro, 1966; Ryan et al.. 1968; Goldenberg, Bridson & Kohler, 1972b;
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Merk, Botticelli & Albright, 1972; Shirley & Stevenson, 1973;
Challis, Erickson & Ryan, 1974; Seamark, Moor & Mcintosh, 1974),
However very limited use ha3 been made of this technique for studies
on ovarian steroid secretion in women (Channing, Butt & Crooke,
1968; Channing, 1969a).
It is often assumed incorrectly that granulosa cells
'spontaneously' luteinize in vitro and consequently do not reflect
the activities of the cell in vivo. Studies on granulosa cells
from women, rhesus monkeys and mares have shown clearly that
morphological and functional luteinization can only occur
'spontaneously* when the cells are harvested from large preovulatory
follicles or after the cells are stimulated with gonadotropins,
C-AMP or PGE2 in culture (Channing, 1970a; Channing & Crisp, 1372).
Even to say that luteinization is 'spontaneous' is probably
misleading since there is now evidence from women, rhesus monkeys
and sheep to suggest that the initiation of luteinization occurs in. »
vivo following the mid-cycle LH 3urge but prior to follicular
rupture (Neill, Johansson & Knobil, 1967; Baird et al.t 1975;
A. G. Wheeler, ft. B. Land, D.T. Baird, R. J. Scaramuzzi, unpublished
data). Thus granulosa cells from large preovulatory follicles are
probably undergoing hypertrophy and secretory changes prior to
collection. By contrast cells harvested from smaller follicles do
not undergo morphological and functional luteinization in vitro,
unless stimulated in culture with either gonadotrophins, C-AMP or
PGE2. Granulosa cells were said to luteinize in culture when they
increased in size, accumulated eosinophilic granules and lipid
droplets in the cytoplasm and secreted large amounts of progesterone
(Channing, 1970a). However it is difficult to assess morphological
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luteinization in cultured cells by light microscopy, since the
degree of cellular enlargement may be related to the density of
the cell suspension growing on the coverslips (Erickson at al..
1974; Challis, personal communication). Nevertheless the validity
of granulosa cells in tissue culture as a model for ovarian function
in vivo was further enhanced by the electron microscopy studies of
Crisp & Channing (1972); these authors found that the fine
structural appearance of granulosa cells after tissue culture was
similar to those found in vivo.
Incubations of isolated granulosa cell suspensions with radio¬
active precursors of steroid hormones (e.g. Kyan et al.t 1968)
provides information as to which enzymes are present but tells us
little about which are the important ones in vivo. In a study
whero granulosa cells and Graafian follicles were cultured in vitro,
and their secretions were compared to those which occurred in vivo
it is abundantly clear that the qualitative pattern of steroidogenesis
by the granulosa cells in vitro is similar to that occurring in vivo
(Seamark et al.. 1974). It has al3o become clear that the
steroidogenic capacity of granulosa cell3 in culture is markedly
influenced by the endocrine environment that they were subjected to
prior to harvesting and to the hormonal environment in which they
were cultured (Channing, 1970a; Seamark et al., 1974). In addition
isolated granulosa cells appear to retain their biosynthetic capacity
and also their morphological integrity for at least 16 days in tissue
culture (Channing, 1969a).
The fact that the steroidogenic potential of these cells is
influenced by their previous hormonal environment provides an ideal
way of assessing the degree of maturation a follicle has achieved
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at the time of cell harvest. It would be of interest therefore
to measure the hormone levels in follicular fluid and
to culture granulosa cell3 from individual follicles. By
comparing the hormone level3 in plasma to those in follicular
fluid it may be possible to determine which hormones influence
the biosynthetic potential of the granulsa cells in culture.
Ideally an in vitro technique provides a method for culturing
cells in an environment devoid of gonadotrophin. In practice
this is difficult to achieve since a minimal volume of serum
(5 to 20%, v/v) is normally required to maintain the viability of
cell3 in culture (C. P. Channing, personal communication, but see
also Channing, 1975). From a physiological point of view this is
not inconvenient since granulosa cells are previously exposed to
follicular fluid which contains most serum proteins (see Edwards,
1974, for review). However to examine whether granulosa cells
require a certain gonadotrophin for steroidogenesis or to remain
viable the problem remains as to how to remove the endogenous
gonadotrophin(s) from the culture medium. Three methods of
preparing such a culture medium are possible. The first method i3
to culture cells in a medium containing serum collected from patients
who have been hypophysectomized or who have had some type of
treatment to suppress pituitary function. However the search for a
serum totally devoid of gonadotrophins has thus far been unrewarding
M. hunter, A. j. f.icNeilly, personal communication). A second
possibility involves neutralising the endogenous gonddotrophic
activity in culture medium by adding an excess of a highly specific anti¬
serum. This technique has been widely used in vivo and in vitro
(Ahren, Herlitz, Nilsson, Perklev, Hosberg, & -ielstam, 1973; Laurence
& Hassouna, 1973; Koch, Zor, lomerantz, Chobsieng & Lindner, 1974;
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Lindner et al.. 1974). The concentration of gonadotrophin in culture
medium can be measured both before and after treatment since the
antibody-antigen complex can be absorbed out at the end of culture
using a solid phase second antibody. The third possibility is to
incubate the culture medium plus serum with excess antibody, then
remove the antibody-antigen complex prior to tissue culture. Thus,
at least two possible techniques could provide a method for
investigating the dependence of granulosa cells on trophic hormone.
The scope of the in vitro culture system could also be extended
to investigate some aspects of luteal function in women. Human
granulosa cells harvested from large preovulatory follicles undergo
hypertrophy and secrete large amounts of progesterone in vitro
(Channing, 1969a); these cells are probably similar to the granulosa
derived cells of the corpus luteum since preovulatory cells from the
rhesus monkey have a fine structure after culture which is similar to
that found in the luteal cell (Crisp & Channing, 1972). Thus the
role of LH, FSH and prolactin together with those of the prostaglandins
on luteal function in women could be investigated using this simple
in vitro system.
What then are the disadvantages of in vitro culture? The
cells are removed from an avascular environment and also from any
further contact with the thfcca cells, the oocyte and transudates of
plasma which appear in follicular fluid. Thus any physiological
interpretations based on results obtained from in vitro culture must
be related to in vivo histological, histochemical and endocrine
data. At the present time there is a lack of information regarding
the production of steroids after perfusion of human ovarian tissue
or dispersed cell types in vitro. This is rather unfortunate since
an important limitation of any static in vitro culture system is that
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it may well be a rate limiting system because any increase in
steroidogenesis (as a consequence of C-AMP production), is
accompanied by a rise in phosphodiesterase activity which in turn
may limit the rate of steroidogenesis (Channing, 1970a). However
from in vitro studies using whole sheep follicles no clear differences
in steroid production were observed when the culture medium was
changed daily instead of every 3 days (Moor, 1973). In addition
the daily production of steroid into culture medium can be comparable
to that achieved in vivo (Moor, 1973). Thus provided the nutrient
supply is adequate it appears that steroid production in vitro is
not seriously handicapped by the static nature of the system.
A suitable method for confirming the validity of the In vitro
tissue culture system for use as a model for investigating various
aspects of ovarian steroidogenesis, is to compare the 24h secretion
from ovarian tissue in vitro to that which occurs in vivo. This
method requires knowledge of the 24h production rate of steroid both
in vivo and in vitro and in addition an estimate of the number of
cells both in the gland and in culture if a dispersed cell culture
technique is used. Despite the widespread use of tissue and cell
culture techniques, only Moor (1973) and Seamark et al., (1974)
using an organ culture technique have compared the production of
steroid in vitro with that occurring in vivo. In most studies
, employing isolated cell culture techniques the number of cells
present either before, during or at the end of culture were not
deter ined. This is particularly regrettable 3ince there is no way
in which a retrospective study on most of the published data can be
made in order to determine whether the secretion rates achieved in
vitro are comparable to those achieved in vivo. However, in one
study where cell numbers were determined (Channing, 1969a) showed
that human granulosa cells when cultured as a monolayer, after
being harvested from a preovulatory follicle, secreted about
5 pg of progesterone per cell each day (5 pg/cell/day). The
preovulatory follicle or newly formed corpus luteum contains
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between 2 X 10 and i k 10 granulosa cells (K. P. McNatty &
D. K. Green, unpublished observations). Thus if all the
luteinizing granulosa cells of the preovulatory follicle or of
the newly formed corpus luteum were cultured in vitro their
total secretion of progesterone would have been between 1 and
5 mg per day. In vivo, the production rate (PR) of progesterone
can be calculated from the equation PR = MCR X c where the metabolic
clearance rate (MCR) reflects the rate of metabolism of the hormone,
c is the concotration of the hormone in peripheral blood and Pit is
the rate at which the hormone is introduced de novo into the systemic
circulation (Tait & Burstein, 1964). The MCR in women is 2,200 litres?
day (Tagatz & Gurpide, 1973) and in plasma the concentration of
progesterone is about 2 ng/ml or 2^g/litre during the very late
follicular phase of the menstrual cycle (Johansson & Wide, 1969);
thus the PR is 4.4 mg/day. Since more than 80% of the progesterone
during the late follicular phase is secreted by the ovaries
(D. T. Raird, personal communication), the PR is a close estimate
of the total ovarian secretion of progesterone. Therefore a
secretion of progesterone of 5 pg/cell/day in vitro closely correlates
to the estimated secretion rate/cell in vivo. Since these estimates
are based on the total number of granulosa-lutein cells in vivo
they provide further evidence to suggest that most if not all of
the progesterone from the preovulatory follicle or newly formed
corpus luteum originates from the granulosa cells. The Pil of
progesterone during the mid-luteal phase is about 25 mg/day which is,
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if no cell mitoses has taken place, 5 times higher than the
amount of progesterone luteinized granulosa cells can secrete in
vitro. Thus the marked increase in progesterone secretion during
the raid-luteal phase, which is probably in excess of any increase
in cell mitoses (Corner, 1956), may well be due to the presence of
the two cell types in the corpus luteum, i.e. the granulosa and
theca-lutein cells (Ryan et al.. 1968). Alternatively, it may be
that granulosa cells are not fully matured as steroid secreting cells
until the mid-luteal phase of the menstrual cycle.
Interpretation of data obtained U3ing luteinized granulosa cells
as an in vitro model of human corpus luteum function probably requires
the greatest caution because this gland consists of two cell types. In
addition, the role of the vascular system in both the regulation of
steroidogenesis by, and regression of, the corpus luteum cannot be
discounted. However the absence of a vascular system can also be an
advantage when examining the biochemical effects of prostaglandins on
the luteal cell.
There are considerable ethical advantages in studying certain
aspects of ovarian ateroid secretion in women with an in vitro system.
The results can provide information which is otherwise impossible
or unethical to obtain; thia information can complement that obtained
from clinical or experimental studies on human volunteers. Further
knowledge concerning the control of human ovwiian steroid secretion is
urgently required in order to develop new and more acceptable,
methods of contraception.
The 3cope and aim3 of studies undertaken
The experiments described in this thesis were all canled out
using human material. Intact ovaries or ovarian wedge biopsies,
endometria and peripheral blood samples were obtained from women
55.
Caged 21 - 52 years) who were at varying stages of the menstrual
cycle and undergoing hysterectomy for various gynaecological
conditions. Intact Graafian follicles were dissected from the
ovarian specimens: the follicular fluid was aspirated for hormone
assay and the granulosa cells harvested for culturing in vitro.
The concentrations of follicle-stimulating hormone (FSH),
luteinizing hormone (LH), the* and p subunits of LH (LHand LHp ),
prolactin, progesterone, oestradiol-17p and andro3tenedione in
peripheral plasma and follicular fluid were determined by various
specific radioimmunoassays. In addition, the concentration of
testosterone was measured in follicular fluid. Histological sections
were prepared from Graafian follicles and corpora lutea at differing
stages of the raanstrual cycle. The steroidogenic potential, mitotic
activity and viability of granulosa cells were examined after they
were cultured in media containing varying amounts of pituitary
6 2
hormone, the subunits of Lli, oestradiol, prostaglandins, N, O -
dibutryl adenosine 3',5'-cyclic monophosphate (DBG) or serum from
patients with Addison's disease and premature ovarian failure.
It was hoped that the results of these studies could be
integrated to provide new information ant- a) the importance of
the endocrine microenvironment of the follicle in preparing its
granulosa cells for their subsequent secretory activity in the corpus
luteum; b) how a follicle is selected for ovulation; and c) on
the factors influencing the maintenance and the regression of the





One hundred and sixty five women (aged 21 - 48 years) who
were at varying stages of the menstrual cycle were undergoing
hysterectomy for various gynaecological conditions. The indications
for surgery were stage 0 carcinoma of the cervix, (22 patients),
menorrhagia due to fibroids (52), dy3furictianal uterine bleeding (10),
endometriosis (15), or chronic pelvic pains or dysmenorrhoea (66).
Those with stage 0 carcinoma of the cervix had regular menstrual
cycles (21 - 32 days) and were considered to be endocrinologically
normal (Raird & Fraser, 1974a). The previous menstrual cycles of
the group with menorrhagia varied in length from 21-34 days and
about 407« of these subjects had ovulated in the cycle under study,
as indicated by the presence of a secretory endometrium and of at
lea3t one corpus luteum at the time of the operation. The remaining
subjects were in the proliferative phase as assessed by their endo¬
metrial histology and date of the last menstrual period. Full
details relating to the clinical histories of all the patients are
shown in Appendix 1 and a summary of thi3 data is shown in Table 1.
Dating the Menstrual Cycle
An endometrial biopsy and a peripheral blood sample (15 - 20 ml
collected before oophorectomy) were obtained during the operation.
The endometrium was examined histologically and dated according to the
criteria of Noyes, Hertig & Rock (1950). The stage of the menstrual
cycle was assessed in all subjects from:- (a) the date of the last
menstrual period; (b) the concentrations in plasma of LH, F.SH,
oe3tradiol and progesterone; (c) endometrial histology; and
(d) the presence or absence of a corpus luteum. The menstrual cycle
was divided into six phases: early follicular, still menstruating,(EF);












































































































































































luteal (ML) and late luteal (LL).
Ovarian morphology
Ovaries were examined in situ to assess gross morphology and
to record the presence or absence of a corpus luteum. In some cases
histological sections of the excised ovaries were examined by light
microscopy after removal of the Graafian follicles to ascertain that
no major ovarian pathology existed.
Collection of follicular fluid
The follicular fluid which was analysed for pituitary and steroid
hormones was obtained from the ovaries of the women described above.
Two different methods were used for the collection of the fluid.
In 23 subjects, antral fluid was aspirated from 36 Graafian follicles
through a 23G needle into a syringe during surgery. For technical
reasons it was not possible to measure the size of these follicles
accurately, consequently they were classified as large (^.8 mm) or
small (< 8 mm).
In 142 subjects, ovarian specimens (whole ovaries or wedge biopsies)
were collected into chilled media (Medium 199 containing Hank's
salts and HE*-£3* buffer (20m. ), gentamicin (50^g/ral), amphotericin-B
(2.5^g/ml),(Flow Laboratories, Irvine, Scotland)) and all follicles
which were ^ 4 mm diameter (238) were dissected out within 2h of
surgery. The diameter of each isolated follicle was measured and
the aaAiral fluid aspirated through a 27G needle into a 550^1 hamilton
o
syringe. Fluid collected by either method was frozen at -20 until
assayed. No attempt was made to recover the oocyte from the follicular
fluid. Follicles without a lining of granulosa cells, irrespective
♦HEI ES: N-2-ifydroxyethylpiperazine N^-E-ethanesulphonic acid.
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of size were defined as *cystic'. Subsequent data reported
for the cystic follicles are considered separately from those
obtained for normal follicles.
Technique for culturing granulosa cells
The method of collecting and culturing human granulosa cells
was a modification of that described by Channlng (1969a). The
granulosa cells were harvested from each of the follicles and each
culture chamber contained cells from individual follicles. The
only exception to this procedure was adopted in the experiment
described in Chapter 9, where, in many cases cells from different
follicles were pooled to provide the large number of cultures
required. The collapsed follicle (after removal of the follicular
fluid) was slit open and the granulosa cells scraped into culture
medium using a platinum loop. The remainder of the follicle was
fixed in Bouin*s aqueous fixative for subsequent histological
examination to ensure that the basement membrane was still intact
(and thus that the culture was free of theca cells). An aliquot
of the suspension of granulosa cells was counted using a
haemocytometer, and cell viability was determined with either nigrosin
(Paul, 1972) or lissamine green (Charming, 1969b). The remaining
cell suspension was subdivided into aliquots each containing a
minimum of 5 X 104 "live cells", and layered onto 18 mm2. No. 3
coverslips which had previously been washed in acetone, dried with
len3 tissue and then heated to 200°C. These coverslips were placed
2
in a tissue culture box containing twenty-one 19.0 mm compartments
(Flow Laboratories, Irvine, Scotland). Whenever possible cultures
were carried out in triplicate although the low viabilities (< 10%)
of some cell preparations meant that some studies had to be carried
out on individual cultures. Each culture chamber received 1 ml of
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medium containing antibiotics and 20% serum (v/v). Granulosa
cells in the experiments described in Chapters 4, 5, 7 and 10,
were cultured in medium containing 20% calf serum (batch 40498,
Flow Laboratories, Irvine, Scotland), while in the experiments
described in Chapters 6 and 8 they were cultured in medium containing
20% human serum (batch 40515, Flow Laboratories, Irvine, Scotland),
with or without antiserum treatment. In the experiment described in
Chapter 9 the cells were cultured in medium containing variable
amounts of human serum (batch 40515) and/or serum from patients with
Addison's disease with fresh serum or heat inactivated fresh serum
being added as a source of complement or complement control. Calf
serum (Flow laboratories, batch 40498) was used as the main source of
serum for tissue culture because only a limited supply of pooled
human sera (batch 40515) wa3 available. Thus all experiments
which involved the addition of hormones, etc., to cells in culture
were carried out using the same batch of calf serum so that the
result3 from different experiments could be compared. Similarly
all studies involving antibodies to human pituitary hormones were
carried out using the same batch of human serum.
o
All cultures were incubated at 37 C using air as the gas phase.
Each culture was maintained for 1 to 30 days and the culture medium
o
was replaced daily and stored fpczen at -20 C until assayed for
progesterone. At the ond of culture the coverslips were removed
and were extensively rinsed in medium without serum, and fixed with
Smearfix ( iaymond A. Lamb, London). The coverslips were stained
with haematoxylin and eosin and the cell numbers determined by
2
counting the number of cell3 within a 0.12 mm area at 23 uniformly
2
spaced sampling points within the 18 mm of the coverslip boundaries.
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A PDP-9 computer, mechanical microscope and yuantimet television
system was used (Green, 1974).
Histology
Endometria, follicle walls and in some cases sections of
intact ovaries were fixed overnight in Bouin's aqueous fluid and
were subsequently dehydrated with ethanol and embedded in paraffin
wax. Serial 3ection3 cut at 6/i m were stained with Harris's
haematoxylin and eosin and mounted with DePex (Raymond A. Lamb,
London). The endometria were examined in order to assess the
stage of the menstrual cycle as described above.
All the follicle walls from which granulosa cells had been
removed were examined to see whether the basement membrane was still
intact; two or three sites on each follicle wall were sectioned.
In most cases a recognisable lining of granulosa cells was observed.
20
In approximately 9% of all the follicles examined (i.e. TTgg) there
were indications of extensive damage to the basement membrane. Of
this group of follicles, 14 were 'cystic* (i.e.<50,000 cells
recovered) and the results obtained following culture of the granulosa
cell3 from the remaining 6 damaged follicles were discarded.
Serial sections (6^111) were cut from 2 ovarian wedges and 2 intact
pieces of follicle wall to obtain histological specimens of the walls
of large antral follicles and the corpora lutea for the experiment
described in Chapter 4.
Pituitary and 3teroid preparations
The LH and FSH which were added to the cultures were: human
LH (Hartree IRC-2, 24.6.69) containing 7550 u. LH/mg and<25 u.
FSH/mg; human F8H (Butt CPDS/6) containing 2,20O u. FSH/mg and 90 u.
LH/mg and human FSH (MRC 73/519) containing 2,200 u. FSH/mg and
8.8 u. LH/mg. These immunological potencies were assessed using the
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following standards: LH, MRC 68/40, assumed 77 u./ampoule;
FSH, M2C 68/39, assumed 32.8 u./ampoule (MliC National Institute
for Biological Standards and Control). The concentrations of LH
and FSH were expressed as mu./ml. The gonadotrophins were dissolved
o
in culture medium and stored at -20 C until used in culture.
The human prolactin preparation which was added to the cultures
was Friesen prolactin of which 1 ng = 20^U MHC standard 71/222.
The Friesen prolactin preparation was 90% pure and the human
pituitary hormone contaminants were found by radioimmunoassay to be
negligible: growth hormone (HGH), HLH, HFSH, all 2 0,4b and the
concentration of human placental lactogen was undetectable. The
concentration of prolactin is expressed as ng/ml. rolactin was
o
dissolved in culture medium ani stored at -20 C until U3ed. The
biological activity of human rolactin in aqueous solutions even at
-20°C, falls rapidly with time (3. G. ?riesen, personal communication)
consequently prolactin solutions were discarded after storage for three
months.
lillipore filtration Millipora Corporation, Bedford,
U. .A.) of LH, FSH or prolactin in medium 199 effectively removed
>95 of the protein. Nonprotein filtrates of all the gonadotrophin3
were examined for their ability to alter steroidogenesis by granulosa
cells in culture and all were found to be inactive.
The gonadotrophin subunits which were added to the cultures were
the cf and p subunits of human pituitary LH, MAC 72/40 and MHC 71/342,
respectively (i'iC National Institute for Biological Standards and
Control). The o< subunit contained approximately 15% intact LH
contamination whilst the p subunit contained^ 8% intact LH (A. flartree,
personal communication). The concentrations of the subunits were
expressed as ng/ml. The subunits were diluted in culture medium and
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stored at -2Q°C until used in culture.
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0estradiol-17(J at a concentration of 10 g/ml and N , 0 -
dibutryl adenosine 3', 3' - cyclic monophosphate (DEC), 465/tg/ml,
were made up in the culture medium and 0.1 ml aliquots were used for
each culture. The final concentration of oestradiol (l^g/ml) which
was present in the culture medium is similar to that found in actively
developing human Graafian follicles while that for DBC (46.5^g/ial)
was the maximum dose which did not cause cellular necrosis.
Prostaglandin F2o< and E2 preparations
Prostaglandin F2<* and E2 (Upjohn Company, Kalamazoo, U.S.A.)
o
were each dissolved in 70% ethanol and stored in ampoules at 4 C
until added directly to the cell cultures in a vcMws of 5 or 10><1.
All other cultures in the prostaglandin control experiments not
receiving the hormone received a similar volume of 70% alcohol alone.
Determination of the biological activity of the gonadotrophins
Human granulosa cells were cultured in medium containing calf
serum and the progesterone secretion compared to that achieved by cells
cultured in media containing human sera with known concentrations of
LH and FSH. In this way the endogenous gonadotrophic activity of calf
serum was related to further additions of human gonadotrophins.
The biological activity of the exogenous LH, FSH, prolactin, and oi
and/or subunits of LH preparations which were added to the cultures
was examined by measuring the daily production of progesterone by
granulosa cells in response to varying amounts of the pituitary hormones.
Preparation and specificity of the antisera to gonadotrophins
The LH antisera was raised in a rabbit (H6) and a guinea pig (7252)
against human pituitary LH (Hartree, DE Fraction) which had a potency
which was about 60% of the Hartree IKC-2, human LH preparation (Hartree,
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1966). The major contaminant of the LH antigen (DE Fraction) was
denatured LH (W. M. Hunter, personal communication). The anti-LH
125
serum (116 or 7252) bound 50% of I LH (IRC-2, 100 pg) at a final
dilution of 1:102,400 or 1:160,000 respectively. The LH antisera
125
also bound 50% of I human FSH (Butt CFD3/6, 100 pg) at a final
dilution of 1:200 or 1:10,000 respectively but did not bind
125
significant amounts of I human prolactin (supplied by
Or. H. G. Friesen, University of Manitoba, Winnipeg, Canada). Thus
the LH antiserum (7252) contained antibodies capable of binding
significant amounts of FSH as well as LH. The LH antisera (7252 and
R6) were used to remove the endogenous LH (and FSH) from human serum
prior to its use in tissue culture.
The prolactin antiserum A3 was raised in a rabbit against a crude
pituitary prolactin extract (supplied by Dr. R. /. Davies &
Dr. ;. Hartree, University of Cambridge) containing about 30%
prolactin, 60% human growth hormone (HGH) and 10% LH and FSH.
125
Antiserum A3 bound 50% I human prolactin (Friesen, 100 pg) at a
125
final dilution of 1:128,000, 50% I human LH at a final dilution of
125
1:6000 and 50% " I human FSH at 1:400. The prolactin antiserum A4
was obtained from the same rabbit following a booster immunisation with
a different pituitary prolactin extract (supplied by Dr. R. V. javies &
Dr. A. 3. Hartree) which was approximately 50% prolactin and 25% HGH.
125
Antiserum A4 bound 507o of 1 human prolactin at a final dilution of
125
l:10fooof 50% of I human LH at 1:2500 with insignificant binding of
125
I human FSH. Thus the prolactin antisera, and A^, also
contained antibodies capable of binding significant amounts of LH.
These antiaera were used to remove or neutralise the endogenous prolactin
(and/or LH) in human serum prior to or during tissue culture.
The HGH antiserum ('»¥ 105) (sup; lied by Dr. B. Burn, ellcome
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Laboratories, Kent, England) was raised in a rabbit against Haben
125
HGH and bound 50% I prolactin at a final dilution of 1:400 with
125 125
insignificant binding of both I M and I FSH. Thus the HGH
antiserum did not appear to bind appreciable amounts of LH, FSH or
prolactin and was therefore used a3 a control.
*
The anti-bovine 3erum atfclumin (anti-BSA) was raised in a rabbit
against crystallised BSA and did not bind significant amounts of
iodine -125 labelled LH, FSH or prolactin, and was used as a non¬
specific antiserum control.
Treatment of human serum with antiserum to gonadotrophlns
In order to assess whether prolactin was an essential hormone for
the maintenance of steroidogenesis by human granulosa cells (see
Chapter 6) the cells were cultured in a medium containing 20% human
serum, 20% human serum and normal rabbit serum or rabbit antiserum
to prolactin, HGH or BSA. Normal rabbit serum, rabbit anti-BSA,
rabbit anti-human HGH (W1G5) or rabbit anti-human prolactin (A4)
which were previously dialysed extensively (4-5x) against medium 199
containing Hank's salts, Hepes' buffer (20mM$, ^entamicin (SO/ig/ml)
and amphotericin -B (2.5/«g/ml) in order to remove any cytotoxic
preservatives, were added to the culture medium at a final dilution
of 1:500 v/v. These culture media including the control with
rabbit serum (1:500 v/v) were incubated at 37°C for 24h before being
used in tissue culture. After these media had been used in culture,
aliquots of each daily change of culture medium were treated with an
equal volume of solid phase immunosorbent (sheep anti (rabbit t-globulin)
(Organon, Oss, Holland))* suspended in medium 199. The mixture was
♦Antibodies to purified rabbit ^globulin raised in a sheep.
continuously slurried by gentle mechanical agitation for 8 hours
o
at 40 C. After this time, the precipitated antibody-antigen complex
was centrifuged at 2QOO rpm for 15 min.: the precipitate was discarded
and the supernatant was assayed for LH, FSH and prolactin. Using
this procedure it was possible to examine the progesterone content of
the culture medium and relate the biological and immunological
neutralisation of endogenous prolactin to changes in the daily rate
of progesterone secretion.
In the experiments described in Chapter 8, granulosa cells were
cultured in medium containing 207o human serum which was devoid of
either FSH, LH, prolactin or prolactin and LH, The procedure for
removing selectively the endogenous gonadotrophins in the human serum
was similar to that described for the experiment in Chapter 6, Serum
from rabbits immunised against the human pituitary hormones LH (H6),
prolactin (Ag and A^), GH (W105) or BSA together with normal rabbit
serum (all previously stored at -20°C) were dialysed as described
above. Serum from a guinea-pig immunised against human LH (7252), and
normal guinea-pig serum, both previously stored at -20°C were dialysed
in the same manner. Each dialysed immune or control 3erum was
o
incubated at 4 C for 4 days with an aliquot of the same batch of pooled
human serum (40515, with known concentrations of LH, FSH and prolactin)
at a final dilution of between 1:200 and 1:400 (v/v). On the fourth
day of incubation a solid phase immunosorbent (sheep anti- (rabbit
globulin) or sheep anti- (guinea-pig 'if- globulin)) suspended in medium
after being extensively washed (4-5x) with medium to remove any cytotoxic
preservatives, was added (50/50, v/v). The supernatant was obtained
TM
as previously described and filtered through 0,22^0 Millex filter
(Millipore Corporation, Bedford, U.S.A.) and was subsequently diluted
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with medium so that the serum fraction was 205 by volume. Aliquots
were assayed for LH, FSH and prolactin while the remainder was stored
o
frozen at -20 C until used for tissue culture.
In addition a further series of culture media were used as
controls. For these, serum from patients with antibodies* to
gastric parietal cells (3 patients), thyroid microsomal fraction
and thyroglobulin (3), adrenal (3) and corpus luteum (S) (supplied
by Dr. vV. J. Irvine, Edinburgh) were each added to culture medium
containing 205 untreated human serum so that the final dilution of
antiserum was 1:400 (v/v). These culture media were added to HeLa
or granulosa cell cultures without any further treatments.
U3e of HeLa cells to test for non-specific antiserum toxicity
All sera treated with antibodies, together with control sera
previously diluted to 205 (v/v) with medium, were then added to
monolayer cultures of HeLa cells (adapted for culture in human serum,
Flow Laboratories, Irvine, Scotland). The cells were grown on
coverslips in Leighton tubes (16 X 120 mm) in 2 mis of culture medium
o
at 37 C using air as the gas phase. Each serum was tested for its
cytotoxic properties in triplicate and the culture medium changed
daily. After six days the coverslips were removed, washed extensively
with medium without serum, fixed with .uearf ix (Raymond A. Lamb, London)
and stained with haematoxylln and eosin.
Autoimmune serum and the test for cytotoxicity
(i) Serum
S rum was obtained from 21 women and 2 men with idiopathic
♦These organ, cell or subcellular specific antibodies were obtained
from patients with Addison's disease (Irvine & Barnes, 1974).
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Addison'3 disease and stored at -20°C. All 23 sera were found by
an indirect immunofluorescence technique to contain antibodies to
human luteal tissue (Irvine, Chan & Scarth, 1989); nine gave
"clumpy", eight gave "patchy" and four gave "confluent staining"
patterns.* Two sera did not react with luteal tissue, one reacted
with theca interna alone and one with Leydig cells.
The clinical histories of these patients, together with
immunofluorescent staining pattern and antibody titre (as assessed
on air dried, cryostat sections of human corpus luteum) are shown
in Table 2.
Control 3era were obtained from women who were either showing
normal menstrual cycles (20) or who were post-menopausal with a
previous normal menstrual history (20). In addition sera were
obtained from patients with 'anti-nuclear factor antibodies' (4),
with antibodies to gastric parietal cells and to intrinsic factor (3),
with antibodies to thyroid microsomal antigen and to thyroglobulin (2),
with antibodies to adrenal cortical antigens not shared with other
steroid producing tissues (2), and with mitochondrial antibodies (1).
Since these sera contained antibodies which did not react with luteal
cells, they were suitable for use as controls.
*These refer to the staining patterns in the cytoplasm of cells
after 3lices of tissue were incubated with serum from patients with
Addison's disease and horse anti-human IgG - fluoroscein





























































































































































































































































(ii) Test for cytotoxicity
The technique for culturing granulosa cells was identical to
that described previously. In some cases granulosa cells were
pooled from follicles of similar size from the same ovary to obtain
sufficient numbers of 'live' cells in order to culture eight
separate aliquots simultaneously.
Sera from patients with Addisoafe disease or control sera were
added to the culture media at the start of each culture period and at
each medium change. The 'Addisonian* serum and controls were added
in the following volumes and made up to 1 ml with medium; 0.5 ml
(6 experiments); 0.2 ml (8); with smaller volumes (0.1 ml, 0.05 ml,
0.025 ml and 0.01 ml, 8 experiments each), the serum volume was made
up to 0.2 ml with heat inactivated fresh human serum. In addition
to varying the amount and nature of the antiserum it ws also
important to check for the effects of complement.* To each 1 ml of
culture medium plus serum was added either 0.1 ml of fresh human male
serum as a source of complement or O.1 ml of the same serum after
heat inactivation (56°C for 30 mins.) as a com- lenient control. All
the experiments using the test antiserum together with the controls
were carried out in quadruplicate.
After 3 days of culture the coverslips were fixed and stained with
haematoxylin and eosin. The number of damaged and intact granulosa
cells on each coverslip were counted using a UK - 9 computer
mechanical microscope, and a '.uantimet 720-D cell counter as described
previously. When less than 13% of the total number of granulosa cells
^Complements orum protein components (m.w. between 180,000 and 400,000)
whose activation by antibody may lead to a cytotoxic reaction (Roitt, 1972).
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were damaged this was regarded as non-signifleant and scored
However, when between 15 and 804 of the cells were damaged the
preparations were scored at +, and greater than 80% as ++.
Clumping of the cells which was a consequence of the short period
of culture led to 3ome difficulty in counting the proportion of
damaged cells and hence the broad classification of degrees of
cytotoxicity.
Coverslips containing granulosa cells which were cultured in
serum from patients with Mdison's disease in the absence of
o
complement were incubated at 37 C with horse anti-human IgG -
fluorescein isothiocyanate (IgG - PITC) (<ellcome Laboratories,
Kent, England) and were examined daily to see if affinity for the
antibody changed with time. The cells were examined under ultra¬
violet light and the intensity of staining was assessed subjectively
as ++, +, - or negative.
HadioiiBEiunoassav of ritultary and steroid hormones
Luteinlslnk hormone and follicle-stimulating hormone
The radioimmunoassays for LH and P8H in plasma and follicular
fluid were based upon those previously described (Hunter, iidmond,
Wotson St McLean, 1974). Some modifications were made to accommodate
the small volumes of antral fluid recovered from the follicles. The
original concentrations of standards, tracer and antiserum were retained
but the incubation volume was reduced to 150^1 of which 50^1 was
neat (or diluted) follicular fluid, or standard. The time taken to
count the radio-activity was increased proportionately so that in this
respect assay precision was not diminished. The following standards
were used: LH, MitC 98/40, assumed 77 units/ampoule; FSH, MRC 33/39,
assumed 32.8 units/ampoule (MHC National Institute for Biological
Y3.
• Standards and Control). The concentrations of LH and FSH axe
expressed as mu./ml, where 1 mu. LH = 11.6 ng LER 907 and 1 mu.
FSH a 44,6 ng LBR 907. These assays would normally measure LH
and FSII over the ranges 0.8 - 12.8 and 0.4 - 6.4 mu./ml respectively
in undiluted follicular fluid. With the fluid obtained from large
follicles ( > 8 mm diameter) assays were in general carried out in
duplicate, whilst those for follicles < 8 inm diameter were single
determinations. A number of LH assays were also carried out on
larger volumes of pooled fluid from small follicles.
prolactin
Prolactin was measured in samples of peripheral plasma and
follicular fluid using a specific double antibody radioimmunoassay
(McNeilly, 1973; McNeilly & Ilagen, 1974). The purified human
125
prolactin for standards and labelling with I was generously
supplied by Dr. H. G. Friesen, University of Manitoba, Winnipeg,
Canada. The concentration of prolactin is expressed as ng Friesen
prolactin of which 1 ng 32.O4 U MRC 71/222. The minimum detectable
level of prolactin was 1.5 ng/ml for both follicular fluid and plasma.
Assays were carried out in duplicate in specimens of both plasma and
fluid.
cx and (3 subunits of LH
The o< and ^ subunits of LH (Lri<* and LHp, respectively) in
peripheral plasma and follicular fluid were measured U3ing specific
double antibody radioimmunoassays (Hagen & McNeilly, 1975a; Hagen a
McNeilly, 1975b). The purified human pituitary preparations LH oC
(: iiC 72/20), LH^ (MKC 71/342) were used for standards and labelling
125
with J. The concentrations of LHoCand LH^were expressed as
ng/ml. The minimum detectable level of LH<Xand LH^J in plasma or
undiluted follicular fluid was 0.12 ng/ml and 0.04 ng/ml respectively.
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Oestradiol-17/5
Antiserum for the a33ay of oe3tradiol-17^g wa3 rai3ed in a
rabbit to a conjugate of oe3tradiol 6 - carboxymethyloxime and bovine
serum albumin. Cross-reactions of other steroids in the routine
assay procedures were: oestrone, 3% oestriol, 0.4%; 6-oxo-
oestradiol, 100%; testosterone, 0.003%; progesterone, 0.0002%.
For estimations of oestradiol in plasma an ether extract was
evaporated to dryness, equal volumes of 0.05 M NaOH and carbon
tetrachloride were added and shaken together with the residue.
Samples of the aqueous phase were then neutralised in a slightly
acid diluent for incubation in the radioimmunoassay system described
by A. Bolton & F. iutherford (personal communication). Oestradiol
in follicular fluid was assayed without prior extraction (Abraham,
Odell, Edwards & Purdy, B70). The assays were carried out in
duplicate and the minimum detectable level of oestradiol was 8 ng/ml
in follicular fluid and 20 pg/ml in plasma.
(v) ; rogesterone assay
Progesterone in peripheral plasma, follicular fluid or culture
medium was measured using modifications of published radioimmunoassay
techniques (Abraham, Swerdloff, 'fulchinsky & Odell, 1971;
Thorneycroft & Stone, 1972; , Dighe & Hunter, 1974).
(i) Solvents and reatents
Anular grade petroleum ether (40 - 60°) benzene, chloroform,
ethanol, heptane and water (B.D.H.) were used without further
purification. The assay buffer, phosphate buffered saline, 0.1M,
0.17o gelatin, pH 7.0 was prepared by dissolving sodium dihydrogen
phosphate (5.38g), disodium hydrogen phosphate (8.67g), sodium
chloride (9.00g) (all BDH, Analar grade) and gelatin (l.Og) (BDH)
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in one litre of water. ^odium azide (0.1%, v/v) wa3 added to the
buffer as a preservative. Norit A charcoal (25 rag) and dextran T-70
(250 mg) (Sigma Chemical Co.) per 100 ml of assay buffer (D/C) was
prepared as a fresh suspension just prior to use.
(ii) Steroid3
Non radioactive steroids (Sigma Chemical Co.) were dissolved in
o
ethanol and stored at 4 C at a concentration of 1 rag/ml.
Radioactive progesterone (l,2-3H-.progesterone, <*• lGO^Ci/mg,
(The fladiochemical Centre, Amershara) was diluted to a concentration
of 20-25,# Ci/ml in benzene and ethanol (9/1, v/v) for storage at 4°C
for up to 13 months.
(iii) Materials
Disposable glass test tubes and pipettes were used throughout the
assay. The counting fluid used, was prepared by dissolving lOg of
2,5 - diphenyloxazole (PPO) and 0.75g of p-bis (2-(2-phenyloxazolyl)) -
benzene (iOPOP) in 2.5 litres of toluene (analytical grade, Koch-Light)
which was then added to 1.25 litres of Triton X-100 (analytical grade,
Koch-Light) and mixed thoroughly until a homogeneous solution was
obtained. Glass counting vials were of the low background type
(Packard Instrument Company).
(iv) Progesterone antiserum
The antiserum to progesterone (Rl-4), generously sup lied by
Dr. K. K. Dighe (MiiC Radioimmunoassay Team, Edinburgh) was raised in a
rabbit against the progesterone - llc< hemisuccinate-bovine serum albumin
conjugate. The dilution of antiserum (1/2000, v/v) was that which bound
30-50% of 1,2 - 3jj - progesterone (36,000 d.p.m.,~50 pg).
(v) Extraction of progesterone from plasma
Aliquots of plasma (0.2 ml) were pipetted into 125 X 15 mm glas3
test tubes. The extraction was carried out by vigorous mechanical
('vortex') mixing of the plasma with 20 volumes of petroleum ether for at
least 60 sec. After clear separation of the 2 phases, the lower
phase (plasma) was quick-frozen by dipping in alcohol containing
chips of dry ice. The petroleum ether was then decanted into a
o
75 X 9 mm test-tube partially submerged in a water bath at 60 C and
evaporated to dryness under nitrogen.
(vi) Radiolmniunoass ay
The dried residue from the plasma extraction was redissolved in
0.1 ml buffer. For the measurement of progesterone in follicular
fluid or culture medium, 0.1 ml aliquots (either undiluted or diluted
from 1/10 to 1/1000, v/v, with buffer), were added to 75 X 9 mm test
tubes an i assayed without extraction. To replicate aliquots (0.1 ml)
of the samples to be assayed, 0.1 ml of diluted antiserum (1/2000, v/v)
in buffer was added to each tube and mixed, followed by 0.1 ml of buffer
3
containing 30,000 d.p.m. of 1,2,- H - progesterone and further mixing.
A standard curve was constructed for each assay by serially diluting
with buffer a solution of progesterone (100 ng/ml) previously prepared
in buffer so that a series of tubes contained known amounts of
progesterone, each in triplicate and ranging from 10 to 5000 pg. The
incubation volume for the standard curve assay tubes after the
addition of antiserum (O.l ml) and radioactive progesterone (0.1 ml)
was kept the same as the unknowns, by adding further amounts of buffer
if necessary, so that the final volume in each tube was 0.3 ml. A
further six tubes were added to the assay with each containing 0.2 ml
3
assay buffer and 0.1 ml of 1,2- H - progesterone; three were used to
evaluate the blank of the assay (w&ter blank) while the other three
were used as controls so that the average amount of radioactive
progesterone added to each tube could be checked at the end of the assay.
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After incubation at 4°C overnight, 1.0 ml of D/C suspension at
o
4 C was added to the tubes, which were then 'vortex* mixed and
centrifuged (2,500 rpm) for 15 min. at 3r4°C. The same procedure
was adopted for the three radioactive control tubes except that 1.0 ml
of buffer was added instead of the D/c suspension. The supernatant
was decanted into counting vials, 10 ml of scintillation fluid was
then added and the contents mixed. The vials were allowed to
o
equilibrate in the scintillation counter for 2 hours at 4 C prior
to counting,
(vii) Counting
The liquid scintillation counter (Packard, Model 3375) had a
3
counting efficiency of 30% for H in the system described with a
background of 18-20 cpm. Samples were counted for sufficient time
so that the cousting error was less than 2% (i.e. -olO mins).
(viii) Calculations
The concentration of progesterone in aliquots of the unknown
samples was calculated by interpolation on the standard curve. The
three water samples treated like the unknowns, served as a check on the
blank of the system. The blank values were consistently below the
sensitivity of the assay in all but two of the 192 separate assays
conducted. In the two assays where the blank values were unacceptable
the cause was attributed to incorrect amounts of D/C used in the
separation procedure and these results were discarded.
(ix) Effect of time of incubation
No significant alteration in binding was observed after 4h
o




Fig. 3. Effect of time on the binding of 1, 2 - H - progesterone
to progesterone antiserum. Vertical bars =* - 1 S.E.M. Each
point represents the mean of 10 observations.
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(x) -Sensitivity
For the standard curve, the percent counts/min (cpra) of bound
progesterone was plotted against the logarithm of the do3e of
progesterone added (Fig. 4). The cpm bound when unlabelled
progesterone was not added was defined as 100%. At the 95%
confidence limit, 50 pg was significantly different from zero pg
and the coefficient of variation at each point of the standard
curve was less than 5%. The sensitivity varied from 50 to 80 pg
of progesterone.
(xi) Effect of "stripping" by the dextran-charcoal (D/C) separation
procedure.
This was evalu&ed by comparing the percent of radioactive
progesterone remaining in the supernatant (% bound) with the delay in
time between addition of the D/C mixture and centrifugation. This
study was carried out U3ing three different concentrations of
charcoal (50, 100 fit 250 mg respectively in 100 ml of buffer) while
keeping the concentration of dextran (25 mg/lOO ml) constant.(Fig.5).
Concentrations of charcoal in excess of 250 mg/100 ml were not
examined since some difficulty was found in pipetting this suspension
freely. The 250 mg charcoal + 25 mg dextran/100 ml mixture proved
to be the most suitable for the separation of the 'bound' and 'free'
progesterone provided that the time delay between addition of the
D/C and centrifugation was less than 8 min. Investigation of the
time delay in decanting the supernatant following centrifugation
revealed no significant alterations in the percent of progesterone
o
bound provided the as3ay tubes remained at 4 C.
3
(xii) Parity of 1,2- H - progesterone
3
The purity of the 1,2- H - progesterone was checked on receipt of
80.
Fig. 4. Standard curve for progesterone. Vertical bars o - 1 S.E.M.
Each point represents the mean of 6 observations.
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Fig. 5, Effect of 'stripping' with dextran-charcoal.
O 0 = 50 mg charcoal
O ■ 6 = 100 mg charcoal
X —-X = 250 mg charcoal
Blank refers to the amount of radioactivity remaining in the
supernatants after dextran-charcoal treatment of assay tubes which
3
previously contained 1, 2 - H - progesterone + buffer but no antiserum
to progesterone; 0 refers to the amount of radioactivity remaining
in the aupernatants of those assay tubes which previously contained
3
1,2- H - progesterone + antiserum to progesterone. Each point
represents the mean of triplicate experiments.
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the sample and routinely at approximately 3 monthly intervals using
4
column chromatography (Murphy, 1970, 1971). A 30 :C 0.9 sephadex
LH-20 column was prepared using a water-saturated chloroform-heptane-
ethanol (50/50/0.25, v/v/v) mixture as solvent.
An aliquot of the radioactive progesterone in a solution of
benzene and ethanol (9/1, v/v) was evaporated to dryness, redissolved »
in the chromatographic solvent (0.2 mis) and transferred to the tope
of the previously washed sephadex column. One ml eluates were
collected directly into liquid scintillation vials and evaporated
to dryness. The dried residue was redissolved in scintillant and
the amount of radioactivity in each vial determined. A typical
elution profile for radioactive progesterone is shown in Fig. 6.
The progesterone isotope retained>93% of its purity for at least
o
12 months when kept at 4 C in benzene and ethanol (9/1, v/v).
(xiii) Recovery
The recovery of progesterone from each plasma sample was assumed
to be>90% and in routine assay procedures the concentration of
progesterone in peripheral plasma was not corrected for recovery.
This assumption was made after testing the three factors which were
thought to influence the quantitative recovery of progesterone:
(1) time taken in mixing the plasma-petroleum ether layers;
(2) mass of progesterone to be recovered and (3) loss of progesterone
through adsorption to glass.
3
To evaluate the first two factors, 1,2 - H - progesterone in 10/tl
of the buffer was added to a 0.2 aliquot of plasma mixed and subsequently
extracted with petroleum ether as described above except that the
petroleum ether was decanted directly into a scintillation vial and
the radioactive counts recovered were compared to tho.so added to the
original plasma sample. The effect of the time taken in mixing the
83.
Fig. 0. Slution profile of radioactive progesterone. Progesterone
was eluted through a sephadex LH-20 column (30 X 0.9 cm) using a
water saturated, chloroform-heptane-ethanol mixture (50/5O/0.25, »/v/v)
as solvent.
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plasma-petroleum ether layers on the recovery of varying amounts
of progesterone (expressed as a percentage of the amount originally
added to plasma) is shown in Table 3.
85.




Progesterone (10) (30) (60) (120) (240)
(Pg)
(50) 73.9 87.8 96.7 97.8 96.3
(145) 80.4 90.1 98.6 98.4 17.9
(1450) 82.2 87.6 10O.1 99.7 98.6
The mass of progesterone was assessed from the specific activity
of the radioactive progesterone. Each result is the mean of
triplicate experiments.
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Provided the petroleum ether-plasma layers were mixed
thoroughly ('vortex' mixed) for at least 60 sec. a recovery of
98.4 - 0.9% (mean - s.e.m., n=9) was achieved, irrespective of
the amount of progesterone in plasma.
To evaluate the third factor (adsorption of progesterone to
glass) known amounts of radioactive progesterone 50, 145 or 1450 pg
in 10 1 of assay buffer were added to 0.2 ml plasma samples on
3ix different occasions over an 18 months period. These samples
were extracted as described above and incubated in 0.2 ml buffer
and ©.1 ml of antiserum as described, but prior to the separation
procedure, 1.0 ml of buffer was added to these samples which were
then decanted into scintillation vials and counted to determine the
amount of radioactive progesterone which remained in solution.
Their mean recoveries were 98.1 - 1.9% (mean - s.e.m., n-18)
for 50 pg radioactive rogesterone added, 19.7 - 0.7%, n-18, for
"4"
145 pg added and 93.1 - 1.6, n=18 for 1450 pg added. The small
loss (^ 6$) in recovery after proceeding through the assay until the
separation step, when compared to recovering the radioactivity
directly from pla3ma into a counting vial, was attributed to some
progesterone being adsorbed to the walls of the test tube,
(xiv) Specificity
The specificity of an assay system relates to the ability of
the antiserum to respond only to the compound which the assay is
intended to quantify. A large number of C18, C19 and C21 steroids
were tested for their ability to displace the radioactive progesterone
from the antiserum.(Table 4). The cross-reactions were expressed
a3 a percentage after dividing the mass of unlabelled progesterone
displacing 50% of the radioactive progesterone by the mass of
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unlabelled steroid displacing 50% of the radioactive progesterone.
The cross-reaction of progesterone was taken as 100%. Apart from
the hapten* components of the antigen used to raise the antiserum
(i.e. llix-hydroxyprogesterone and progesterone-llrf-hemisuccinate)
only 3 other progestins showed significant cross-reaction (see Table 4).
None of these polar cross-reacting steroids were likely to interfere
significantly with the measurement of progesterone, 3ince if they
were present in plasma, they were unlikely to be recovered
quantitatively using petroleum ether as a solvent (Digte& Hunter,
1974). The available evidence suggests that human granulosa cells
in tissue culture secrete predominantly progesterone and pregnenolone
but little if any of the potentially cross-reacting C18, C19 or C21
steroids (Channing, 1969a, and ersonal communication). Since
pregnenolone has only a low cross-reaction with the antiserum which
was used, the radioimmunoassay of unextracted aliquots of culture
medium is probably specific for progesterone. The measurement of
progesterone in human follicular fluid without prior extraction has not
previously been reported. The CIS, C19 and C21 steroids present in
human follicular fluid in relatively high concentrations (other than
progesterone) are 17«-hydroxyprogesterone, androstenedione, testosterone,
oestradiol-17(3 and oestrone, and hone of these steroids significantly
cross-reacts (^ 2%) with the antiserum used (Short & London, 1961;
Short, 1962b, 1964b; Giorgi, 1963a, b, 1365; Edwards, teptoe,
Abraham, Walters, i urdy & *"0therby, 1972; Baird & Fraser, 1974b;
de Jong, Baird It Van der Molen, 1974; Sanyal et al.. 1974).
♦Hapten: Steroids as such are not immunogenic; but when covslently




Specificity of the rabbit antiserum to
progesterone-llc* - hemisucclnate-bovine serum albumin (Rl-4)
Compound Cross-Reaction (%)
Progesterone lOO.O
Progesterone-llc< - homisuccinate 85.20
ll^-Hydraxyprogesterone 28.62
ll(5-Hydroxyprogesterone 10.00
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Oes trone ^ 0.005
89.
(xv) Precision
the within-assay precision for the assay of progesterone for all
of the biological fluids U3ed were evaluated by duplicate measurements
of the same samples in the same assay. The coefficient of variation
(CV) of the results of duplicate determinations from their means was
estimated by the following formulae (Snedecor, 194G):
From duplicate determinations of progesterone in peripheral plasma
(n = 48, range 0.5 to 9.6 ng/ml), follicular fluid (n = 50, range 8 to
2,200 ng/ml), or culture medium containing 20% calf serum (n = 64,
range 50 - 6000 ng/ml) the CV was 6.6%, 8.3% and 5.0% respectively.
The between-assay variance was evaluated by duplicate measurements
of the same sample in two different assays. The CV in 30 duplicate
determinations of either plasma, follicular fluid or culture medium
containing 20% calf serum was 14.8%, 13.9% or 6.8% respectively.
(xvi) Validation of the assay for follicular fluid
The accuracy of the assay was determined by the addition of known
amounts of progesterone to a pool of follicular fluid so that the
final concentrations were 60, 100, 2QO, 550, 1000 & 2500 ng/ml. The
mean results of assays conducted in quadruplicate at two different
dilutions <1/100 and 1/1000) and corrected for the dilution factor are
shown in Fig. 7. The calculated linear regression equation is
Y = 0.92 X + 23 (X = concentration of progesterone added to the medium;
Y = estimated value by the assay; n = 10).
where
n = number of duplicate determinations
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Fig. 7. Accuracy of the progesterone assay on unextracted samples
of follicular fluid containing known amounts of progesterone. Each
point is the mean of quadruplicate determinations.
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Table 5. Comparison of the results of radioimmunoassay for
progesterone in extracted versus unextracted follicular fluid.
i rogesterone (ng/ml)
(without^'extraction) ^ob69*61*01*8 added Expect Extracted Unextracted
55 100 155 132 165
74 50 124 110 125
520 50 570 545 545
1,600 1,000 2,600 2,700 2,300
17 lOO 117 117 112
5 50 55 52 68
66 250 316 324 311
Each result is the mean of triplicate determinations
92.
A comparison of the results of assays for follicular fluid
extracted with petroleum ether (20/v, v/v) and unextracted is
shown in Table 5.
These results confirm the accuracy, specificity and precision
of the radioimmunoassay technique for the measurement of progesterone
in unextracted aliquots of follicular fluid.
(xvii) Validation of the assay for culture medium
The assay of progesterone in culture medium containing 20;i human
serum was identical to that described for human peripheral plasma.
The within-assay and between-assay variance was also similar to that
achieved for peripheral plasma. However, the majority of assays
of progesterone, in culture media were measured in the presence of
207i calf serum (v/v) (batch 40498, Flow Laboratories, Irvine,
Scotland) and were estimated without prior extraction of the media.
The accuracy of the assay was determined by the addition of known
amounts of progesterone to a pool of culture medium so that the
final concentrations were 100, 200, 500, 1000, 2000 and 5000 pg/ml.
The results of assays at these dilutions are shown in Fig. 8 for
which the calculated linear regression equation is Y = 0.99 X + 10.90
where X = concentration of progesterone added to the medium;
Y = estimated value by the assay (n = 40).
A comparison of the results of assays for medium extracted with
petroleum ether (20/1, v/v) and unextracted medium is shown in
Fig. 9. Regression analysis of the results gave the equation
Y = 0.99 X + 0.75 where X = concentration of progesterone in
unextracted medium and Y = the value obtained after extraction
(n = 18). Assays were also carried out on extracted and unextracted
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fig. 8. Accuracy of the progesterone assay on unextracted
samples of culture medium containing 20% calf serum (v/v)
and known amounts of progesterone. Vertical bars = - 1 standard




Fig. 9. Comparison of the results of progesterone assays for
culture medium extracted with petroleum ether (20/1, v/v) and
unextracted culture medium.
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results which are shown in Table Q indicate that either method
is acceptable.
The assay of culture medium without extraction appears to
be applicable only when the culture medium contains calf 3erum
since a similar analysis of the assay procedure for culture medium
containing either human or lamb serum produced spurious results
(see Table 7).
Androatenedione
Antiserum for the assay of androstenedione was raised in
rabbits immunised with llo(-hydroxy-4-andro3tene-3,17 dione-11-
hemisuccinate coupled to bovine serum albumin (supplied by
Dr. W, Schopman, Rotterdam, Holland). Cross-reactions f other
steroids in the assay were : llo(-hydroxyandrostenedione (36%),
andrenosterone (43%) and testosterone (0.3%).
The assay for androstenedione in plasma and follicular fluid
differed from that described by Baird, Burger, Heavon-Jones &
Scaramuzzi (1974) only in the method of extraction. For estimation
of androstenedione in plasma, O.l ml aliquots containing a tracer
3
amount of 1,2- H androstenedione (2000 dpm = 5 pg) was extracted
with 16 volumes of hexane and ether, 4/1 (v/v). The organic layer
which was separated from the aqueous layer by qbick-freezing in
dry ice was transferred to a 28 X 8 mm alumina column previously washed
sequentially with 3.2 ml ethanol, 6.4 ml methanol, 4.8 ml
dichloromethane and methanol (1/1, v/v) and 4.8 ml dichloromethane.
The sample was allowed to run through the column which was then
washed with a further 2.4 ml of hexane and ether (4/1, v/v) and also
6.4 ml of 0.1% ethanol in hexane. The androstenedione fraction was
then collected after adding 3.2 ml of 1.0% ethanol in hexane to the
96.
Table 6. Comparison of the results of radioimmunoassay for


























♦Blank culture medium. Each result is the mean of triplicate
determinations
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Table 7. Comparison of the results at radioimmunoassay for
progesterone in unextracted culture medium containing either
2Q£o human, lamb or calf serum.
Progesterone added (ng) Progesterone measured (ng)
Human Lamb Calf
1000 250 500 900
5GO 200 300 450
250 100 160 230
100 40 70 110
50 21 50 50
25 7 21 27
10 - 8 11
5 • 2 4
Each result is the mean of triplicate determinations
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column. The sample was evaporated to dryness and redissolved
in 0.5 ml phosphate buffer (0.1M, pH 7.0) containing 0.1%
gelatin. An aliquot (0.1 ml) was removed for estimating
3
the recovery of 1,2- H androstenedione through the extraction
procedure and aliquots of the remainder were assayed by the
radioimmunoassay technique reported elsewhere (Baird et al..
1974).
After;it had been established that both the extraction
and chromatographic procedures were unnecessary, androstenedione
in follicular fluid were assayed directly on O.l ml aliquots
of diluted fluid (1/50 to 1/100, v/v) in buffer.
The assays in plasma were carried out in duplicate while
those for follicular fluid were carried out in triplicate.
The minimum detectable level of androstenedione in plasma was
150 pg/ml and in follicular fluid was 8-15 ng/ml.
Testosterone
The antiserum (Eoi, supplied by Dr. 3. A. Tillson, Aliza
Corporation, Palo Alto, U.S.A.) for the assay of testosterone
was raised in a goat immunised with testosterone-3-oxime
coupled to bovine serum albumin. Cross-reactions of other
steroids were: 5o(- dihydrotestosterone (25%), oestradiol
(0.20%) and androstenedione (0.08%).
The assay for testosterone in follicular fluid was similar
to that described by Furuyama, Mayes & Nugent (1970) except
that the chromatographic step in the extraction procedure was
found to be unnecessary. The concentration of testosterone
in follicular fluid was relatively low when compared to the other
steroids measured and consequently sufficient volumes of fluid
99.
(after previously assaying other hormones on the 3ame
sample) were only available from large follicles (^-8 nun).
Undiluted extracts of follicular fluid containing tracer
amounts of testosterone (3000 dpm = 20 pg) were extracted
into 10 volumes of hexane and ether (4/1, v/v) which was
evaporated to dryness and the residue dissolved in phosphate
buffer (O.l M, OH 7.0) + 0.1% gelatin for assessment of
recovery and the unknown amount by radioimmunoassay (Furuyama
et al.. 1970). The minimum detectable level of testosterone
in follicular fluid was 2 ng/ml. Testosterone was not
measured in peripheral plasma.
CHAPTER 3
CHANGES IN THE CONCENTRATION OF PITUITARY AND
STEROID HORMONES IN FOLLICULAR FLUID OF
HUMAN GRAAFIAN FOLLICLES THROUGHOUT THE MENSTRUAL CYCLE
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INTRODUCTION
There is considerable evidence to suggest that pituitary
hormones are obligatory for the later stages of follicular
growth, maturation of the oocyte and ovulation (see reviews by
Mauleon, 1969; Baker, 1972; see also General Introduction).
Although it is possible to correlate changes in gonadotrophins
in peripheral plasma with the production of steroids from the
ovary, the actions of luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) on the follicle remain obscure.
It has been suggested that the gonadotxphins within the
follicular fluid itself may have important consequences for
follicular steroidogenesis (Channing, 1970a, 1972; Edwards,
1974), growth of the follicle, oocyte maturation and ovulation
(Edwards, 1974).
In the present study the concentrations of LH, FSH, prolactin,
oestradiol-17^, progesterone and androstenedione were measured
in samples of peripheral plasma and follicular fluid collected
from women at varying stages of the menstrual cycle. In
addition, testosterone was measured in follicular fluid. It
was hoped in this way to investigate the relationships between
the concentrations of pituitary and steroid hormones in
follicular fluid and to relate them to concentrations in plasma,
follicle size and the stage of the menstrual cycle.
RESULTS
The concentrations of horatones in plasma and follicular
fluid in subjects with stage 0 carcinoma of the cervix were
compared with those of patients with monorrhagia and were not
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found to be significantly different. The results from all
patients have therefore been pooled.
Concentrations of FSH, LH, oestradlol, progesterone,
androstenedione and testosterone in the antral fluid of
follicles aspirated in situ were not significantly different
from those aspirated after ovariectomy (P > 0.2, Student's
t test). The results obtained for each hormone from the
two methods of collection have therefore been pooled.
Concentrations of prolactin in the antral fluid of
follicles aspirated in situ are not reported, 3ince these
o
samples were stored at -20 C for at least 12 months before
being assayed and the immunological and biological activity
of prolactin in physiological fluids declines with prolonged
storage (H. G. Friesen, personal communication). All results
were compared using the Student's t ta3t.
Concentration of luteinizing hormone, follicle-stimulating hormone.
prolactin, progesterone. oestradiol and androstenedione in
peripheral plasma
+
Mean values (- S.E.M.) obtained for the concentrations of
LH, FSH, prolactin, progesterone, oestrndiol and androstenedione
in peripheral plasma with respect to the stage of the menstrual
cycle are shown in Fig. 10.
-distribution of the size of excised follicles in relation to
the stage of the menstrual cycle
A scatter plot of follicle size in relation to the stage of
the menstrual cycle is shown in Fig. 11. The greatest range
in follicle sizes (4-20 mm) was found in the late follicular
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Fig. IP. Mean concentrations of LH, F8H, prolactin, progesterone,
oestradiol and androstenedione in peripheral plasma during the
menstrual cycle. Vertical lines represent + 1 standard error
of the mean (+ 1 S.E.M.). EF, MF, and LF refer to early
(still menstruating), mid- and late-follicular phases
respectively, while EL, ML, and LL refer to early-, mid-
and late-luteal phases respectively. Numbers of observations
arc given at the top of the figure.
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STAGE OF MENSTRUAL CYCLE
Fig. 11. Distribution of size of excised follicles in
relation to the stage of the menstrual cycle. Follicles
4 mm were not collected; •, 'cystic* follicles;
x, 'non-cystic' follicles. See Fig. 10 for abbreviations.
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follicles (45.;,) was found in the early follicular phase
whereas none was found during the late follicular or early
luteal phase.
The concentrations of pituitary and steroid hormones in the
follicular fluid of individual Graafian follicles
(1) Follicle, -stimulating hormone
The mean concentration of F6H in all antral fluids in
relation to size and the stage of the menstrual cycle is
shown in Fig. 12. The minimum detectable level of FS'H in
the smallest follicles ( 4 mm) was 1.3 mu/ml, which was
therefore chosen as the limit of detection for all follicles.
The percentage of follicles with detectable F3H at each
stage of the cycle is shown in Table 8. In general, the
s rc-atest proportion of follicles with detectable F3II wa3
found either during or immediately after the increase in
levels in the plasma (fig. 10 and Table 8). In contrast,
the concentration of JH in scmie large follicles was high when
the plasma concentrations wore low (Fig. 10 and Fig. 12).
Follicle-stimulating hormone was detectable in a proportion of
the smallest follicles examined (see Table 8 and 9).
However, at no time during the cycle was the concentration of
FdH in follicular fluid more than 60,. of the levels found in
plasma.
(ii) Luteinizing hormone
The meem concentration of LH in all antral fluids examined
with respect to follicle size and the stage of the menstrual
cycle is shown in Fig. 13. The percentage of follicles
containing detectable concentrations of LH at various stages
of the cycle is shown in Table 8; the lowest detectable level
105.
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EF MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fit;. 12. Concentration of FSH in antral fluid in relation
to follicle size and phase of the menstrual cycle. The
vertical bars represent + 1 s.E.M. Broken line = minimal
detectable level of FSH (1.3 mu./ml). See Fig. 10 for
abbreviations. Mumber of observations in parentheses.
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Table 8. ! ereentage of follicles with detectable levels of luteinizing
hormone and follicle-stimulating hormone in relation to size at each




EF MF LF EL ML LL
(limit of sensitivity)
PSH (1.3 rau./ml) > 8 * 38.0 82.5 45.5 38.5 28.0
< 8 33.0 15.3 25.0 46.5 0.0 3.5
LH (2.8 am ./ml) > 8 * 11.0 69.5 25.0 14.0 22.0
< 8 0.0 0.0 16.5 16.5 0.0 0.0
LH and FSH both present > 8 0.0 11.0 69.5 25.0 14.0 22.0
C 8 0.0 0.0 16.5 16.5 0.0 0.0
EF, MF and LH refer to early-still menstruating, mid- and late follicular
phase respectively, while £L, ML and LL refer to early, mid- and late
luteal phase respectively. * = no follicles present.
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Table 9. Concentration of F3H in fluid from different sized
follicles at each phase of the human menstrual cycle.
+
(Values are means - S«E#M, in Samples less than the
detection limit were assumed to have a concentration of 1.3 mu./ml
for the purposes of the group mean.)
Stage of
menstrual Follicle diameter (mm)
cycle*
3 6-8 9-12 12
er 1.50*0.09 2.30 •» -
(6) (3)
MF 1.30 1.40*0.05 2.30*0.40 -
(3) (18) (13)
LF 1.76-0.23 1.38 2.20*0.26 3.20
(8) (3) (10) (3)
EL 1.63*0.23 2.10*0.50 2.10 r
(S) (9) (3)
ML 1.30 1.30 1.30 -
(7) (11) (3)
LL 1.46*0.13 1.30 3.00*1.10 3.28
(20) (12) (8) (2)





















EF MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fig. 13. Concentration of LH in antral fluid in relation to
follicle size and phase of the menstrual cycle. The vertical
bars represent + 1 3.E.M. Broken line = minimal detectable
level of LH (2.8 mu./ml). See Fig. 10 for abbreviations.
Number of observations in parentheses.
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in the smallest follicles examined (4 mm) was 2.8 mu./ml, which
was therefore chosen as the limit of sensitivity. There was
a greater proportion of large follicles with detectable LH
during the late follicular phase (Table 8), when the concentrations
were higher than at any other stage of the cycle (Pig. 13).
Luteinizing hormone was not detectable in any follicle of < 8 mm
during the early and mid-follicular phases and mid-and late
luteal phases. Fluids from 20 early and mid-follicular phase
follicles were pooled to give a total volume of 50/<l, and the
concentration of LH was 0.96 mu./ml (detection limit 0.8 mu./ml).
Throughout all stages of the cycle the fluid concentration of
LH was ^30% of that found in peripheral plasma. Furthermore,
LH was only found in those follicles that also contained F8H
(Table 8).
(iii) srolactin
Unlike LH and FSH, prolactin was detectable in almost all the
follicles examined. The minimum detectable concentration was
1.5 ng/ml. The concentration of prolactin was significantly
lower in the large follicles during the late follicular phase
than in any other stage of the menstrual cycle (P<0.O5)
(Fig. 14) with the exception of the large follicles during the
early luteal phase. The general pattern of prolactin in antral
fluid indicates a progressive fall in concentration during the
follicular phase followed by a rise in concentration during the
luteal phase.
(iv) Qestradiol
The concentration of ©estradiol with respect to size of follicle

























EF MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fi^» 14• Concentration of pjtiLactin in follicular fluid in
relation to follicle size and stage of the cycle. Vertical
bars represent + 1 S.E.M. Minimal detectable level of
prolactin (1.! ng/ml) i3 indicated by the broken line. See































EL MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fig, 15. Concentration of oestradlol in follicular fluid in
relation to follicle size and stage of the cycle. Vertical
bars represent + 1 S.E.M. See Fig. 10 for abbreviations.
Numbers of observations in parentheses.
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oestradiol in follicles at all stages of the cycle are between
40 and 40000 times higher than those in peripheral plasma. During
the mid and late follicular phases the large follicles contained a
significantly higher concentration than that in small follicles at
the same phase (P < 0.001). During the luteal phase there were
no significant differences in the concentration of oestradiol
between small and large follicles (P > 0.05), and the levels did
not exceed those found in follicles during the early follicular
phase.
(v) Progesterone
The concentration of progesterone with respect to size of
follicle and stage of menstrual cycle is shown in Fig. 16. Levels
of progesterone in large follicles during the proliferative phase
were significantly higher than those found in the corresponding small
follicles (P 0.001). The most dramatic increase was found in the
large follicles during the late follicular phase, where the levels
were up to 20 times higher than in any other follicle throughout the
cycle. By contrast, the small follicles (<8 mm) during the early
luteal phase had a significantly higher concentration of progesterone
than any other follicle during the luteal phase (P O.OOl).
(vi) Androstenedione
The concentration of androstenedione with respect to size of
follicle and stage of menstrual cycle is shown in Fig. 17. The
levels of androstenedione in all follicles throughout the menstrual
cycle were between 100 to 500 times higher than those in peripheral
plasma. Unlike all the other steroids measured, the concentration of
androstenedione in follicular fluid was relatively constant


























EF MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fig. 16. Concentration of progesterone In follicular fluid in
relation to follicle size and stage of the cycle. Vertical bars
represent + 1 S.E.M. See Fig. 10 for abbreviations. Numbers
of observations ihiparentheses.
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EF MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fig, 17. Concentration of androstenedione in follicular fluid in
relation to follicle size and 3tage of the cycle. Vertical bars
represent + 1 S.E.M. See Fig. 10 for abbreviations. Numbers
of observations in parentheses.
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the large (^8 mm) and small (<8 nun) follicles. The single
exception to this was found during the late follicular phase when
the concentration of androstenedione in the large follicles was
significantly lower than in the small follicles at this time
(P < 0.05).
(vii) Testosterone
The concentration of testosterone in large follicles (^-8 mm)
with respect to stage of menstrual cycle is shown in Fig. 18.
The concentration of testosterone in follicular fluid throughout the
menstrual cycle was between 10 and 3000 times higher than those in
peripheral plasma (Mayes & Nugent, 1968; Vermeulen & Verdonck, 1970).
During the early and mid-follicular and mid-and late luteal phases
the mean concentration of testosteronev«s relatively constant. By
contrast during the late follicular phase the mean concentration of
testosterone was 2 times higher than at any other stage of the menstrual
cycle.
Hormones in the fluid of recently ruptured and 'cystic* follicles
Haemorrhagic fluid was aspirated in vitro from two recently
ruptured follicles in subjects whose endometria still showed very
late proliferative changes. The concentrations of hormones in the
fluids were: progesterone, 8,GOO - 10,800 ng/ml; oestradiol ,
335 - 210 ng/ml; LH, 9.6 - 7.6 mu./ml; F3H, 7.9 - 6.8 mu./ml;
prolactin, 14.6 - 12.1 ng/ml. The levels of LH and FSH were similar
to those in peripheral plasma whereas the concentrations of prolactin
were about half the peripheral plasma concentrations. The oestradiol
and progesterone concentrations were 100 to 1000-fold higher than the
concentrations in peripheral plasma. The concentration of progesterone
in the fluid was also four to eight time3 higher than in late follicular
phase fluid, but the concentration of oestradiol was at lea3t ten times
116.
Fig. 18. Concentration of testosterone in follicular fluid of
large follicles (> 8 ram) with respect to stage of the menstrual
cycle. The vertical bars represent + 1 S.E.M. See Fig. 10 for
abbreviations. Number of observations in parentheses.
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lower.
Data relating to the hormone levels in cystic follicles
are shown in Table 10. All these follicles contained low levels
of oestradiol and progesterone irrespective of the stage of the cycle,
suggesting that they were inactive (Baird & Fraser, 1974b).
Relationship between follicular concentration of hormones
Those follicles which had detectable levels of FSH during the
follicular phase without exception contained significantly higher
concentrations of oestradiol than those with undetectable FSH
(Table 11) (EF, MF, LF; P < O.Ol, I < 0.001, P < 0.001, respectively).
Conversely, follicles with undetectable FSH contained low levels
of oestradiol irrespective of the stage of the cycle. During the
luteal phase these correlations no longer held, since follicles
with or without FSH had consistently low levels of oestradiol.
A significantly higher concentration of progesterone was found
in follicles containing LH (Table 11) (MF, LF, EL, ML, LL;
P < 0.001, P < 0.001, P < 0.05, P <. 0.01, respectively). All the
follicles containing LH and a high concentration of progesterone
were ^ 8 mm diameter and also contained FSH.
During the mid-follicular, late-follicular and the late luteal
phase of the cycle the concentration of oestradiol in follicular
fluid was correlated with that of progesterone, (r = 0.44, n =43,
P <-0.01; r = 0.88, n = 23, P < 0.001; and r = 0.49, n = 37,
P <-0.01, respectively).
The concentrations of oestradiol-17^ and androstenedione
measured in the same samples of follicular fluid with respect to
follicular size and stage of the menstrual cycle are shown in
Fig, 19 and Fig. 20. In small follicles (<8 mm) throughout the
118.
Table 10. Hormone levels in human cy3tic follicles.
(Samples less than the detection limit were assumed to have a
concentration of 1.3 mu./ml , 2.8 mu. /ml, 1.5 ng/ml for FSH, LH

















EF 20 2.8 2.9 13.8 9 55
ie 6.02 1.7 39.0 205 20
14 2.8 1.4 25.2 17 20
20 2.8 1.2 47.0 40 15
MF 20 2.8 6.6 19.9 18 90
15 12.0 1.3 23.0 230 17
25 2.8 2.2 28.2 36 58
ML 10 2.8 1.3 23.0 150 90
13 10.0 1.3 21.0 104 70
10 2.8 1.3 21.0 30 80
LL 10 14.0 2.4 3.0 19 48
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STAGE OF CYCLE
Fig. 19. Concentration of androstenedione and oestrodiol in
large follicles (^8 mm) with respect to stage of the cycle.
Vertical bars represent + 1 S.S.M. See Fig. 10 for abbreviations,





















EF MF LF EL ML LL
20. Concentration of androstenedione and oestradiol in
follicular fluid of small follicles (< 8 on) with respect to stage
of the cycle. Vertical bars represent + 1 S.E.M. See Fig. 10
for abbreviations. Numbers of observations in parentheses.
(MM) trual cycle and In $990* follicles ( £• 8 ») throughout the
luteal phase, the ratio of androatenedione (A{) to ©estradiol (0^)
was always>1 and vnried fro® 2 to 7. The highest ratio was
found in the small follicles during the late follicular phase.
By contrast the ratio in large follicles during the follicular phase
was always<1 and ranged from 0.05 to O.G, the lowest ratio being
found in the large follicles during th® late follicular phase.
PI ^CU-USICM
There «tl no difference between the concentration of hormones
In fluid collected fro® follicles after ovariectomy and thoae
collected in vivo, suggesting that there was little if any production
or Metabolism of hormones in the time between ovariectomy and
aspiration of fluid Ccf Oiorgi, Addis & Colombo, 1063; iaayal
et al., 1971). Although patients were undergoing surgery for a
variety of reasons, the general pattern of hormones in peripheral
pJgams (Fig. 10) was similar to that described in normal women
during the menstrual cycle (e.g. Hobyn ®t si.. 1973; Baird, Burger,
Heavon-Jones & earaauxr.l, 1974). However, the concentration of
prolactin in peripheral plasma was up to sixfold higher than that
in normal women (McNeilly c-t si.. 1973; McNeilly & Chard, 1974),
This is probably because the samples were collected under the stress
of anaesthesia and surgery, which is known to stimulate the release
of prolactin (Hobyn et al.. 1973). The overall mean concentration
of prolactin in follicular fluid (HO-ng/ial, n a 189) was much lower
than that in peripheral plasma. In the absence of information
about the rate of exchange Of prolactin between plasma end
follicular fluid in vivo it is impossible to determine whether this
difference is of physiological importance or whether it is as
artifact due to the «lev ted prolactin concentration in peripheral
plasma as a result of stress. Since all the sam lea were collected
under similar conditions, the striking change in concentration of
rol ctin in follicular fluid at different stages of the cycle
(Fig. li) is robably not an artefact.
The distribution of follicle size in relation to the stage
of the cycle is similar to that previously described in women
(Block, 1951a) and rhesus monkeys (Koering, 1969). Large follicles
<> ft ram) were much commoner during the mid-.-n..! late follicular
and late luteal phases than at any other stages of the cycle.
Although it is difficult to draw conclusions about the dynamics
of follicle growth from these cross-sectional observations, it is
tempting to speculate that these large follicles represent the
end result of two waves of follicular development initiated by the
peaks of secretion of FiB occurring at the onset of menses and
again at rali-cycle. The minimum tirae necessary to develop a
follicle fro® the eatral to the mature preovulatory stage in women
is robably 6 - 1 > days (Brown et al.. 1969; Gerazell & Johansson,
1971; Bertrand, Coleman, Crooks, 'acnaughton u 'ills, 1972). The
concentration of F M in small follicles reaches a maximum during
the early follicular, late follicular or early luteal phases of
the cycle (Table 9) which is either during or just after the peak
concentration of FSH in peripheral blood. Furthermore, the
concentration of F31T in these follicles apparently increases as
they develop into rantur© preovulatory follicles in spite of the
falling levels of PFH in peripheral blood (cf Table 9 and ig. 1).
Some factor may Increase the affinity f these follicles for F H.
©estradiol, the concentration of which i3 extremely high in the
mid- and late proliferative hase fall idea* ia known to increase
the sensitivity of the ovary to FSH (Goldenberg et al., 1972a),
The high levels of oestradiol in the large follicles during the
mid-and late follicular phase are similar to those previously
reported by other workers in normal (Smith, 1960; Short &
London, 19S1; Baird & fraser, 1974b; Sanyal et al.. 1974)
and gonadotrophin-atimulated ovaries (Short, 1964b; Edwards
et al.. 1972). Follicles which have detectable levels of F3H
during the follicular phase also have a high concentration of
oestradiol and an androster.edi .ne to oestradiol ratio of <1 whereas those
follicles with undetectable levels of FSH have significantly lower
levels of oestradiol and an androstenedione to oestradiol ratio>1
(see Fig. 12 and Table 10).
When the concentration of FSH in peripheral plasma was high
(early follicular phase and at mid-cycle) FSH was detectable in only
a minority of small follicles (diameter< Q am) (Tables 3 and 9).
Presumably follicles in which the concentration of FSH is high are
those which are stimulated to further development (Table 11). It
is not known how this minority of small antral follicles are selected
although it has been suggested that oocytes are 'programmed' for
development in the order in which they enter meiosis during fetal
life (Henderson & Edwards, 1968).
About 17% of the small follicles (disaster <8 mm) in the early
luteal phase of the cycle had measurable amounts of FSH and LH
(Table 8), presumably a3 a result of the preovulatory peaks of the
gonadotrophins. In contrast to the follicular phase of the cycle,
none of the follicles in the luteal phase were functionally 'active'
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as indicated by the persistently low concentrations of oestradiol
and an androstenedione to oestradiol ratio of >1, From the time
of the LII 'surge' there is an abrupt fall in the mitotic activity
of granulosa cells (Delforge et al., 1972). Thus the presence of
LH in some of these small follicles (Table 8) may interfere with
their normal orderly development and consequently their
steroidogenic potential (Table 11). The marked increase in
cystic follicles (Fig. 11) from the mid-luteal phase is probably
a consequence of this. It may be that an ordered sequence of
gonadotrophins, e.g. FSH alone followed by FSH and LH, is necessary
for normal follicular development,
Luteinization of the granulosa cells of the preovulatory follicle
commences some 24-36h before ovulation in response to the mid-cycle
LH surge (Hertig, 1967; delforge et al.. 1972). .After exposure
to LH, the preovulatory follicle secretes increasing amounts of
progesterone as indicated by the rise in concentration in the ovarian
vein (Mikhail, 1970; Lloyd et al.. 1971), and in peripheral plasma
(Johansson & Wide, 1969; Yussman & Taymor, 1970). The relatively
high concentration of progesterone in follicular fluid of
preovulatory follicles i3 similar to that found by other workers in
normal (Sanyal et al.. 1974) and gonadotrophin-stimulated ovaries
(Short, 1964b; Edwards et al.. 1972) and it is likely that the
luteinizing granulosa cells are the source of this 3teroid (Channing,
1969a, 1970a; Edwards et al.. 1972). The ovary containing the
preovulatory follicle secretes significantly more androstenedione
than the contralateral ovary, presumably due to increased secretion
from the preovulatory follicle since there is a significant
correlation between androstenedione and oestradiol in ovarian and
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peripheral venous plasma (Baird et al.. 1974; de Jong et al.. 1974)
By contrast the follicular concentration of androstenedione in the
preovulatory follicle is significantly lower than in smaller follicles
at the same stage of the cycle. It is unlikely that luteini3ing
granulosa cells have the capacity to convert androstenedione to
oestradiol in vivo since they have an extremely weak aromatizing
ability (Ryan et al.. 1968; Tounglai & Short, 1970). The ltiw
concentrations of androstenedione in the preovulatory follicle might
be attributable to both an increased permeability of the follicle
(Edwards, 1974) and a lack of a binding protein for this hormone in
contrast to oestradiol (Takikawa, 1966; Takikawa & Yoshinaga, 1968).
The concentrations of testosterone in follicular fluid indicate that
the source of this steroid is ovarian and probably follicular in
origin since it is present at levels which are 100 times higher than
in peripheral plasma (Tagatz & Gurpide, 1973) and 7 to 10 times
higher than in ovarian venous plasma (de Jong et al., 1974). Although
the highest concentrations were present in the large preovulatory
follicle they were variable and not significantly different from those
at other stages of the cycle. Presumably testosterone binding
globulin is present in follicular fluid since the electrophoretic
pattern of follicular fluid is similar to that of serum (Edwards, 1974)
and this may account for the increased accumulation of testosterone
in follicular fluid during the late follicular phase.
The large preovulatory follicles were characterised by a highly
vascular appearance (Short, 1964a). The granulosa cells were very
loosely attached to one another; the walls of the follicle were
slimy and mucoid, and the follicular fluid was bright yellow and
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viscous. When the granulosa cells from large follicles
collected during the preovulatory phase were cultured in vitro
they secreted maximal amounts of progesterone in response to
minimal physiological concentration of gonadotrophin3 in the
medium (Channing, 1970a; see also results, Chapter 5).
The granulosa cells are stimulated in vivo by the relatively
high concentrations of LH in blood and follicular fluid.
Presumably the metabolic requirement of these actively secreting
cells is high and may account for the relatively low oxygen
tension within the follicle (Fraser, Baird & Cockburn, 1973).
The relatively low concentration of prolactin may also reflect
utilization or metabolism of this hormone by the follicle. It
may also play a key role in controlling steroid synthesis, for
the production of progesterone by human granulosa cells in vitro
is inhibited when the concentration of prolactin in the medium
exceeds 20 ng/ml (see results, Chapter 6).
It is apparent that despite the presence of FSH in antral
fluid the granulosa cells do not secrete progesterone in the absence
of LH. Furthermore, the concentration of progesterone in follicular
fluid of small follicles during the luteal phase is significantly
lower than in preovulatory follicles, even though they contain both
FSH and LH. The failure of the granulosa cells in small follicles
to secrete substantial amounts of progesterone when exposed to LH
suggests that these cells require time before they are capable of
responding fully. The latter finding is consistent with the
observation that granulosa cells harvested from preovulatory
follicles in the pig have a significantly greater number of receptors
for LH when compared with the cells harvested at other stages of the
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oestrous cycle (Channing & Kammerman, 1973a; C. P. Channing,
personal communication).
The concentration of oestradiol in the haemorrhagic fluid of
recently ruptured follicles was very much lower than that found
in the large preovulatory follicles. Although most of the fluid
is lost at ovulation the low concentration of oestradiol in
haemorrhagic fluid is consistent with the low plasma levels
during the immediate post-ovulatory period (Fig. 10) (Moor, 1974).
In contrast however, the levels of progesterone were higher than
those found in the preovulatory follicle and this is consistent
with the increased plasma levels, indicating the increasing
secretory capacity of the luteinizing granulosa cells.
Steroid levels in the 'cystic' follicles were low irrespective
of the 3tage of the cycle and in many the pitulary gonadotrophin
concentrations were high and similar to those found in plasma.
These findings suggest that 'cystic' follicles are relatively
inactive and are incapable of secreting much oestradiol or progesterone
even in the presence of gonadotrophin3.
These data suggest that a precise sequence of hormonal changes
occurs within the microenvironment of the developing Graafian follicle;
the order in which the changes occur may well be of considerable
importance for the growth of that follicle and the secretory activity
of the granulosa cells both before and after ovulation. Figure 21
shows the possible inter-relationships between the concentrations
of pituitary hormones in plasma and follicular fluid with respect
to the steroidogenic activity and growth of a follicle during the
follicular and luteal phase of the menstrual cycle. The changes in
the concentrations of pituitary hormones in follicular fluid
throughout the menstrual cycle are related to those which occur in
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FOLLICULAR LUTEAL
STAGE OF MENSTRUAL CYCLE
Fig. 21. The postulated relationships between the concentrations
of pituitary and steroid hormones in peripheral plasma and in the
follicular fluid of a developing follicle during the follicular or
luteal phase of the menstrual cycle (see test). 02 = oestradiol,
P4 = progesterone, j6 = follicle diameter. See Fig. 10 for
abbreviations.
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peripheral plasma. The presence of FSH in the smallest follicles
appears to be important for their development. The presence of
FSH and oestradiol in the follicular phase follicles prepares them
for the preovulatory production of progesterone under the influence
of LH. The very low concentrations of prolactin in these follicles
may be related to the upsurge in metabolic activity within the
follicle during this time. The antral fluid of the preovulatory
follicle contains relatively large amounts of oestradiol and
progesterone, low physiological levels of prolactin, and
concentrations of LH and FSH approaching 30 and 60% respectively of
those found in plasma. These changes in the growth of a follicle
destined to ovulate are different from those proposed for the pig
(Channing, 1972). Such differences that exist will possibly
depend on the permeability of a Graafian follicle in different
species to protein hormones (see Hdwards, 1974, for review).
Furthermore it is suggested that the large inactive follicles
found during the luteal phase are a consequence of LH interference
during the growth of these follicles under the influence of FSH.
The consequence of these findings may prove to be important in




The concentration of FSH, LH, prolactin, oestradiol,
progesterone and androstenedione were measured in peripheral
plasma and follicular fluid of women throughout the menstrual
cycle. In addition testosterone was also measured in follicular
fluid. With the exception of prolactin and androstenedione,
concentrations of pituitary and steroid hormones in follicular
fluid could be correlated with those in peripheral plasma.
Follicle-stimulating hormone was present in a greater number
of small follicles (<8 mm) during or just after the peaks of
F3H in peripheral plasma. During the mid-follicular phase the
concentration of both FSH and oestradiol wa3 high in fluid from
large follicles (^-8 mm). During the late follicular phase the
large follicles (>8 mm) contained high levels of progesterone
and testosterone in addition to oestradiol, low levels of prolactin
and androstenedione and concentrations of LH and FSH of about
30 and 60% respectively of those found in plasma. By contrast
no large "active* follicles O 8 mm) were found during the luteal
phase although many contained both LH and FSH: the concentration
of androstenedione in these follicles always exceeded that of
oestradiol. Luteinizing hormone wa3 present in a proportion of
small follicles « 8 mm) during the late follicular and early
luteal phases but not at other stages of the menstrual cycle.
%
CHAPTER 4
CHANGES IN THE MORPHOLOGY OF HUMAN GRANULOSA CELLS IN VIVO
AND IN VITRO AFTER EXPOSURE TO DIFFERING HORMONAL ENVIRONMENTS.
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INTRODUCTION
Histological sections were prepared from large follicles from
corpora lutea and from granulosa cells which had been cultured
in vitro for ten days. In addition histological sections of the
endometrium from each patient were prepared. The pituitary and
steroid hormones in plasma and follicular fluid were measured.
The morphology of both the theca and granulosa cells in vivo
were related to the hormone concentrations in plasma and follicular
fluid. Similarly the morphology of the endometrium was related to
the hormonal status of each patient. In addition the Morphology
of human granulosa cells after in vitro culture were compared to
the luteinised granulosa cells of the corpus luteum.
RESULTS
The Graafian follicle during the mid~to late follicular phase
The morphological changes occuring in the wall of the large
Graafian follicle (12 mm diameter) and those occuring simultaneously
in the endometrium are shown in Plates 6 and 7 respectively. The
follicle and endometrium were obtained on Day 11 of the menstrual
cycle from a patient (E.A. afce 32 yrs.) whose previous menstrual
5
cycles were normal (7^ days). The hormone levels in plasma
(Table 2) indicate that the specimens were obtained during peak
concentrations of oestradiol-17^g but immediately prior to the mid-
cycle peak of III, at which time the levels would normally exceed
30 mji./ml. The endometrium displays an oedematous stroma and the
glands are lined with cuboidal epithelial cells showing a degree of
pseudostratification. Some mitotic figures are present; however
the general picture is of an endometrium undergoing mid- to late
proliferative changes (Noyes, Hertig & Rock, 1950).
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i late 7Plate 6
Plate 6. 12 mm Graafian follicle removed from a woman (E.A. aged
5
32 yrs.) on day 11. revioua cycle record gg. The cytoplasm of
the theca cells (T) is abundant and pale staining in contrast to
that of the granulosa cell3 (G). Mag. X 580.
%
Plate 7. oid-late proliferative phase endometrium from the same
woman (E.A.). Note the oedematous 3troma (3) and the complete








































































The cytoplasm of the theca cells (T: Plate 6) is abundant
and pale staining in contrast to that of the granulosa cells (G).
The theca cells appear to be actively secretin^ steroid, presumably
oestradiol (Table 12). By contrast the granulosa cells which are
smaller and more compact show no sign of secretory activity.
The Graalfan follicle during the late-follicular phase
The morphological changes ocauring in the wall of the large
Graafian follicle (18 mm) about 24-48 hours prior to rupture and
those occuring simultaneously in the endometrium are shown in
Plates 8 and 9 respectively. The follicle and endometrium were
obtained on Day 15 of the menstrual cycle from a patient (M.B.
3
aged 38 yrs.) whose previous menstrual cycles were normal ("jjfs days).
The hormone levels in plasma (Table 12) indicate that the specimens
were obtained during peak levels of LH and FSH in plasma. The
endometrium shows enlarged and tortuous glands, the epithelial cells
of which 3how evidence of mitotic activity and pseudostratification
is more pronounced than that shown in Plate 7. This is a picture of
an endometrium undergoing late proliferative changes.
The theca cells (T) resemble those in i late 6, but the granulosa
cells closest to the basement membrane and the blood vascular system,
are showing signs of early luteinization. The cytoplasm of the
granulosa cells is enlarged and granular in appearance. The
concentration of progesterone in follicular fluid has increased
70-fold compared to that in the mid-to-late proliferative phase
follicle.
The newly-formed corpus luteum
The morphological changes occuring within the recently ruptured




Plate 8, 18 mm Graafian follicle removed from a woman (M.B.) aged
3
38 years on Day 15. Previous cycle record: The theca cells
(T) resemble those in PJ:ate 6, while the cells of the membrana
granulosa (G) are well dispersed and display a more abundant
cytoplasm. Mgg. X 580.
Plate 9. Late proliferative phase endometrium from the same patient
(M.B.). Note the marked reduction in oedema compared to that shown
by the mid- to late proliferative phase endometrium (see Plate 7).
Mag. X 30.
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simultaneously in the endometrium are shown in Plate 10 and 11
respectively. The CL and endometrium were obtained on Day 15
of the menstrual cycle from a patient (J.C., aged 34 years) whose
4
previous menstrual cycles were normal ("25 days). The hormone levels
in plasma (Table 12) indicate that the specimens were obtained during
the early progestational phase at a time when the gonadotrophlns
were still elevated. The endometrium shows epithelial cells with
marked mfctotic activity, with a 3troma that is much less
oedematous than is the case during the proliferative phase, moreover
many of the glands are displaying basal vacuolation of the epithelium.
The endometrium thU3 3hows changes characteristic of both very late
proliferative as well a3 early secretory stages and the changes in
the endometrium are consistent with the hormonal 3tatus of the
patient.
Histologically the theca cells appear less active than those
shown in Plates Q and 8. The concentration of oestradiol in plasma
and in the haemorrhagic fluid is very low (Table 12) indicating that
this gland is secreting little if any oestradiol at this time.
The corpus luteum during; the mid-luteal phase
The morphological appearance of a fully functional CL(2.42 gins,
19 mm diameter) and that of the endometrium are shown in Plates 12
and 13 respectively. The CL and endometrium were obtained on
Day 18 of the menstrual cycle from a patient (A.S., aged 43 years)
5
whose previous menstrual cycles were normal (days). The hormone
levels (Table 12) in plasma indicate that the specimens were
obtained during the mid-progestational phase. The endometrium has
a very oedematous stroma with tortuous glands. The eosinophiljla of
the luminal cells within the gland3 is indicative of secretion.
These changes are consistent with an endometrium showiig early to mid-
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Plate 10. Plate 11.
late 10. Recently ruptured Graafian follicle removed from a
woman (J.C.) aged 34 years on Day 15. Previous cycle record:
4
The granulosa cells (G) are well dispersed while the
cytoplasm of the thcca cells (T) is much le3s abundant than those
in the late follicular phase follicle (see Plate 8). Mag. X 580.
i lote 11. Very late proliferative-early secretory phase
endometrium from the same patient (JQC,). Note the 'tortuous'
appearance of the glands compared to those during the late-
proliferative phase (see Plate 9). Mag. X 30.
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Plate 12 Plate 13
Plate 12. Corpus luteum of a woman (A.S.) aged 43 years on Day 18.
5
Previous cycle record: 35. Granulosa cells have fully luteinized
and are well dispersed. The theca cells (T) appear large and show
an abundant cytoplasm. Mag. X 580.
Plate 13. Mid-secretory phase endometrium from the same patient
(.A.S.) Note the oederaatous stroma and the 'tortuous* appearance
of the glands. Mag. X 30.
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secretory changes.
The theca cells (T) appear in strands of tissue between the
t
granulosa cells (G) which have fully luteinized. The theca cells
unlike those in the newly formed CL, are apparently secreting
oestradiol since the plasma levels of this hormone are elevated.
Granulosa cells in culture
*
Granulosa cells harvested from either the mid to late or
late proliferative phase follicles described earlier (Plates 6 and 8),
after 10 days culture in vitro, are shown in Plates 14 and 15 respectively.
In both cases the cells display a large prominent nucleus and
extensive cytoplasmic mas3, and are similar in appearance to the
cells of the CL. The cytoplasm of the granulosa cells in culture
appears granular and vacuolated which suggests that they are actively
secreting progesterone. Although the cells in both cultures are
similar in appearance there is a 5-fold difference in their daily
output of progesterone. By contrast there were no detectable levels
of oestradiol in either culture medium. Histologically the difference
appears to be that the cells secreting more progesterone are muc£
more eosinophilic (Plate 15).
DISCUSSION
These studies have described the temporal relationships between
the histological and endocrine changes within the human Graafian follicle,
and corpus luteum. They strongly suggest that oestradiol Is
secreted mainly by the theca cells of the follicle and that the
dramatic rise in progesterone concentration in the preovulatory follicle
is a consequence of early luteinization by the membrana granulosa.
Furthermore they also suggest that the newly formed CL (or haemorrhagic
follicle) is histologically similar to the mature CL since the
granulosa cells are well dispersed and the theca cells which are
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Plate 14. Granulosa cells after 10 days in culture. Cells were
harvested from the same follicle described in Plate 6. Note that
these cells are similar in appearance to those of the corpus luteum
(see Plate 12). Mag. X 580.
Plate 15. Granulosa cells after 10 days culture. Cells were
harvested from the same follicle described in Plate 8. Note that
these cells appear more darkly stained than those in Plate 14,
although they appear similar in appearance overall. Mag. X 580.
localised in streaks of tissue have penetrated deeply into the
gland. However the cytoplasm of the theca cells in the newly
formed CL is les3 extensive than in the mature CL and non-secretory
in appearance. Since most of the antral fluid is lost during
follicular rupture the levels of steroid in the haeraorrhagic fluid
probably reflects the secretory status of this gland since it
contains high concentrations of progesterone and low concentrations
of oestradiol. The levels of gonadotrophin in the fluid are- similar
to those found in plasma, highlighting the marked increase in
vascularis ition which has taken place. Although there are probably
qualitative differences in the secretory products of the CL when
compared to the secretions from the follicle (Ryan et al.. 1968)
it is of interest to note that in women (Lloyd et al., 1971)
and rhesus monkeys (Weiss et al.. 1973; Baird, Hearn & Short,
unpublished observations) where there are distinct populations of
theca lutein cells (Corner, 1956; Gillim, Christensen &, McLennan,
1969; Koering, 1969, and Plate 12) there are higher concentrations
of oestradiol in the vein draining the ovary containing the CL than
on the contralateral side. By contrast the theca lutein cells of
the ewe and cow are barely identifiable (Harrison, 1948; Hansel
et al., 1973) and the CL in both species are unable to synthesize
oestrogen in vitro (Savard et al., 1965; Kaltenbach et al.. 1967).
Furthermore the sheep CL secretes only progesterone and 20 -dlhydro
progesterone in vivo (Short, 1964b; Baird et~al.. 1973). It seems
reasonable therefore to assume that the luteinized granulosa cells
of the mature human CL secrete mainly progestins and that the theca
lutein cells 3ecrete oestradiol although both cell types may
secrete significant amounts of androgens (Lloyd et al.. 1971).
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Histologically granulosa cells in in vitro culture are
similar in appearance to the granulosa lutein cells of the corpus
luteum. Cells harvested from preovulatory follicles when cultured
in vitro are markedly eosinophilic and they exhibit most of the fine
structural features of human luteal cells in situ.(Channlng & Crisp,
1972; T. M. Crisp, personal communication). By contrast cells
harvested from follicles other than preovulatory and cultured
in vitro secrete significantly less progesterone (Fig. 16) and
are less eosinophilic (Plate 14) than the preovulatory cultured
cells and show some fine structural characteristics similar to
those of follicular granulosa cells in situ (Channing & Crisp, 1972).
Human granulosa cells cultured in vitro therefore, provide a convenient
biochemical model system for studying a number of factors
associated with the formation and function of the corpus luteum.
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The morphology of Graafian follicles, corpora ]utea and
granulosa cells after in vitro culture was examined in relation
to the stage of the menstrual cycle, hormone levels in plasma and
follicular or haemorrhagic fluid. In addition, the morphology of
the endometrium from each patient was described and related to the
hormone levels in plasma.
Histologically the granulosa or theca cells of the follicle
or corpus luteura 3how changes which correlate with the hormone
levels in both plasma and follicular or haemorrhagic fluid.
In general the granulosa and theca cell3 have an enlarged cytoplasm
which i3 granular and vacuolated if there are high concaitrations
of progesterone and oestradiol in pla3raa and fluid. In vitro
however, granulosa cells regardless of their daily rate of
progesterone secretion were similar in appearance to tho3e in the
corpus luteum.
CHAPTER 5
RELATIONSHIP BETWEEN THE ENDOCRINE ENVIRONMENT WITHIN THE GRAAFIAN
FOLLICLE AND THE SUBSEQUENT RATE OF PROGESTERONE SECRETION BY
HUMAN GRANULOSA CELLS IN VITRO
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introduction
The granulosa cells within the Graafian follicle do not have
direct access to a blood supply but are bathed in a follicular fluid
which contains most serum proteins, variable amounts of gonadotrophins
and high concentrations of steroids (Edwards, 1974; see also
Chapter 3). Thi3 hormonal microenvironment may be of importance
in determining the subsequent function of these cells in the
corpus luteum.
There is considerable evidence in mammals to suggest that
the steroidogenic potential of granulosa cells in vitro is related
to the stage of the ovarian cycle at which they are harvested
(Channing, 1969, 1970a). It ha3 been shown that a precise
sequence of hormonal changes occurs in the follicular fluid of
the developing human Graafian follicle, and it has been suggested
that the sequence in which these changes occur is of considerable
importance for the growth of that follicle and the secretory
activity of its granulosa cells both before and after ovulation
(see Chapter 3). In order to obtain direct evidence on this
point, follicular fluid and granulosa cells were obtained from
human Graafian follicles of varying sizes throughout the menstrual
cycle. The concentrations of luteinizing hormone (LH), follicle-
stimulating hormone (FSH), oestradiol and progesterone were measured
in follicular fluid and cells from each follicle were cultured
in vitro to assess their steroidogenic potential.
RESULTS
Viability of granulosa cells prior to and during in vitro culture
The mean viability of human granulosa cells at harvesting was
37.0% (range 4.4-100.0%, n - 138). There were no apparent
relationships between cell viability and stage of the cycle, follicle
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size, or the hormone concentrations in follicular fluid at the
time of harvest. The greatest proportion of live cells were
found in follicles harvested soonest after oophorectomy. There
were no significant differences in the assessment of viability
when either nigrosin or lissamine green vital stains were used
(P > 0.2).
Granulosa cells remained viable in culture for at least
16 days, although after 20 days the numbers remaining on the
coverslips declined rapidly. The mitotic index (number of cells
present after ten days, divided by the number of live cells at the
commencement of culture) was related to the environment that they
had been subjected to in the follicle in vivo (Table 13). Details
of the hormone concentrations in follicular fluid are shown in
Table 14. When granulosa cells from any stage of the cycle were
grown in culture medium containing <1 mu. LH/ml, mitosis only
occurred in the presence of added FSH (30 mu./ml) and oestradiol
•f
(l^g/ml), when the mitotic index was S.6-1.9, n = 10).
Biological activity of the hormones
The calf serum which was added to the culture medium contained
immunological LH activity equivalent to 0.7 ng/ml NIH-LH-S14, or
<0.4 mu./ml MUG 68/40 (FSH was not determined). However, this
calf serum stimulated progesterone production by human granulosa cells
in vitro in a manner comparable to a human serum preparation
containing 1.8 mu./ml and 1.7 mu./ml FSH (Fig. 22).
The immunoreactive FSH and LH concentrations in calf serum
were comparable to the lowest levels of FSH and LH found at any
stage of the human menstrual cycle. Progesterone and oestradiol were
undetectable in the calf serum (<50 and <6 pg/ml respectively).
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Table 13. The mitotic activity of human granulosa cells in
vitro when harvested from follicles containing different
combinations of steroid and pituitary hormones.
Hormones in follicular fluid
-FSH +FSH +FSH +FSH -FSH -FSH
-LH -LH -LH -t-LH +LH +LH
~°2 "*°2 +°2 +02 ~°2 ~°'o
Mitotic index 0.66 1.29 3.67 0.98 0.50 0.25
i S.E.M. -0.66 ^0.10 —0.56 ^0.20 *0.05 ±0.11
(No. of bbs.) (186) (43) (53) (72) (9) (11)
The mitotic index refers to the average number of cells remaining at
the end of 10 days in culture divided by the number of live cells at
the commencement of culture. The symbols + or - LH or FSH or
oestradiol (02) indicate the presence or absence of these hormones in
the follicular fluid from which the cells were harvested (3ee Table 14).
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Table 14. Concentrations of hormones in follicular fluid.
♦LH 2.8 mu./ml^ LH
+F >11 } 1.3 rau./ml^ FSH
♦oestrsdiol,^ 230 ng/ml^ oestradlol
The minimum detectable levels for LH and ?>H in the smallest
follicles (4 mm diameter) examined were 2.8 mu./ral and 1.3 mu./ral
respectively, consequently these were chosen as the detection
limits for all follicles for the purpose of group means. The
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DAYS IN CULTURE
Fig. 22. Production of progesterone by granulosa cells grown in
a medium of either calf serum or human serum with a known
concentration of gonadotrophins. Cellular production of progesterone
in calf (white bars) or human (black bars) serum culture medium for
9 days after the cells were harvested from a single 5 mm early
follicular phase (a), 12 mm mid-follicular phase (b), 10 mm late
follicular phase (c), or 6 mm late luteal phase follicle (d). The
concentration of LH and F3H in the culture medium with 20% calf
serum was unknown whereas in the 20% human serum preparation it was
1.8 and 1.7 inu./ml respectively. Each histogram is the mean of
triplicate cultures.
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The production of progesterone by granulosa cells in response
to the addition of LH, FSH, or LH + FSH was variable. The doses
of gonadotrophins which would induce the maximum steroidogenic
response in all follicles was tested in granulosa cells harvested
from the smallest follicles ( 4 mm diameter), and the results are
shown in Figure 23. There wa3 no significant change in production
of progesterone when the concentration of LH was increased from
1.8 mu./ml to 30 mu./ml provided that the dose of FSH was held
constant. Similarly there was no increase in the production of
progesterone when FSH was increased to 30 mu./ml when LH was held
constant. However^ with increased concentrations of FSH the
steroidogenic response to LH was enhanced (Figure 23). There
was no significant increase in the production of progesterone when
the concentration of both LH and FSH were increased from 30 mu./ml
to 90 mu./ml (P> 0.5) (paired t test).
In all subsequent gonaxlotrophin stimulation experiments, the
concentrations of LH and FSH were 30 mu./ml; there wez-e no
significant differences in response between FSH (CPDS/6) and FSH
(73/519). The concentrations of LH and FSH which were added to
the culture were within the normal physiological ranges for these
hormones at the time of the mid cycle 'surge'.(e.g. 25-60 mu./ml)
but about three times higher than the mean levels in follicular
fluid (see Fig. 13).
The effect of differing hormone concentrations in follicular fluid
on the production of progesterone by granulosa cells in vitro
Since there were no differences in the way granulosa cells grew
or secreted progesterone when harvested from patients with stage 0
carcinoma of the cervix or menorrhagia, the results from all follicles
were pooled. The variation in the daily production of progesterone
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Fig, 23. Production of progesterone by granulosa cells
In vitro in response to varying amounts of LH and FSH.
Production of progesterone per cell per day when the following
concentrations of gonadotrophin were present (or added) in
culture medium containing 20>i serum from hypophysectomized
patients: (x) 0.6 and 0.4 mu. LH and FSH/ml; (A) 1,8 and
1.7, 4.4 and 1.7, 16.4 and 1.7 or 30.0 and 1.7 mu. LH and FSH/ml:
(•) 4.0 and 30.0 mu. LH and FSH/mlJ (A) 30.0 and 30.0 LH and
FSH/iol, and (o) 90.0 and 90.0 mu. LH and FSH/ral. The cells
were harvested from 5 early and mid-follicular phase follicles
(all 4 mm in diameter) and each experiment is the mean result
of duplicate cultures.
Fig. 23. (legend on p. 151)
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between replicate cultures for all treatments was 4.9% (range
0.0-19.6%, n = 315).
The daily production of progesterone during 10 days in culture
after various treatments in relation to the hormone concentrations
in follicular fluid at the time of harvesting is shown in
Figures 24-29.
Cells harvested from follicles containing LH, FSH and high
concentrations of oestradiol secreted maximum amounts of
progesterone into the culture medium, and were not influenced by
the addition of LH, FSH, LH + FSH, LH + FSH + oestradiol or
dibutryl cyclic AJfi (DBC) (Fig. 27). By contrast cells fro$
follicles lacking FSH, LH or oestradiol secreted less progesterone
(P 0.001), but were stimulated by the daily addition of LH + FSH,
DBC or LH + FSH + oestradiol (P <C 0.01, paired t test of the means)
(see Figs. 24-29). The response to DBC was similar to LH + FSH
and was significantly less effective than LH + FSH + oestradiol but
more effective than LH, FSH, FSH + oestradiol or oestradiol alone with
one exception (see Fig. 29) (P < 0,001 and P < 0.01 respectively).
The steroidogenic response by granulosa cells in culture to the daily
addition of LH + FSH or DBC was related to the hormone environment
from which the cells were harvested (FSH + oestradiol FSH + LH or
FSH alone^> ** LH or no hormone; *P < 0.01, ^ 6.01).
The maximum production of progesterone by a granulosa cell was
about 5 pg/day and this was achieved within 1-2 days in culture if
cells had been harvested from follicles containing LH, FSH and
oestradiol. By contrast, cells harvested from follicles devoid of any
hormone never achieved the maximum daily production during 10 days
in culture, even after the addition of LH + FSH + oestradiol (Fig. 24).
Fig's 24-29. Average daily production of progesterone by human
granulosa cells during 10 days of culture after various treatments
in relation to the hormone concentrations in follicular fluid are
shown in the next six figures. The average results (+ 1 S.E.M.)
for the individual treatments are represented by the lines
indicated. The average results of a number of different treatments
were not significantly different from each other (1^0.05, paired t
test), eonsequently they are represented by the same line. The
symbols + or - indicate the levels of hormones in follicular fluid:
+ LH > 2.8 mu./ml, - LH ^ 2.8 mu./ml; + FSH > 1.3 mu./ral and
- FSH ^ 1.3 mu./ml; + oestradiol > 250 ng/ml and - oestradiol (02)
^250 ng/ml. The follicular fluid contents are indicated in the
boxes. The hormone treatments given in the culture media are shown
on the figures. The number of experiments is shown in parentheses.
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Fig. 27. (legend on p. 154)
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Fig. 98. (legend on p. 154)
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Fig, 29. (legend top. 154)
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DISCUSSION
The most interesting aspect of this study is the clear
demonstration that the ability of human granulosa cells in culture
to undergo mitosis or secrete progesterone is predetermined by the
hormonal environment of the follicle from which they have been
harvested. This therefore gives added point to the previous study
(see discussion, Chapter 3) which documented a critical sequence
of hormonal changes that take place within the follicular fluid
prior to ovulation.
It seems that the mitotic activity of the granulosa cells
in the intact follicle is stimulated by the presence of FSH and
high concentrations of oestradiol in follicular fluid, an ability
that is retained in culture. However, the presence of LH in the
follicular fluid, or the addition of LH to culture medium impairs
this mitotic activity (Delforge et al.. 1972; see discussion,
Chapter 3).
The biosynthetic activity of the granulosa cells in culture is
also influenced by their prior hormonal environment. Progesterone
secretion was greatest from cells harvested from follicles that
contained high concentrations of FSH, LH and oestradiol. Similarly,
the addition of these three hormones to the culture wqs able to
stimulate progesterone secretion if the cells had been obtained from
hormone deprived follicles. These findings are consistent with
those reported by Goldenberg et al., 1972b) for porcine granulosa cells.
It is of interest to relate these findings to the sequence of
hormonal changes taking place in the Graafian follicle during the
course of follicular maturation (see Fig. 21). During the early
follicular phase FSH and lew concentrations of oestradiol were present
in a large proportion of small antral follicles. By the mid-
follicular j hase there were few small follicles with F3H, but
3ome of the larger ones now contained high concentrations of both
FSH and oestradiol. Ju3t prior to ovulation, the largest follicle
contained high concentrations of LH in addition to FSH and oestradiol.
It is tempting to conclude that the initial appearance of FSH may
be essential for follicular growth (Baird et al., 1975);
subsequent exposure to FSH and oestradiol stimulates both the mitotic
activity of the granulosa cells and an increase in the number of
receptors for LH (Zeleznick et al., 1974; Channing, 1975) which
prepares them for eventual steroid secretion. The final entry
of LH into the follicle inhibits further mitosis and together with
prolactin (see results in Chapters 6 and 8) initiates progesterone
secretion.
There seems to be good agreement between the time course of
these events in vivo and in vitro. For example, FSH treatment
in vivo takes 6-10 days to mature a follicle (Brown et al., 1969;
Gerazell & Johansson, 1971; Bertrand et al.. 1972) and granulosa
cells harvested from 3mall early follicular phase follicles (containing
FSH) achieve their maximum biosynthetic capacity in vitro after
S-IO days if LH, FSH and oestradiol is added to the cultures each
day. Although it is necessary to add LH to assess the steroidogenic
potential of granulosa cells in vitro, LH does not enter the follicle
in appreciable amounts until the mid-cycle peak in plasma (see
Fig. 13). These studies suggest therefore that a relatively long
period, 8-10 days, of continual exposure to FSH and oestradiol is
required before the maximum biosynthetic capacity of the granulosa
cells is achieved; this synthetic potential is then only realised
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and sustained in the presence of low physiological amounts of
gonadotrophin and prolactin (see results section, Chapter 6).
During the luteal phase, Graafian follicles secrete little
or no oe3tradlol (Baird & Eraser, 1974a>, presumably because of the
insufficient gonadotrophic support (Baird et al., 1975). These
follicles have low concentrations of oestradiol in their follicular
fluid (Baird & Fraser, 1974b; de Jong et al., 1974; Sanyal et al..
1974; Fig. 15),,but they may contain LK or LH + FSH. Granulosa
cells harvested from these follicles do not undergo mitosis in culture
and furthermore they secrete only low amounts of progesterone. Thus
it appears that granulosa cell3 within follicles in the luteal phase
and lacking oestradiol are unable to proliferate or achieve their
maximum biosynthetic capacity. These findings also suggest that the
premature appearance of LH in the follicular fluid of a Graafian
follicle could arrest mitosis and interfere with the ability of
granulosa cells to achieve their maximum bioaynthetic potential. It
appears that only the actively maturing follicle receives the critical
sequence of hormones that will allow its granulosa cells to proliferate
and achieve their maximum biosynthetic potential following ovulation.
These studies have shown that it is only granulosa cells from
the actively maturing follicles whose steroidogenic potential is
related to the stage of the ovarian cycle; Channing (1969c, 1970a,
1970b, 1970c) has made similar observations for horse, pig and rhesus
monkey. However, most follicles recovered throughout the menstrual
cycle were presumably not active because they were devoid of
gonadotrophin(s) and/or oestradiol, and the steroidogenic potential
of their granulosa cells were unrelated to the stage of the cycle.
These studies 3tronly suggest that the hormonal environment of
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the Graafian follicle influences both the mitotic activity and
bioaynthetic potential of its granulosa cells, so that endocrine
events occurring some considerable time before ovulation may
dictate the subsequent activity of the corpus luteum.
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SUMMARY
The steroidogenic potential of granulosa cells harvested from
human Graafian follicles containing varying concentrations of
pituitary and steroid hormones was examined. The mitotic activity
and production of progesterone by granulosa cells in vitro was
found to be correlated with their hormonal environment at the time
of harvesting. Only cells from follicles containing some FSH
and high concentrations of oestradiol underwent spontaneous
mitosis in vitro. However, mitosis could be induced by adding
FSH and high concentrations of oestradiol to the culture, provided
that the concentration of LH was low. Cells harvested from
follicles containing LH, FSH and high concentrations of oestradiol
secreted significantly more progesterone than cells from follicles
which did not contain all three hormones.
CHAPTER 6
A POSSIBLE ROLE FOR PROLACTIN IN THE CONTROL OF STEROID
SECRETION BY THE HUMAN GRAAFIAN FOLLICLE
1 NTRGD uCT I ON
In an attempt to gain more insight into the possible role of
prolactin in controlling ovarian activity in women, the effects of
the addition or neutralisation of human prolactin in culture media on
the production of progesterone by human granulosa cells growing in
tissue culture were studied.
lidd ULTd
The effect of prolactin on the viability and mitotic activity of human
granulosa cells in culture
hen cells were exposed to prolactin at concentrations between
0.2 and lOO ng/ml with or without added LH + F3H there was no significant
increase or decrease in cell numbers during the 10 days of culture
when compared to untreated controls.
The production of progesterone by granulosa cells in culture medium
in which the endogenous prolactin was neutralised with excess prolactin
antiserum
Neutralisation of prolactin in the culture medium by the addition
of rabbit anti-human prolactin 3erum (A4) (1/5CO, v/v final dilution)
caused a significant decrease in the production of progesterone when
compared to the controls (Fig. 30) (p < 0.001, tudent3 t test).
The controls were either untreated culture medium (5 duplicate
experiments) or culture medium treated with normal rabbit serum (3),
rabbit anti-bovine serum albumin (3) or rabbit anti-human growth
hormone (5) all of which were present at a final dilution of 1/500
(v/v). There were no significant diffex-ences in the production of
progesterone between these control cultures (p ^ 0.05) which were found
to be within the precision achieved in replicate cultures. To confirm
that free prolactin in the culture medium had been completely neutralised
by the antiserum, the anti-i rolactin-prolactin complex was precipitated
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Fie. 30. The daily production of progesterone by human granulosa
cells in a culture medium in which the endogenous prolactin activity
was neutralised with excess rabbit anti-human prolactin serum.
itesults are expressed as a percentage of the controls and represent
+
the mean of 5 replicate cultures. Vertical bars = - 1 S.E.M.
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FSH in the medium were unaltered whereas prolactin was undetectable
( CO.2 ng/ml) .
The daily ;reduction of progesterone by granulosa cells in a culture
medium containing high concentrations of prolactin
The effect of adding prolactin to culture medium on the daily
production of progesterone is shown in Fig. 31. There was no effect
on progesterone secretion if the concentration of prolactin wa3 between
5 and 20 ng/ml; the mean concentration of prolactin in peripheral blood
of women during the menstrual cycle is 15 - 1 (- S.3.M.) (McNeilly,
Evans Ss Chard, 1973). hen the concentrations in the culture medium
were increased from 25 to 100 ng/ml, there was a progressive decrease
in the daily production of progesterone. hen the concentration of
prolactin in the culture medium was 1O0 ng/ml, the total progesterone
output after 10 days culture was only 10% of that ahcieved in the
control (Fig. 31). This inhibitory effect persisted even when the
concentrations of LH (1.8 mu./ml) and FSH (1.7 mu./ml) were both
increased to 30 mu./ml (Fig. 32) and it could be obtained with
granulosa cells collected from follicles at any stage of the menstrual
cycle.
When the concentrations of prolactin were increased on the 5th
and 6th day of culture from 10 to 100 ng/ml there was an immediate
fall in the daily secretion of progesterone (Fig. 33) which returned
to control values when the prolactin concentrations were lowered once
more.
DISCUSSION
These studies clearly demonstrate that granulosa cells are
dependent on low physiological levels of prolactin for the secretion
of progesterone. Furthermore the cells appear to secrete at
maximum capacity when the concentration of prolactin is within the
169
ng Prolactin/ml
Fig. 31. Effect of varying concentrations of prolactin on the
total production of progesterone by humnn granulosa colls during
10 days culture when the cells were exposed to low levels of LH and
FSH (each <2 mu./ml). Each point (x) is the mean result of
5 duplicate experiments. The vertical bars represent - 1 .E.M.
The results are expressed as a percentage of the controls.
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ng Prolactin/ml
Fig. 32. Effect of varying concentrations of prolactin on the
total production of progesterone by human granulosa cells during
10 day3 of culture when the cells were exposed to high concentrations
of LH and FSH (each 30 mu./ml). Each point (x) is the mean result
of 5 replicate experiments. The vertical bars represent
+
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PiK. 33. liffect of increasing the concentration of prolactin in
culture medium on Days 5 and 6 on the daily production of progesterone
by human granulosa cells. f f represents the mean daily production
by cells exposed to 100 ng prolactin/ml on Days 5 and 6 (Q duplicate
experiments); X ■ X represents the mean daily production by cells
exposed to 10 ng prolactin/ml each day (6 duplicate experiments).
Vertical bars represent - 1 3.E.M.
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normal physiological range (i.e. 5-20 ng/ral) (McNeilly et al.. 1973).
If the concentration exceeds 20 ng/ml however, there is a marked
inhibition of progesterone secretion which is not overcome by
increasing the levels of LH and F3H although secretion returns to
normal immediately after the levels of prolactin are lowered. Since
neither the viability nor the mitotic activity of the cells are
affected when they are exposed to high concentrations of prolactin,
the inhibitory effect is probably a consequence of changes in the
biosynthetic potential of the cell. Similar results have been
obtained with intact mouse follicles maintained in organ culture using
human, rat or sheep prolactin (McNatty, Neal & Baker, unpublished
observations). Those findings suggest that prolactin may have an
important role in controlling steroidogenesis by the Graafian follicle.
Prolactin is probably essential for steroidogenesis since it influences
the amount of cholesterol available for metabolism through to
progesterone (Armstrong, Knudsen & Miller, 1969; Behrman et al.,
1970; Behrman, MacDonald & Greep, 1971b). However the way in which
high levels of prolactin alter the biosynthetic potential of the cells
remains unknown.
These in vitro experiments suggest that high concentrations within
the follicular fluid may actually depress progesterone secretion by the
granulosa cells. This might provide an explanation for the fact that
galactorrhoea with high prolactin levels is commonly associated with
amenorrhoea (Perez, Vela, Masnick & Potter, 1972), and that if the
prolactin levels are lowered by treatment with 2-Br-o(-ergocryptine-
methanesulphonate (CB-154), ovulation and menstruation recur (Besser,
Parke, Edwards, Forsyth & McNeilly, 1972; del Pozo, Brun del Re,
Varga & Friesen, 1972). It is well recognised that post-partum
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lactation can inhibit ovulation in women and other animals
(Perez et al.. 1972; Bonte & van Balen, 1969) although the
mechanism has never been explained.
Although there are now numerous descriptive accounts of the
changing hormone levels in blood and urine throughout the menstrual
cycle, we do not really understand what factors are responsible for
the formation, maintenance and regression of the human corpus luteum.
This is an area of great potential interest for the development of
new forms of contrace tion. The in vitro results presented here
cast doubt on the simplistic view that LH is the only gonadotrophin
necessary for luteal maintenance (Vande Wiele et al.. 1970)
and suggest that prolactin is also involved. Furthermore, they
add further support to the hypothesis that the gonadotrophin content
of the follicular fluid has important consequences for the secretory
activity of the granulosa cells both before and after ovulation.
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iUMFAKY
Granulosa cells were cultured in a medium in which the rolactin
activity was neutralised with excess antiserum to prolactin or in a
medium in which the concentration of rolactin was increased with or
without a concomitant increase in LH and 7 H.
The production of progesterone by granulosa cells was inhibited
either after complete neutralisation of free prolactin in the
culture medium or when the concentration of prolactin was > 25 ng/ml.
The inhibitory effect with high concentrations of prolactin with or
without LII + F3H was not due to changes in cell viability or
mitotic activity. Furthermore the inhibitory effect with high
concentrations of prolactin was reversible.
CHAPTER 7
IMMUNOREACTIVE SUBUNITS OF LUTEINIZING HORMONE IN I-ERIFHSRAL
PLASMA AND FOLLICULAR FLUID THROUGHOUT THE MENSTRUAL CYCLE AND
THEIR EFFECT ON THE SECRETION RATE OF i-ROGSSTERONE BY
GRANULOSA CELLS IN CULTURE
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INTRODUCTION
The pituitary glycoproteins, LH, F3H and thyroid-3timulating
hormone (T3H) consist of two non-identical, noni-covalently linked
polypeptide chains or subunits termedo( and ^ (Ryan, 1968;
Papkoff & Ekblad, 1970; Papkoff, Jairam & Li, 1971; Pierce, Liao,
Howard & Shome, 1971; Saxens & Rathnam, 1971; Stockell-Hartree,
Thomas, Braikevitch, Bell, Christie, Spaull, Taylor & Pierce, 1971).
Similarly the subunit nature of HCG has been established (Swaminathan
5s Bahl, 1970; Canfield, Morgan, Kammerman, Bell 8s Agosto, 1971;
"organ 8s Canfield, 1971), The c<-subunits of all four hormones
T3H, LH, FSH and HCG are chemically and immunologically similar
whereas the ^-subunits are all different and responsible for the
biological and Immunological specificity of the hormones
(Vaitukaitis St Ros3, 1972). Thus the p(-subunit of one of the four
glycoproteins can be combined with the^-3ubunit of any of the other
three and the biological activity i3 characteristic of the hormone
from which the p-subunit is derived (Greep, 1974).
Most studies have generally shown that the and ^-subunits are
both very low in biological activity (i.e. ~33% or less of the
activity of the native molecule (Fapkoff & Li, B70; Pierce et al.. 1971;
Channing & Kammerman, 1973b; Stockell-Hartree, personal communication)
whilst the biological activity of the recombined subunits is largely
or completely restored. However, a few studies have suggested that
the subunits may have considerable biological activity. For example
the p-subunit of ovine F3II, when tested in lizards, has all the
activity of the native or reconstituted (ctf +^) hormone, whereas the
o(-subunit is totally inactive (Licht fit Papkoff, 1971). Similarly
the p-subunit of ovine LH when tested in rats for lipotrophic
activity i3 as active as the complete molecule (Gospodarowicz, 1971)
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More recently the (J- subunit of ovine LH has been shown to be
effective in the induction of ovulation in intact and hypophyaectomized
hamsters, whilst the o(-subunit is totally inactive (Yang, Sairam,
Papkoff & Li, 1972).
The subunits of human LH probably circulate in plasma
independently of the intact hormone (Laburthe, Dolais & Rosselin,
1973; Hagen & McNeilly, 1975a; Hagen, McNatty & McNeilly,
unpublished data), with peaks occurring during fche late follicular
phase of the menstrual cycle. It is not known whether the subunits are
released independently by the pituitary or whether their presence in
plasma is a consequence of intact hormone dissociating (Stockell-
Hartree, personal communication).
Proteins can cross the blood-follicle barrier and the
distribution of serum proteins in follicular fluid is approximately
proportional to their molecular weights (Johnson, 1973), It is
reasonable to assume therefore that the subunits of LH are present
in follicular fluid in greater amounts than the intact hormone.
The possibility of raising antibodies against the p-subunit of a
protein hormone may provide a method of neutralising the biological
activity of the intact hormone from which the (3 -subunit was derived
without interfering with the biological activities of other closely
related protein hormones (Hearn, Short & Lunn, 1975; Stevens, 1975).
This technique provides an immunological method for the control of
fertility. Since there are probably circulating levels of subunits
in plasma and follicular fluid it seems necessary to examine the
effects of the 3ubunits on follicular development and/or ovarian
steroid secretion. Furthermore it seems necessary to use an in vivo or
in vitro biological teat system from the same species as that from
which the pituitary or placental subunit i3 derived in view of the
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potent activities they can have in an unrelated species (see Licht &
Papkoff, 1971)
The concentrations of o( - ond (3 -subunits of luteinizing hormone
(IH</ and LH (3 respectively) were measured in samples of peripheral
plasma and follicular fluid collected from women at varying 3tages of
the menstrual cycle. The aim of this study was to investigate the
relationship between the concentrations of LHe< and LHp in follicular
fluid and to relate them to concentrations in plasma, follicle size
and the stage of the menstrual cycle. In addition the rate of
progesterone secretion by human granulosa cells in tissue culture
after exposure to the f*- and [3-subunits of LH was compared to that
achieved after the cells were exposed to Intact LH.
ftESTPDES
Concentration of LHt* and LHp In plasma
Figure 34 shows the concentration of LHe<and LHp in plasma in
relation to the stage of the menstrual cycle. The samples were
obtained from patients during surgery and immediately prior to
oophorect omy.
Concentration of LHo< in follicular fluid
The mean concentration of LHoCin all antral fluids in relation
to follicular size and the stage of the menstrual cycle is shown in
Fig. 35. The minimum detectable level of LH<X in the smallest
follicles (4 mm) examined wa3 0.6 ng/ml which was therefore chosen
as the limit of detection for all follicles. The percentage of
follicles with detectable LHo< at each phase of the cycle is shown
in Table 15. The greatest proportion of follicles with itf-subunit
are found when there are peak levels in peripheral plasma (Fig. 35),
The o(-subunit was detectable in a proportion of large follicles
17ff.
Fig. 34. Concentration of tx and p subunits of LH in peripheral
plasma in relation to the 3tage of the menstrual cycle. Results
shown represent means + 1 S.E.M. For abbreviations see Fig. 10.
Numbers in parentheses represent number of observations.
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Fig. 35. Concentration of LHcx' in follicular fluid in relation
to follicle size and stage of the cycle. Results shown represent
means + 1 S.E.M. For abbreviations see Fig. 10. Numbers in
parentheses represent number of observations. The dotted line
represents the detection limit of the assay (0.6 ng/ml).
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Table 15. Percentage of follicles with detectable levels of LH<=</










LF EL ML LL
< 8 mm oi 0.0 25.0 45.6 25.0 0.0 0.0
V 0.0 0.0 30.0 25.0 0.0 0.0
^ 8 mm oC 33.0 25.0 5O.0 25.0 16.0 16.0
f 0.0 0.0 45.6 25.0 0.0 0.0
EF, MF and LF refer to early, patient still menstruating, mid- and late
follicular phase repsectively, while EL, ML and LL refer to early, mid-
and late luteal phase respectively.
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( ^.8 mm) at every phase of the menstrual cycle at concentrations
similar to those found in plasma. By contrasto(-subunit was only
detectable in small follicles (< 8 ram) during the mid- to late
proliferative phase and the early secretory phase of the cycle.
Concentration of LH p in follicular fluid
The mean concentration of LHp in all antral fluids in relation
to follicular sire and the stage of the menstrual cycle is shown in
Fig. 36. The percentage of follicles with detectable LHp at each
phase of the cycle is shown in Table 15. The minimum detectable
level of LHp in the 3mall©3t follicle examined was 0.6 ng/ml which
was therefore chosen as the limit of detection for all follicles.
The p-subunit was only detectable in a similar proportion of small
or large follicles either during or just after peak concentrations in
peripheral plasma. The concentration of p-subunit in follicular
fluid at mid-cycle was similar to that in plasma.
The effect of subunlts of LH on the viability and mitotic activity of
granulosa ceil3 in vitro
When cells were exposed to LHcX and LHp alone or in combination,
there wa3 no significant increase or decrease in cell numbers during
the 10 days of culture, when compared to untreated controls.
The effect of differing; doses of LHck or LHp teubunit on the daily
production of progesterone by granulosa cells in culture.
Figures 37 and 38 show the daily production of progesterone by
granulosa cells after daily exposure to LHp< and LH|3 at concentrations
between 1 and 100 ng/ml. The daily production was expressed as a
fraction of that achieved by the untreated control; if the subunit
had no effect on steroidogenesis then the production rate/day was 1,
but if stimulation occurred then the production rate was^>l. There
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EF MF LF EL ML LL
STAGE OF MENSTRUAL CYCLE
Fig, 30. Concentration of LHj3 in follicular fluid in relation to
follicle size and stage of the cycle. itesults shown represent means
+ 1 j.E.M. For abbreviations see Fig. 10. Numbers in parentheses
represent number of observations. Dotted line represents the
detection limit of the assay (O.o ng/ml).
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Fig. 37. Effect of differing doses of LHc/dn the daily production
of progesterone by granulosa cells. The results are expressed as
the ratio of LHo(stimulated cells divided by the controls.
Results of each experiment are the mean of 4 duplicate cultures.
Every culture contained 30 rau. FSH/ml of the medium each day.
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Fig, 38, Effect of differing doses of LH|3 on the daily production
of progesterone by granulosa cells in culture. The results are
expressed as the ratio of the LH^ stimulated cells divided by the
controls. Results of each experiment are the mean of 4 duplicate
cultures. Every culture contained 30 mu. FSH/ml of medium each day.
was no increase in the daily production of progesterone when the
concentration of oC - or |3-subunit was between 1 and 20 ng/ml;
however there wa3 a progeessive increase in production if the
concentration of either 3ubunit was increased from 40 to 100 ng/inl.
I'he effect of adding both LHof and LHp subunita on the daily production
rate of progesterone by granulosa cells in culture.
The daily addition of 10 or 40 ng LH<x and LH{3 simultaneously is
shown in Fig. 39. By the 10th day of culture, 10 ng LH« + 10 ng LH p
increased the daily production rate 7-fold while 40 ng LH<*+ 40 ng LHp
induced a 15 fold increase. By contrast 30 rnu. LH induced a 10 fold
increase in the production rate on the 10th day of culture. Since
7 mu. of Lil is approximately equivalent to 1 ng LH (W. M. Hunter,
personal communication) then equivalent amounts of os+p, subunits
only produced ~30% of the activity of intact LH (m/m).
DISCUSSION
During the normal menstrual cycle there are peak concentrations
of LH and FSH at mid cycle (Fainrvan St iiyan, 1967; Burger, Catt &
Brown, 1968; Midgley & Jaffe, 1968; Frinohimont, 1969; abraham,
Odell, Swerdloff & Hopper, 1972). It is al3o apparent that there
axe peak concentrations of both subunits ooincident with both LH and
F3H.
The pattern of LH cF and LH|? in follicular fluid is reminiscent
to that for FSH and LH (see discussion, Chapter 3). Follicle-
stimulating hormone wa3 present in a greater number of large follicles
( ^.8 mm) both at the early and late follicular phases, Similar
results were found for LH<*. Unlike FSH however, the concentration
of the o(-subunit in fluid was similar to that found in plasma. This
difference may either be due to lack of uptake or utilization of the
186;
Fig. 39. Effect of LHo( + LHp on the production of progesterone
by granulosa cells in culture. The results are expressed as the
ratio of the LUt* + LHp stimulated cells divided by the controls.
Results for each experiment are the mean of 3 duplicate cultures.
Every culture contained 30 mu. FSH/ml of medium each day.
subunit or merely due to differences in the rate of tiansfer across
the blood-follicle barrier. Intact LH was found only in follicles
either at the late-follicular or early luteal phase of the cycje.
Similar results wore found for LHjJ. Although LHp, was not
detectable in any follicle other than at mid-cycle, this may be because
the minimum detectable level in fluid was close to the actual levels
in plasma. Nevertheless the results clearly show that the
concentrations of LH^ in follicular fluid at miu-cycle were similar to
those in plasma.
It seems unlikely in view of the in vitro findings that the
subunits either alone or in combination influence the rate of cell
mitosis or their viability unless both subunits are present in
follicular fluid in high concentrations prior to the mid-cycle
gonadotrophin peak (Table 13), Furthermore when I.Hof is present in
follicular fluid even with FSH it is unlikely to alter or disrupt
the developing steroidogenic potential of the granulosa cells.
However at mid-cycle when both o^- and p-subunit are present in the
fluid of a large preovulatory Graafian follicle it is not unreasonable
to expect recombination of the subunits to occur which would enhance
steroidogenesis by the granulosa cells undergoing luteinization at
this time (3ee Fig. 39).
The biological activity of the glycoproteins and their 3ubunits
have been studies in vivo and in vitro and mo3t studies have 3hown
that the subunit3 themselves have little or no intrinsic biological
activity ( eichert, 1972; Catt, Dufau fc Tsuruhara, 1973; Cole, Davis,
Hu3©by & Rice, 1973). The present studies 3upport these conclusions
and suggest that the role of the subunit3 of LH in follicular
development is at beat only of minor significance.
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SUMMARY
The concentration of theo<- and |$ -subunits of LH in peripheral
plasma and follicular fluid was measured throughout the menstrual
cycle, and the effects of LHc* and LHp either alone or in combination
on the production of progesterone by human granulosa cells in tissue
culture was investigated.
Changes in the plasma concentrations of LIIi* and LHj3 throughout
the menstrual cycle were similar to those of LH and F3H. In
follicular fluid, LH<* was detectable in large follicles (^8 mm)
throughout the menstrual cycle at concentrations similar to those
found in plasma. By contrast LHwas only detectable in small
follicles (< 8 mm) and LHp in all follicles during or just £fter
peak concentrations in peripheral plasma. The LH subunits,
even at levels 5 times higher than those in plasma did not increase
the rate of progesterone secretion by human granulosa cells when
each were added alone. However when both subunits were added
simultaneously the increased rate in progesterone secretion was
about 30>o of that achieved with intact LH.
CHAPTER 8
THE EFFECTS OF ANTIBODIES TO HUMAN GONADOTROPINS ON THE
VIABILITY OF, AND RATE OF PROGESTERONE SECRETION BY
HUMAN GRANULOSA CELLS IN CULTURE
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INTRODUCTION
Human serum was treated with antibodies to gonadotropins to
remove selectively either FSH, prolactin and/or LH before adding the
serum to preovulatory granulosa cells in tissue culture. In this
way the role of each pituitary hormone in the initiation and
maintenance of steroidogenesis by luteinizing granulosa cells in
tissue culture was investigated.
RESULTS
Concentrations of ^onadotrophlns in human serum after antigonadotrophin
treatment
The concentrations of LH, F3H and prolactin in human serum before and
after treatment with antigonadotrophin sera are shown in Table 16.
The concentrations of LH and FSH were generally unaffected after
treatment with normal rabbit or guinea pig 3erum, or rabbit anti-
bovine serum albumin. Rabbit anti-growth hormone treatment removed
about 50/i of the endogenous prolactin. The rabbit anti-human prolactin
Am removed selectively>95% of the endogenous prolactin while the anti
prolactin A3 removed >95% of both LH and prolactin. Guinea-pig anti-
human LH treatment removed "-95;i of the FSH and about SO/o of the LH
while rabbit anti-human LH removed ~ of the LH and ~50% of the FSH;
in both cases the concentration of prolactin did not change.
Viability of HeLa cell3 cultured in antlgonadotrophin treated serum
There was no morphological evidence to suggest that the
antigonadotrophin treated culture media or untreated control media
contained cytotoxic agents or lacked serum components essential for
the maintenance of cells in culture. In all cultures mitosis had
occurred, and the coverslips on which - 90,i of the surface area was
covered in cells at the start of culture were nearly all completely































































































Concentrations of gonadotrpphins and oestradiol In the follicular
fluid of the Graafian follicles
All 30 samples of follicular fluid contained detectable amounts
of LH (range 0.8-1,8 mu./ml), FSH (mean 2.0, range 1.3-3.9 mu./ml),
prolactin (mean 9.6 range 1.5-18.1 ng/ml), and high concentrations of
oestradiol (mean 704, range 239-3600 ng/ml). Thus all the granulosa
cells were harvested from actively developing follicles (see Chapter
3 and 5).
I rogesterone secretion by granulosa cells grown in a culture medium
devoid of gonadotrophin(s)
The secretion of progesterone by granulosa cells in normal human
serum (36 experiments) was not significantly different from that
achieved by cells cultured in human serum containing antibodies to
steroid producing tissues (42) (P > 0.2, paired t test). iimilarly
there were no significant differences in the secretion of progesterone
between cells cultured in normal human serum (36 experiments), human
serum treated with normal rabbit serum (20), normal guinea pig serum
(10), rabbit anti-BSA serum (8) or rabbit anti-HGII serum (12)
(P y 0.05, paired t test). Consequently the secretion of progesterone
from the granulosa cells cultured in gonadotrophin deprived culture
medium was compared to the average secretion rate from all control
cultures in the same experiment. The variation in the secretion of
+
„ +
progesterone between duplicate cultures was 7.3 - 1.9%, mean -
(n = 174).
Granulosa cells in the control cultures achieved their maximum
rate of secretion (about 5 pg/cell/day) after 2 to 5 days in culture
and maintained this secretion rate until the cultures were stopped
on Day 10 (see Fig. 26 and 27).
The daily progesterone secretion by granulosa cells cultured in
a medium devoid of prolactin alone or prolactin + LH is shown in
Fig. 40. After 24 hours in either medium, the secretion of
progesterone was only 60% of the controls, and from Day 6 to 10 of
culture the secretion rates were only 30 and 20% of the controls
respectively although the number of cells was similar in treatment
and control groups. In all experiments, between SO and 125% of
the cells remained after 10 days culture when compared to the number
of live cells on the first day of culture. The daily secretion of
progesterone by granulosa cells grown in a culture medium with a
concentration of LH which wa3 about 20 times lower than the controls
(0.17 mu./ml compared to 3.1 mu./ml LH) is shown in Fig. 41. The
number of cells remaining in the treatment and control groups was
similar and was between 91 and 140% of the number at the start of
culture. Although the cells remained viable when exposed to
extremely low levels of LH their daily secretion of progesterone
in vitro declined in a manner similar to those cultured in a medium
devoid of prolactin.
The number of cells remaining on the coverslips after 10 days
culture in serum devoid of FSH (<0.09 mu./ml) was only 7.8 - 1,4%
(n = 5) of those remaining in the controls. The addition of 30 mu.
FSH (MKC Std. 73/519) each day in 50^1 of phosphate buffered saline
to the culture medium devoid of FSH maintained the cells at similar
numbers to those in the controls (Table 17).
DISCUSSION
This 3tudy has clearly demonstrated the involvement of all three
human pituitary gonadotropins (LH, FSH and prolactin) in the initiation
and maintenance of progesterone secretion by human granulosa cells
in vitro. The granulosa cells were obtained from large active
follicles just prior to ovulation, and they secreted maximum amounts
193.
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Fig. 40. The daily production of progesterone by human granulosa
cells in culture medium devoid of prolactin O 1 #)(5 duplicate
experiments) or prolactin plu3 LH (4———A) (3 duplicate experiments)
expressed as a percentage of the controls. The vertical lines
represent - 1 S.E.M. The controls are represented by the hatched











Fig. 41. The daily production of progesterone by human granulosa
cells in a culture medium containing 20 times less LH than the
controls . -£\) <7 duplicate experiments), expressed as a
+
percentage of the controls. The vertical lines represent - 1 S.E.M.
The controls are represented by the hatched lines which illustrate
the mean and - 1 S.E.M.
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Table 17. The effect of FSH on the viability of granulosa cells
in culture
No. of cells alive
at time of
inoculation (X lO3)
No. of cells alive after





























-FSH refers to culture medium devoid of FSH
-FSH + FSH refers to culture medium devoid of FSH with 30 mu.
FSH/ral added each day
Control refers to culture medium with untreated human serum with
2.5 mu./ESH/ml.
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of progesterone after 2 to 5 days in culture, when exposed
continuously to low physiological levels of gonadotrophins
(see Fig. 27). During the first few days of culture, when the
cells in the controls secreted progressively more progesterone,
those in culture medium devoid of LH and/or prolactin were unable
to increase their secretion rate in a similar manner. This
suggests that granulosa cells undergoing luteinlzation require
both LH and prolactin to express their full biosynthetic potential.
The declining concentration of prolactin in the follicular fluid
as the follicle approaches ovulation could be a result of prolactin
utilisation in the early stages of luteinization (see Figs. 14 & 16).
When granulosa cells finally achieved their maximum secretion rate
in culture (i.e. from Days 6 to 10) they required continuous
exposure to both LH and prolactin; these findings give added
support to the earlier hypothesis which suggested that both
pituitary hormones were essential for maintaining the secretory
activity of the human corpus luteum (see discussion for Chapter 6).
Granulosa cells also seem to require FSH in order to prepare
for their subsequent secretory activity (Zeleznik et al.. 1974;
Channing, 1974; see results for Chapter 5). However, the role
of FSH in either initiating or maintaining steroid secretion by these
cells has not been defined. Although the gra nulosa cells in this
study were harvested from follicles containing FSH, the decline in
cell numbers during 10 days culture in a serum devoid of FSH suggests
that the continued presence of this gonadotrophin is essential.
This is in agreement with the in vivo findings of Peters et al. (1975)
for the mouse; they have suggested that the role of FSH may be to
prevent the granulosa cells undergoing premature atresia.
Human granulosa cells in vivo show no histological signs of
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secretory activity until immediately prior to ovulation, when
changes consistent with early luteinization first appear. The
cytoplasm of the granulosa cells enlarges and becomes granular
in appearance (Hertig, 1967; Baird et al.. 1975; see results
Chapter 4) and there appears to be an increase in the amount of
smooth endoplasmic reticulum and mitochondria (Crisp et al., 1970;
Delforge et al.. 1972), Histochemically, 3p-ol steroid dehydrogen
activity can be demonstrated in the granulosa cells of preovulatory
follicles (Friedrich et al.. 1974). At this time and coincidental
with the LH peak, the concentration of progesterone rises in
peripheral plasma (Johansson & Wide, 1969; ^teaman & Taymor, 1970)
in ovarian venous plasma (Mikhail, 1970; Lloyd et al.. 1971;
de Jong et al., 1974) and particularly in follicular fluid (Sanyal
et al., 1974; Fig. 16). These findings taken together suggest
that the preovulatory source of progesterone originates from the
luteinizing granulosa cells.
It is suggested therefore that LH, prolactin and FSH may
constitute the luteotrophic complex necessary for the initiation




The role of F3I1 and prolactin in the initiation and maintenance
of steroidogenesis by luteinizing human granulosa cells in vitro
was investigated. Human serum was treated with antibodies to human
gonadotrophins to remove selectively either FSH, prolactin and/or
LH before adding the serum to preovulatory granulosa cells in tissue
culture.
Granulosa cells regained viable when cultured for 10 days in a
serum devoid of LH and/or prolactin. After 6 days of culture the
cells were secreting approximately 7CPo less progesterone each day
than in the controls. Only 8% of the granulosa cells remained
viable after 10 days culture in a serum devoid of FSH. The addition
of FSH to granulosa cells in culture media devoid of FSH maintained
the cell a&mberS at a similar level to those found in the controls.
CHAPTER 9
THE CYTOTOXIC EFFECT OF SERUM FROM PATIENTS WITH




The eera of a proportion of patients with Idiopathic Addison's
disease are known to contain antibodies that cross-react in vitro
with other 3teroid producing tissues, i.e. ovary, trophoblast and
Leydig cells, as well as to adrenal cortical tissue (Anderson,
Goudie, Gray & Stuart-Smith, 1968; Irvine, Chan, Scarth, Kolb,
Hartog, Bayliss & Drury, 1968; Irvine et al.. 1969; Irvine &
Barnes, 1974). Female patients in this group have a high incidence
of premature ovarian failure, with either primary or secondary
amenorrhoea, and the ovaries are characterised by total fibrous
replacement or lymphocytic infiltration around developing Graafian
follicles (Irvine et al.. 1968, 1969 & 1974). The ovaries of women
with premature ovarian failure often contain numerous primary
follicles but are completely devoid of large Graafian follicles.
It seems that as the follicles attempt to develop they fail to do
so and are apparently destroyed (Irvine & Barnes, 1974; E. Barnes,
peisonal communication) .
Slices of human luteal tissue previously incubated with
Addisonian sera from patients with ovarian failure gave rise to
three distinctive patterns of immunofluorescence after further
incubation in the present of horse IgG-fluorescein isothiocyanate
(IgG - FITC). The staining patterns are observed most frequently
in the cytoplasm of the granulosa-derived luteal cells and are
described as "clumpy", "patchy" or "confluent" (Irvine, 1969).
These findings raise the possibility that in patients with
antibodies to luteal tissue, the lack of follicular development may
partly be due to destruction of the granulosa cells after the
antibodies have crossed the blood-follicle barrier. Irvine (1960)
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and Pulvertaft, Ooniach, Roitt & Hudson (1961) have demonstrated
a cytotoxic effect on thyroid and adrenal cells in tissue culture
only if complement was present. Thus the role of complement-
fixing antibodies in the destruction of human Graafian follicles
must also be considered. Serum contains complement which consists
of nine distinct components (C^ to c9>; these can be inactivated
when serum is heated at 56°C for 30 minutes. Presumably complement
is present in follicular fluid since the immunoelectrophoretic or
disc-gel electrophoretic patterns of follicular fluid are similar
to those of serum (Edwards, 1974). The action of complement in
cell destruction remains obscure. The antibody binds to the
antigenic site on the cell membrane, then complement binds to the
antibody thu3 forming a complex; in the absence of this complex
formation it seems that cell destruction does not normally occur
(Irvine, 1974; Roitt, 1974).
Granulosa cells can readily be obtained from human Graafian
follicles as a dispersed cell suspension without chemical or
enzymatic pretreatment. In culture, granulosa cells grow as a
monolayer, undergoing hypertrophy and secreting progesterone into
the medium (Channing, 1969a) see also Chapter 5).
Serum containing antibodiew reactive with human ovarian tissue
was obtained from patients with Addison's disease and premature
ovarian failure. The effects of these sera on both the morphology
and steroid producing ability of granulosa cells in tissue culture
was investigated.
RESULTS
A cytotoxic effect was only observed when some 'Addisonian'
sera were added to granulosa cells in culture in the presence of
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complement (Plate 18b)j no cytotoxic effect was observed in
the absence of complement (Plate 16a). Control sera from
post menopausal or normally menstruating women, or sera containing
other antibodies (i.e. to antinuclear factors or to gastric parietal
cells, etc.), were not cytotoxic to granulosa cells in culture in
the presence of complement. Neither the test nor the control sera
which failed to produce a cytotoxic effect reduced cell viability.
The cytotoxic effect was related to the immunofluorescent
staining ppttern of the seruip, since none of the 9 sera giving a
"clumpy" immunofluorescent staining pattern produced a cytotoxic
effect (Group 4, Table 18) and three of the eight "patchy"
staining sera were also non-cytotoxic (Group 3, Table 18). However,
all four "confluent" staining sera produced a marked cytotoxic
effect, as did five of the "patchy" staining sera (Groups 1 and 2,
Table 18). The degree of cellular damage in culture was also
related to the immunofluorescent titre of the antibody (Table 19).
There was evidence that the affinity of the granulosa cells for
antibody declined markedly with time in culture since horse anti-
human IgG - FITC conjugate showed the mo3t intense staining after
only 24 hours (++) with a marked decline in intensity after 48 hours
(+ and ~) and wa3 undetectable after 72 hours (negative). This
would explain why no cytotoxic effect was observed if the addition
of a cytotoxic 'Addisonian' serum plus complement to granulosa
cell cultures was delayed for 24 hours.
The inhibitory effect of 'Addisonian* sera plus complement on
the production of progesterone by granulosa cells in culture is
shown in Fig. 42. A progressive fall in progesterone output
occurred in those cultures in which a cytotoxic effect wa3
observed, and after 3 days the production rate was 30% of that
202
Plate 16a. Morphological appearance of granulosa cells after
culture in serum giving a "confluent" staining pattern in the
indirect immunofluorescence test with sections of human corpus
luteum. No complement was present. Mag. X 640.
203.
Plate 16b. Morphological appearance of granulosa cells after
the cells were cultured in the same serum as described in Plate 16a
























































































































































































































































































































































































































































Fig, 42, The production of progesterone by human granulosa
cells cultured in 'Addisonian* serum expressed as a percentage
of progesterone produced by cells in control serum. Individual
values are shown by the points and the means by the lines:
(a) cytotoxic sera; (b) non-cytotoxic sera,
• = "confluent" ) Immunofluorescent staining pattern of the
>
A= "patbhy" ) serum using unfixed, air dried, cryo3tat sections
)
X » "clumpy" ) of human corpus luteum as antigen.
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achieved by the controls (Pig. 42). Both the "patchy" and
"confluent" staining cytotoxic sera produced a similar reduction
in progesterone. In contrast, those "clumpy" and "patchy"
staining sera which failed to produce a cytotoxic effect gave
significantly higher progesterone concentrations (P < O.Ol), which
were comparable to the values obtained with control sera (Fig. 42).
DISCUSSION
Premature ovarian failure i3 the most recently recognised
condition in a group of interrelated disorders which are characterised
by organ-specific autoimmunity (Irvine & Barnes, 1974). The
demonstration in the present paper of a direct cytotoxic effect
of 3era from 'Addisonian' patients with ovarian failure on human
granulosa cells in tissue culture clearly confirms the existence
of cytotoxic "steroid cell antibodies". There can be little doubt
that in vivo these antibodies can gain access to the granulosa
cell3 within the Graafian follicle (von Kaulla, Aidawa & Pettigrew,
1958; Heglar, 1962; Menge, 1970) and in man the concentration of
IgG in follicular fluid is about 45% of that in serum (Johnson, 1973),
The cytotoxic effect demonstrated was complement dependent and
proportional to the titre of the antibody In the serum.
Human granulosa cells do not require prior treatment with
chemical agents in order to obtain an isolated cell suspension for
culture. It therefore seems likely that the cytotoxic effect
observed with some 'Addisonian* sera in this study reflects an
affinity of certain antibodies for the intact surface of granulsa
cells. The absence of a cytotoxic effect with other 'Addisonian'
sera may feflect either an intra cellular localisation of the antigens
or a lower antigen affinity. Irvine (1960) and Pulvertaft et al.. (1961)
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demonstrated a similar cytotoxic effect on thyroid and adrenal cells
in tissue culture by complement-fixing thyroid and adrenal antibodies,
respectively. However, in these studies the cell suspensions were
obtained after treatment with trypsin. It is likely that trypsin
might expose receptors on the cell surfaces which then become
available for reaction with the auto-antibody (Irvine, 1969). The
present study is therefore the first demonstration of a direct cyto¬
toxic effect of auto-antibody on intact cells.
The antigenic characteristics of the surface of the cultured
granulosa cells alters with time, as demonstrated by the lack of
effect when cytotoxic sera are added later than 24 hours after
initial culture, and the rapid decline in immunofluorescent staining
of granulosa cells with increasing time in culture. A similar
effect has been noted with thyroid cells in culture (Irvine, 1960).
xhe visible cytotoxic effects were accompanied by a marked
reduction in steroidogenesis. This, taken together with the close
correlation between the presence of steroid cell antibodies in the
serum and a history of amenorrhoea (Table 18), makes it attractive
to speculate that cytotoxic auto-antibody may at least be partially
responsible for the ovarian failure in patients with idiopathic
Addison's disease and premature ovarian failure.
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NUMMARY
Human granulosa cells growing in culture were used to study
the cytotoxic effects of sera from 23 patients with idiopathic
A.ddison's disease. There were two women with primary amenorrhoea,
thirteen with premature ovarian failure following a normal menarche,
and one man with testicular atrophy in this group. The sera from
all 23 patients cross-reacted with fresh sections of human corpus
luteum using an in vitro immuhofluorescent test.
Serum from 9 of the 23 patients contained antibodies which
were cytotoxic to human granulosa cells in tissue culture, the
cytotoxic effect was complement dependent, and related to the
immunofluorescent staining properties of the serum and dilution
of antibody present. No cytotoxic effect was observed when
granulosa cells were cultured in serum from the remaining 14
'Addisonian* patients, or from normally menstruating women, post
menopausal women or in serum containing organ-specific antibodies
to other endocrine tissues.
The cytotoxic effect was parallelled by a fall in progesterone
production by the granulosa cells. The production of progesterone
by cells cultured in any of the non-cytotoxic 3era was significantly
greater than that produced by cells in the presence of cytotoxic
antibody.
CHAPTER 10
THE EFFECTS OF PROSTAGLANDIN F2tf AND E2 ON THE




Human granulosa cells cultured in vitro provide a convenient
biochemical model system for studying some of the activities of
the human corpus luteum. In this study granulosa cells of
differing steroidogenic potentials were used to investigate the
possible effects of i«3F2«: and PGE2 on the human carpus luteum.
RESULTS
The effect of prosterlandins on the viability or siitotic activity
of granulosa cells in vitro
hen cells were exposed to PGF2<* and PGE2 alone or in combination
there was no significant increase or decrease in cell numbers during
the 10 days of culture, when compared to untreated controls with
or without gonadottophins. The 3ingle exception to this was when
PGE2 was added to culture medium containing cells harvested from
inactive follicles; i.e. those containing undetectable levels of
FSH (<1.3 mu./ml) and low concentrations of oestradiol (<"250 ng/ml) ;
in these experiments, a 2 fold increase in cell numbers occurred
(r = 1.91 - 0.22, n = 4) when compared to the controls (r = 1.08
-0.11, n=4) (r= no. of cells after 10 days culture divided by
the number of live cells at the start of culture).
The effect of differing doses of prostaglandin F2o< an the total
production of progesterone by granulosa cells in culture
The total production of progesterone by granulosa cells during
10 days culture after daily exposure to PGF2^ at concentrations between
1 and 8000 ng/ml is shown in Table 50. At every dose level, PCF2<*
lowered the total production of progesterone by 60yo or more when
added to cells harvested from 'active' follicles, i.e. those
containing detectable levels of F..H, (>1.3 mu./ml) and high
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Table 20. Total production of progesterone by human granulosa
cells after ten days culture with varying amounts of PGF2«f
expressed as a percentage of the controls (mean - j.E.M.).
ource of Dose of PGF2<* added (ng/ml of culture medium)
Granulosa
Cells l 10 50 100 500 lOOO 8000
93. 5 88.6 85.7 84.3 70.0 50.0 45.7
•inactive'
follicles ±6.2 ±5.7 *6.6 ±4.7
(2) (2) (4) (4) (4) (4) (4)
39.3 33.3 32.1 22.0 16.0
•Active'
follicles ±4.4 ±1.1 ±2.9 ±3.3
(2) (4) (4) (5) (4)
'Inactive* follicles contained<1.3 mu. FSH/ml and<250 ng
oestradiol-17^/ml in follicular fluid. 'Active' follicles
contained>1.3 mu. FSH/ml and >250 ng oestradiol-17p/ml. The
numbers in parentheses refer to the number of experiments on
individual follicles.
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concentrations of oestradiol (> 250 ng/ml). By contrast a
much smaller reduction in total progesterone output was
observed in cells harvested from 'inactive* follicles (see
Table £0). In both case3 the higher the concentration of
PGF2<>( the greater the inhibition in progesterone output.
The effect of prostaglandin F2*' and gonadotrophins on the dally
production of progesterone by granulosa cells
The daily production of progesterone by granulosa cells harvested
from 'active' follicles and exposed daily to PGF20f with or without
LH + FSH is shown in Fig. 43. There was a marked inhibition
(*>• 00%) in the rate of progesterone secretion compared to the
controls when 50 ng PGF2*' was added. Although LH + FSH induced a
2 fold increase in progesterone secretion, the addition of 50 ng
PGF2«' markedly inhibited this stimulatory effect.
The daily production of progesterone by granulosa cells harvested
from 'inactive' follicles and treated daily with iGF2^with or
without LH + FSH is shown in Fig. 44. A small decrease (-*-10%)
in production occurred compared to the controls when 50 ng PGF2#"
was added. Although LH + FSH induced a 3 to 3 fold increase in
progesterone secretion, the addition of 50 ng PGF2<* markedly
inhibited this stimulatory effect.
The effect of delaying the addition of PGF2cx'an the production
of progesterone by granulosa cells harvested from an 'active'
follicle and exposed to LH + FSH daily is shown in Fig. 45. The
addition of 50 ng of PGF2o' each day from Day 6 had no effect on
the daily production of progesterone. However, when 1000 ng of
I GF2p/ was added daily from Day 6 there was a progressive decrease
in progesterone output so that by Day 12 the output was only one
third of that achieved by the control.
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Fig. 43. The average dally production of progesterone
by cells In vitro which were exposed to PGF2oC(50 ng/ral) with
or without added LH and FSH (both 30 mu./ml). The cells
were harvested from follicles containing FSH and 02
(oestradiol-17jJ): + FSH > 1.3 mu./ml; + 02 > 250 ng/ml.
The numbers in parentheses refer to the number of experiments.
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DAYS IN CULTURE
t'ig. 44. The average daily production of progesterone by
granulosa cells in vitro which were exposed to POF2o<:
(50 ng/ml) with or without added LH and F3H (both 30 mu./ml).
The cells were harvested from follicles containing low
concentrations of FSH and Og (oestradiol-17p): FSH <
1.3 mu./ml; 02 < 250 ng/ml. The numbers in parentheses


















Fig. 45. The effect of delaying the addition of prostaglandin
F2<X on the daily production of progesterone by granulosa cells
in culture. The Fig. shows the average daily production of
progesterone by granulosa cells which were exposed to either
50 or 1000 ng PGF2f(/ral daily from Day 6. The cell3 were
harvested from a follicle containing FSH and 02» See Fig. 43
for abbreviations. Numbers in parentheses refer to the
number of experiments.
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The effect of prostaglandin E2 and gonsrdotrophins on the dally
production of progesterone by granulosa cells
The dally production of progesterone by granulosa cells harvested
from 'active* follicles and exposed daily to FGE2 with or without
LH + FSH is shown in Fig. 46. Luteinizing hormone + FGH only
stimulated a two-fold increase in the production of progesterone,
whilst the daily addition of 50 ng PG£2 stimulated a 3-4 fold
increase so that a maximum secretion rate of about 5 pg/cell/day
(see Fig, 27) was reached within 3-4 days in culture. The daily
addition of LH + FSH together with 50 ng PGE2 did not increase
the production rate of progesterone any further, and the cells
could not be stimulated any more by further additions of PGE2
from 1 to 500 ng/ml.
The daily production of progesterone by granulosa cells harvested
from 'inactive' follicles and exposed to LH + FSH + PGE2 or PGE2
when compared to the controls is shown in Fig. 47. In this case
the addition of between 1-500 ng PGE2 to cells harvested from
'inactive' follicles failed to stimulate the production of
progesterone more than by LH + F3H. Furthermore, the addition of
PGE2 together with LH + FSH failed to produce any further stimulation.
The effect of adding prostaglandins F2o<and S2 on the production of
progesterone by granulosa cells
The effects of adding 50 ng of each prostaglandin to granulosa •
cells harvested from 'active* follicles are shown in Fig. 46; the
daily production of progesterone was similar to that achieved by
adding PGE2 alone. The 10 day production of progesterone by
granulosa cells harvested from preovulatory follicle when exposed
daily to varying doses of FGF2o(, PGE2 or PGF2o<+ PGE2 is shown in
Table 3.1. Addition of PGF2o£ at 10 or 500 ng lowered the total
218.
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Fig. 46. The effect of prostaglandin E2 on the daily production
of progesterone by granulosa cells in culture. The Fig. shows
the average daily production of progesterone by cells which were
exposed to PGE2 (50 ng/ral) with or without added LH and F8H (both
30 mu./ml). The cells were harvested from follicles con&aining
FSH and 02 (oestradiol-17jj). See Fig. 44 for abbreviations.









































Fig, 47. The effect of prostaglandin E2 on the daily production
of progesterone by granulosa cells in culture. The Fig. shows the
average daily production of progesterone by cells which were exposed
to PGE2 (50 ng/ml) with or without added LH and FSH (both 30 rau./ml).
The cells were harvested from follicles containing low concentrations
of FSH and 0.;,» ''ee Pig. 44 for abbreviations. The numbers in
parentheses refer to the numbers of experiments. The average
results after treatment with either LH + FSH + FGE2, PGE2 or LH +
FSH were identical and are indicated by the single line.
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Table 31. The effect of adding prostaglandin F2oi and E2





during 10 day3 of
culture J&g





Control 0.04 51.8 - 4.6 5
PGE2 10 60.3 i 1.9 5
500 61.9 - 2.3 5
PGF2 oC 10 23.2 - 3.7 3
500 17.5 - 2.1 5
PGE2 10 49.9 - 4.9 3
PGF2 o( 10
PGE2 SO 48.8 - 5.1 3
PGF2o( 00
PGE2 100 57.6 - 4.3 3
PGF2 o( 100
PGE2 500 57.2 - 6.6 3
PGF2 e< 500
Cells were harvested from a single 15 mm late follicular phase follicle
(15 mm diameter) with detectable levels of LH (4.8 mu./ml) F3H
(3.3 mu./ml) and oestradiol (2100 ng/ml) in the follicular fluid.
Concentration refers to the final concentration of PGF2(* or PGE2
in the medium.
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production of progesterone achieved by adding PGE2 alone.
DISCUSSION
These results show clearly that PGF2<* inhibits the production
of progesterone by human granulosa cells in vitro without affecting
cell viability. They also show that provided PGF2*' is added at the
commencement of culture it is equally effective in inhibiting the
daily production of progesterone by granulosa cells from active
or inactive follicles, although the former have a greater
biosynthetic potential to secrete progesterone (see Fig. 24-29).
furthermore, when PGF2<y was added at the commencement of culture
it blocked the stimulatory effect of LH + FSH on granulosa cells
at all stages of their development. By contrast, when granulosa
cells were exposed to high concentrations of LH + FSH for several
days before the addition of 50 ng i GF2c(, the production of
progesterone was not inhibited. Although a detailed dose-
relationship was not established, a much higher concentration of
FGF2e( (1000 ng/ml medium) was required to inhibit the production
of progesterone.
The addition of PGE2 to human granulosa cells in vitro
stimulated the secretion of progesterone at a greater rate than any
concomitant increase in cell numbers. These experiments also shownd
that PGE2 was far more effective than LH + FSH in stimulating
progesterone secretion by cells from actively developing follicles.
By contrast, the addition of PGE2 to cells from 'inactive* follicles
wa3 no more effective than LH + FSH in stimulating the production
of progesterone, emphasizing once more the differing biosynthetic
potential of granulosa cells harvested from differing hormonal
environments in follicular fluid (Fig. 24-29).
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There wa3 no evidence of any synergism between PGE2 and LH +
FSH.
The present studies indicate that extremely low levels
(1-50 ng/ml) of both prostaglandins can cause dramatic alterations
in progesterone production under in vitro conditions. Similar
concentrations of PGF2©<. are present in the ovarian artery of the
sheep during luteal regression (Baird & Scaramuzzi, 1975) and
preliminary studies indicate that comparable levels are also
present in the human corpus luteum (I. owan3ton, D. T. Baird,
R. Vf. Kelly & K. l . McNatty). Prostaglandins gound within the
human follicle and corpus luteum could therefore have a major
controlling influence on steroid secretion by these structures.
Although PGF2«,was extremely effective (^ QO/o) in blocking the
stimulatory effect of LH + FSH on progesterone secretion, it was
totally ineffective in blocking the stimulatory effects of PGC2.
These studies provide 3ome clues as to the site of action of
PGF2o(. Both LH (Channing, 1975) and PGE2 (Rao, 1973) have
specific receptors on the plasma membrane and their steroidogenic
response is mediated by activation of the adenylate cyclase system
(Savard, Marsh & Rice, 1965; Dorrington 8s Kilpatrick, 1967;
Kobison, Butcher & Sutherland, 1971). Thi3 suggests that PGFSc*
acts directly on the adenylate cyclase system by blocking its
activation by LH. Similar in vitro data have been obtained suing
porcine and granulosa cells (K. M. Henderson & K. P. McNatty,
unpublished data) suggesting that the interaction of PGF2oC with
this cell type is species independent. These findings however
may not be consistent with the hypothesis proposed by Kuehl (1974)
since in his model PGF,2 is unlikely to overcome the inhibitory
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effect of I GF2<*. Such differences that exist between Xuehl's
hypothesis and the present study may depend on the rates at
which both PGE2 and PGF2(* act on the biochemical pathway to
/
progesterone synthesis. Since continued high levels of LH and
FSH protect the granulosa cells against subsequent inhibition
by PGF2e< it seems likely that the inhibitory effect of PGF2<*' is
inversely related to the amount of gonadotrophin bound to its
receptor; PGF2oC was 200 times less effective when granulosa cells
had been exposed to LH * FSH for 6 days before it3 addition.
These findings are in agreement with those of Hichens et al. (1974)
who 3howed that PGF2o( decreased the binding capacity of luteal
tissue to HCG.
In conclusion these data suggest that functional luteal
regression of the human corpus luteum could occur by a biochemical
mechanism independent of the vascular system. However, the lack
of cell death in vitro after exposure to PGF2c( suggests that other
mechanisms in addition to the inhibition of steroidogenesis may
be necessary to bring about complete structural and functional
regression of the gland.
SUMMARY
Human granulosa cells with differing steroidogenic potential
were cultured in vitro. The effects of PGF2</ and PGE2 on the
progesterone output and viability of these cells were investigated.
Prostaglandin F2<* either alone or in combination with LH and
FSH inhibited the production of progesterone over a wide range of
concentrations (1-8O00 ng/ml). However, the inhibitory effect of
PGF2</ was 200 times less effective when the cells were exposed
to LII and FSH for 6 days prior to the addition of the prostaglandin.
By contrast IGE2, at concentrations from 1 to 500 ng/ml, markedly
stimulated the production of progesterone by granulosa cells, and
this was not prevented by the addition of PGF2^C The degree of
inhibition by PGF2</or stimulation by FGE2 was related to the





The present studies indicate that the hormonal environment
within the developing human Graafian follicle may be of considerable
importance in determining the subsequent secretory activity of its
granulosa cells in the corpus luteum. The precise sequence of
endocrine changes occurring tn the fluid commences well before
ovulation and probably occurs uniquely in the follicle which is
destined to ovulate (see discussion, Chapter 5). However, within
the ovary at all stages of the menstrual cycle there are a large
number of antral follicles present (Block, 1951a). Presumably
this is because follicles are continuously leaving the preantral
pool, unrelated to the cyclic hormonal changes in plasma (Peters,
et al.. 1975). Furthermore1^ Peters et al. (1975) have shown that
follicles do not rest at any stage of growth but continue to grow
until they either became atretic or ovulate.
Most available evidence indicates that the final stages of
follicular development (i.e. from 4 layers of granulosa cells to
a mature Graafian follicle) are controlled by the levels of
circulating FSH and LH (Mauleon, 1939) and in the rat the time taken
for this to occur is between 10 and 17 days (Pedersen, 1970).
Follicle-stimulating hormone in women rises to peak concentrations
some 12 to 16 days prior to ovulation (Wide, Nllliu3, Gemzell &
Koos, 1973). It is suggested that this rise in plasma FSH coinciding
with the spontaneous emergence of a follicle from the pre-antral pool,
set3 in train a precisely timed sequence of endocrine events within
that follicle which leads ultimately to ovulation.
Figure 48 shows 3ome of the factors which may be responsible for
the selection of erne follicle far ovulation. It is suggested that












POOL OF NON-GROWING FOLLICLES
Fig, 48. A summarised dynamic representation of how one follicle
is selected for ovulation (see text). Solid lines originating
from the 'pool of non-growing follicles' represent follicular
growth whilst the dotted lines represent follicular atresia.
EF, MF and LF refer to early-, mid-, and late follicular phase of
the menstrual cycle. Solid lines originating from the hypothalamic-
hypophyseal axis represent the secretions of FSH or LH. The dotted
line labelled oestradiol represents the negative feedback effect of
oestradiol secretion from the developing follicle on FSH secretion
whilst oestradiol entering the follicle (+) indicates intra-
follicular stimulation. The solid line from the large developing
follicle represents increased secretion of oestradiol and its
positive feedback effect on the discharge of LH.
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phase of the cycle accumulates high concentrations of FSH.
As the "follicle grows it secretes oestradiol into the ovarian
vein (Baird, 1971; Baird & Fraser, 1974a) and some accumulates
in the follicular fluid (Table 11). During the early to mid-
follicular phase (^Day 7) the developing follicle is clearly
established as the major source of oestrogen since the concentration
of oestradiol is highest in the vein draining the ovary containing
the developing follicle (Baird & Fraser, 1974a). This 3tage of
follicular growth is perhaps the mo3t crucial in the process of
selecting only one follicle for ovulation; the increasing
secretion of oestradiol inhibits FSH (Fig. 48) so that the
peripheral concentration of thi3 gonadotrophin falls progressively
(Midgely & Jaffe, 1968). Subsequent follicles leaving the
preantral pool are therefore unable to accumulate high levels of
FSH (Fig. 12 and Table 9).
The high concentrations of FSH and ^estradiol within the
developing follicle stimulates an increased mitotic rate in the
granulosa cells (Delforge et al., 1972; Table 13), an increased
steroidogenic potential (Figs. 24 to 29), and an increased number
of LH receptors (Zeleznik et al.. 1974; Channing, 1975) which
prepares the granulosa cells for eventual steroid secretion. The
high levels of FSH in the developing follicle are probably maintained
despite falling levels in plasma because the high concentrations of
follicular oestradiol enhance the incorporation of FSH into that
follicle (Goldenberg et al.. 1972a). Thus the follicle stimulates
it3 own growth while at the same time inhibiting FSH secretion and
hence further maturation of other follicles leaving the preantral
pool, which thus become atretic. Finally the rising levels of
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oe3tradiol from the developing follicle stimulates a reflex
discharge of LH from the pituitary lasting about 48 hours (Ross
et al.. 1970; Knobil, 1974); appreciable amounts of thi3 LH
enter the follicle (Fig. 13) inhibiting further mitosis (Delforge
et al.. 1972; Table 13). The presence of LH in the follicle
together with prolactin (Figs. 30 and 40) and F3H (Fig. 23)
initiates the secretion of progesterone (Figs. 16 and 41). In
addition steroidogenesis by the luteinized granulosa cells i3
probably maintained in the presence of all three pituitary
hormones (see Figs. 30, 40, 41 and Table 17).
This hypothesis therefore suggests that following the early
entry of FSH into the antral fluid of one follicle and the
initiation of oestradiol secretion, this follicle then becomes
essentially autonomous, and is in control 4>f its own destiny,
A number of factors may influence the proportion of antral
follicles which go on to ovulate. It is reasonable to assume that
the uptake of FSH by the developing follicle is important for
protecting the follicle against atresia (Peters et al.. 1975;
Table 17). Thus as more and more follicles accumulate FSH,
presumably a greater proportion of antral follicles will go on to
ovulate. In anovulatory women where follicular growth and ovulation
can be influenced by exogenous gonadotrophin treatment, there is a
clearly established relationship between the dose of human
menopausal gonadotrophin (HMG), which has FSH and LH activity, and
the number of ovulations induced subsequently by human chorionic
gonddotrophin (HCG) (Gemzell, 1965; Brown, 1971). Presumably
therefore the magnitude of the peak or the duration of elevated
concentrations of FSH in plasma may influence the number of
follicles which can be stimulated to further development. In
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addition to varying the amount of FSH, there may also be variation
in the permeability of antral follicles for FSH since there are
considerable species differences in the distribution of serum
proteins found in follicular fluid (see Edwards, 1974).
Furthermore, the frequency at which follicles leave the non-growing
pool independent of gonadotrophic stimuli! could also influence the
proportion of follicles accumulating FSH during peak concentrations
of this hormone in plasma. From studies in the rodent it appears
that the age of the animal (Pedersen, 1969), the number of antral
follicles (Krarup et al., 1969; Peters et al.. 1970) and the
number of degenerating follicles (Peters et al.. 1973a) may all be
factors which influence the rate at which follicles leave the non-
growing pool. Thus, differences both between and within species in
the number of follicles which go an to ovulate are probably
influenced by the hormone concentrations in plasma, the permeability
of follicles for pituitary hormones and the intra-ovarian factors
which regula*»follicular growth.
The present in vitro studies suggest that granulosa cells require
a long period (^8-10 days) of continued exposure to FSH and
oestradiol before they will respond maximally to an ovulatory (surge'
of LH (Fig. 24-29). In addition these data also suggest that the
premature appearance of LH in the follicle containing FSH and
oestradiol may block further granulosa cell mdbtoses. Evidence
to support this concept has been demonstrated by Cargille et al.,
(1973) who showed that a discharge of pituitary LH during the mid-
follicular phase resulted in either anovulation or a shortened
luteal phase. More recently Friedrich, Kemeter, Sulzer and
Breitenecker (1975) administered an ovulatory dose of HCG to women
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with previously regular menstrual cycles on Days 1 to 6 after
the onset of menstruation; they found that ovulation was either
inhibited or postponed and that the granulosa cells within the
large follicles were undergoing degenerative changes. They also
found that there was no increase in progesterone secretion after
the HCG treatment suggesting that granulosa cells were unable to
fully luteinize and function normally. These observations
strongly support the concept that the hormonal microenvironment
is critically important for the maturation of the Graafian follicle.
It is unlikely however that the developing follicle actively
excludes LH since this hormone was detected in very low amounts
in a pool of antral fluid collected from small follicles during the
early follicular phase at a time when there were low concentrations
of LH in plasma. The initial appearance of more FSH than LH in
the developing follicle probably reflects the differing rates of
transfer of these hormones across the blood-follicle barrier.
It is not possible to determine from these studies whether
the presence of the tX -subunit of LH (or FSH) and/or the (3 -subunit
of LH in follicular fluid reflects the transfer of free 3ubunit
across the blood-follicle barrier or whether their presence in antral
fluid merely reflects dissociation of intact LH (or FSH) already
within the follicle. Nevertheless the in vitro studies strongly
suggest that the subunits alone have little or no effect on the
steroidogenic potential of human granulosa cells. These findings
therefore disagree with those of Nalbandov & Bahr (1974); they
found that the o(.-subunit of ovine LH was pt potent stimulator of
steroidogenesis in the rabbit when the subunit was injected
systemically. The reason for the discrepancy may be that in
231
Nalbandov's study the o(-subunit was injected at a dose of 50/<g
per kg of rabbit weight which is likely to be a pharmacological
dose of free subunit, whereas in the present study the subunits
were added to isolated cells which at the lower concentrations are
likely to be much more physiological.
There is now substantial evidence to suggest that the concentrations
of PGF2<Aand B2 rise in the preovulatory rabbit follicle immediately
prior to rupture (Le Maire, Yang, Behrman <k Marsh, 1973; Yang,
Marsh & Le Maire, 1973) and that inhibition of prostaglandin synthesis
results in ovulatory failure (Armstrong & Grinwich, 1972; Behrman
et al.. 1972; Grinwich, Kennedy & Armstrong, 1972; Tsafriri,
Lindner, Zor & Lamprecht, 1972; O'Grady, Caldwell, Auletta &
Speroff, 1972; Orczyk & Behrman, 1972; Tsafriri, Koch & Lindner,
1973). Granulosa cells harvested from preovulatory follicles of
rabbits produce large amounts of PGF2o< in culture medium devoid of
C-AMP (Challis et al.. 1974). By contrast however human granulosa
cells from preovulatory follicles appear to make little of any
PGF2 e< (K. P. McNatty, & R. Kelly, unpublished observations).
The role of C-AMP in the initiation of luteinization seems to
be uncertain and somewhat variable, for its synthesis by the
preovulatory follicle in the rabbit is considerably stimulated by
LH for an hour or so but then declines to very low levels (Marsh,
Mills & Le Maire, 1973; Le Maire et al., 1973), Following the
preovulatory 3urge of LH in the sheep^Moor et al. (1975) have
suggested that C-AMP originates from the theca cells alone and thus
acts as a 'distant diffusion activator' to initiate luteinization
of the granulosa cells within the Graafian follicle.
However the cellular source(3) of the prostaglandins and C-AMP
and also the temporal relationships between LH, C-AMP and the
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prostaglandins in the human preovulatory follicle remain obscure.
At the present time it i3 difficult to establish whether
the presence of prolactin in the follicular fluid of a developing
follicle is important for maturing the biosynthetic potential of
the granulosa cells. Granulosa cell viability is not affected
when this hormone wa3 inactivated or removed from the culture medium
(Figs. 30 & 40) however it seems that when the cells are steroido-
genically competent, just prior to ovulation functional luteinization
may not occur without prolactin. Preliminary studies have shown
that a s granulosa cells luteinize in vitro (i.e. secrete increasing
amounts of progesterone), the concentration of immunoreactive prolactin
in the culture medium declines (A. S. McNeilly & K. P. McNatty,
unpublished observations); thus the declining concentrations of
prolactin in the preovulatory follicle may indeed reflect the
increased utilization or metabolism of thi3 hormone by the granulosa
%
cells undergoing luteinization at this time. The marked differences
in the concentration of prolactin between plasma and follicular fluid
highlight once more the Importance of the endocrine micro-
enviranment within the follicle. It is possible that the secretion
of oestrogen by the theca cells of the developing follicle are
influenced by the concentration of circulating prolactin, since
women with g&lactorrhoea and amenorrhoea appear to have normal levels
of LH and FSH in plasma but low levels of urinary oestradiol
(Holland, 1973; Thorner, McNeilly, Hagen & Besser, 1974;
McNeilly, 1974). Thus high concentrations of prolactin may inhibit
the secretion of oestradiol from the theca cells in a manner similar
to that described for granulosa cells in tissue culture (see results,
Chapter 6). Failure of the growing follicle to secrete oestradiol
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prevents the normal positive feedback to the hypothalamic-
pituitary axis (Knobil, 1974) and this in turn would result in
anovulation and finally amenorrhoea. Thus the effects of prolactin
on the production of oestradiol by theca cells in tissue culture
and the biochemical mechanism by which high concentrations of
prolactin inhibit steroidogenesis may lead to a greater under¬
standing of the physiological role of prolactin in women.
It appears that high or supra-physiological concentrations
of pituitary hormone (either F3H, LH or prolactin) interferes with
either normal follicular development, granulosa cell mitoses and/or
steroidogenic potential of developing follicles, presumably by
abolishing the normal process of follicle selection in addition
to disrupting the normal sequence of endocrine changes occurring
within the follicles. This may be why ovulation does not normally
occur in women during pregnancy when there are sustained high
concentrations of HCG and prolactin (Govan, 1968, 1970; Scrimgeour
& Baker, 1974).
In women, anovulatory menstrual cycles occur frequently at
the extremes of reproductive life, i.e. after the raenarche and
prior to the menopause (Doring, 1969), and are characterised by
the failure of the nonnal pre-ovulatory LH surge in the presence
of an apparently adequate oestrogen secretion by the follicle
(Fraser, Michie, Wide & Baird, 1973; Baird, 1974a). Other
causes of anovulatory cycles can generally be attributed to a
breakdown in the pituitary-ovarian feedback system (Baird, 1974a;
koss & Vande Wiele, 1974). The presence of antibodies in the
serum of some patients with Addison's disease which are cytotoxic
to granulosa cells in tissue culture provides evidence to suggest
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that an Immunological mechanism may also contribute to
ovulatory failure in a number of cases. The in vitro culture
of granulosa cells may prove to be a useful diagnostic aid, to
test the sera of women who have primary or secondary amenorrhoea
and apparently normal pituitary function for the presence of
cytotoxic antibodies.
The present studies using human granulosa cells in culture
suggest that PGF2</ may cause functional luteal regression of the
corpus luteum (see discussion, Chapter 10). Recently, PGF2o^
was also shown to inhibit the secretion of progesterone by porcine
and bovine granulosa cells grown in culture (Henderson & McNatty,
1975; K. M. Henderson & K. P. McNatty, unpublished data). For
effective inhibition of progesterone secretion only minimal
amounts of PGF2c< (50 pg-50 ng) were required (see Table 20;
Henderson & McNatty, 1975). This strongly suggests that i'GF2«'
is capable of exerting a direct biochemical effect on the luteal
cell, thereby inhibiting steroidogenesis.
How is this likely to occur? Behrman et al. (1971b)
have suggested that PGF2«(acts by inhibiting the conversion of
cholesterol ester to free cholesterol. However, in view of the
central role of C-AMP in stimulating ovarian steroidogenesis
(Savard et al.. 1965; Dorrington & Kilpatrick, 1967; Kobison et al..
1971; Channing & Seymour, 1970; Channing, 1970a; Henderson &
McNatty, 1975} MSeft alao General Introduction) it is perhaps more
likely that PGF2tf< acts directly by inhibiting the synthesis of
C-AMP, and so acts on the plasma membrane, the site of C-AMP
synthesis; specific receptors for PGF2<tf have in fact been found in
the plasma membrane of the human, bovine (Powell et al.. 1974a),
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and ovine (Powell, Hammarstrom & Samuelsson, 1974b) corpus luteunt.
Studies by Rodbell, Birnbauraer & Pohl (1969) on the membrane-
bound adenylate cyclase system have led them to propose a three
component model of the hormone-responsive membrane-bound
adenylate cyclase which is shown in Fig. 49a. On binding of a
hormone to its specific regulatory unit, the intermediate coupler
serves to transmit a signal, initiated by the binding event, to
the catalytic site, resulting in the activation of the adenylate
cyclase and an increase in intracellular levels of C-AMP.
It is suggested that PGF2«< acts on the coupling component,
either directly or indirectly, to prevent transmission of the signal
required to activate the catalytic site (see Fig. 49b).
Consequently cellular C-AMP will rapidly disappear, resulting in a
fall in progesterone secretion. This hypothesis is supported by
recent studies an the pig corpus luteura, where Andersen, Schwaitz
& Ulberg (1974) have shown that the adenylate cyclase fail3 to
respond to LH on Jays 16 or 17 of the oestrous cycle when PGF2<*'
secretion is probably maximal. This postulated site of action of
PGF2<tf can be readily tested both in vitro and in vivo. By acting
specifically on the LH coupling unit, PGF2«' should only block the
activation by any other hormone having a separate specific regulatory
unit linked up to the catalytic site via its own coupling unit;
PGG2 is an example of such a hormone since there is substantial
evidence to show that PGE2 utilises the adenylate cyclase system
(Marsh, 1971). When human granulosa cells are cultured in vitro
the PGF2o( inhibition of progesterone synthesis can be overcome hsing
PGE2 (Fig. 46 and Table 81).
Any mechanism of luteal regression must also explain the
inability of PGF2e^ to induce luteolysis of the newly formed corpus
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Fig. 49. Three component model of the LH receptor-linked-
adenylate cyclase system showing the postulated site of PGF2<rt
action (see text).
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luteum In many animals, e.g. sheep. Day 4 (Hearnshaw, Restall &
Gleeson, 1973); cow, Day 4 (ftowson, Tervit & Brand, 1972); Morse,
Day 4 (Allen & Rowson, 1973) and in particular the pig (Polge,
personal communication) where the corpus luteum is resistant to
exogenous PGF2<* for the first 12 days of its life. This could
be explained simply by the fact that the preovulatory surge of
LH saturates the regulatory units of the luteal cells and it is
this bound hormone which protects the young corpus luteum. This
hypothesis i3 supported by the experiments where cultured human
granulosa cells, which had previous exposure to high physiological
concentrations of LH and F3H, required 200 times more F-GF2«( to
effectively inhibit progesterone secretion compared to the amount
of PGF2o( required if it was added at the start of culture (see
Fig3. 43 and 45).
It is well established that the dissociation of LH from its
receptor is a slow process taking several days (Catt, Tsuruhara St
Dufau, 1972; Channing & Hammerman, 1973a; Haour & Saxena, 1974;
Lee St Ryan, 1974). Moreover only a fraction of these receptors
need be occupied to stimulate the adenylate cyclase system
maximally (Koch, Zor, Chobsieng, Lamprecht, Pomerantz & Lindner,
1974).
Relative to the levels of LH occurring at the time of the
preovulatory surge, when the granulosa cell receptors become
saturated with LH those found in peripheral plasma during the luteal
phase are very low (Wide et al.. 1973): this will encourage the
dissociation of LH from its receptor. Thus throughout the luteal
phase the LH receptor sites will gradually be vacated, but this will
not affect the amount of progesterone being produced by the carpus
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luteum. However, a3 more and more LH dissociates the corpu3
luteum would become increasingly susceptible to the luteolytic
action of PGF2<*'.
This is quite feasible when one remembers that the plasma
membrane is not a rigid, static structure, but rather a dynamic
structure best described as a "fluid mosaic" (Singer & Nicolson,
1972), its conformation at any time being the "thermodynamically"
most stable form. As the LH receptors on the plasma membrane
become full, then it is likely that this thermodynamic stability
will be upset and so consequently the membrane will undergo
conformational changes in order to re-establish thermodynamic
stability perhaps producing a form leas suitable for the uptake
of PGF2<*. Similarly, as the LH receptors become vacant again
throughout the luteal phase, the membrane would gradually revert
to its original form, a form possibly facilitating FGF2<x uptake
which in turn would promote more conforaiational changes. This
hypothesis that PGF2 may be inducing conformational and/or
structural changes within the membrane is strengthened by the
recent findings of Hichens et al. (1974), where PGF2c^ was shown
to decrease the binding capacity of luteal tissue to HCG,
possibly by inducing conformational changes.
Data obtained from studies in vivo supports the concept that
the onset of luteal regression is a consequence of an initial
biochemical action of PGF2b<. Data obtained in the ewe by Baird
and 3caramuzzi (1973) shows that low levels of PGF2<*' (~5 ng/ml)
first appear in utero-ovarian venous plasma on Day 13, and progesterone
levels also commence to decline from Day 13 onwards. Although
these falling levels of progesterone are accompanied by some
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structural changes in the luteal cells (Deane et al., 1966)
functional regression can be halted by hysterectomy (i.e. removal
of I-GF2<*) as late as Day 15 (Moor et al.. 1970). Massive amounts
of PGF2<x (~ 20 ng/ml) are then released from the uterus into the
utero-ovarian vein on Days 15 and 16, and it is probably this which
induces the final irreversible morphological deterioration of
the corpus luteum either by directly or indirectly activating the
lysosomes on Days 15 and 16 (Dingle, Hay & Moor, 1968), Recent
studies clearly show that the plasma membrane itself can influence
and control lysomal activity (3zego, 1974). Thus it is possible
that low amounts of PGF2<*, although sufficient to inhibit
steroidogenesis, can only cause a partial activation of the
lysosomes, but for them to be fully activated requires the plasma
membrane to be completely saturated with PGF2«*.
Although functional regression could arise from a biochemical
action of i GF2oC, it is still possible that morphological regression
may be due to a redistribution of blood flow within the ovary, since
the initial structural change in the luteal cell, karyorrhexis,
is indicative of anoxic damage (Deane et al., 1966; Bjersing et al.,
1970). Although PGF2*' will inhibit the secretion of progesterone
by luteal cells in vitro, it does not appear to induce structural
damage, however if morphological regression is mediated by a vascular
effect of PGF2</, then it is difficult to explain why the newly
formed corpus luteum is resistant to PGF2pC
In conclusion therefore, it is suggested that luteal regression
is initiated by a biochemical action of PGF2<* on the luteal cell
membrane, according to the following sequence of events.
1. Throughout the luteal period LH gradually dissociates from its
240.
specific membrane receptors on the luteal cells. This promotes
a conformational change within the plasma membrane facilitating
FGF2ot uptake.
2. Under the influence of progesterone, increased amounts of
PGF2e( are secreted by the uterus or ovary.
3. PGF2<* binds to the plasma membrane of the luteal cell and
either directly or indirectly prevents the LH regulatory unit of
adenylate cyclase activating the catalytic unit; cellular C-AMP
will diminish, and consequently steroidogenesis will decline.
4. Finally the morphological deterioration of the corpus luteum
may result from the subsequent release of larger amounts of PGF2»<-,
which causes lysoraal activation through further changes in the
plasma membrane. However, the possibility of morphological
regression being mediated by a vascular effect of PGF2<* cannot be
ruled out.
In conclusion, the recent demonstration of PGF2e< receptors in
the human corpus luteum (Powell et al.. 1974a) and of inhibition
of progesterone secretion in culture (see Chapter 10) suggests that
PGF2t/ may well prove to be the luteolysin in women. The synthesis
of 16 aryloxy-prostaglandins (ICI 80996 and 81008) which are 100 to
200 times more potent thai FGF2c*' in inducing luteolysis in
experimental animals and sure devoid of the side effects commonly
associated with PGF2c* (Dukes, Russell & Walpole, 1974) suggest that
the use of long acting synthetic prostaglandins as contraceptive
agents should be explored.
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Appendix 1 provides the details relating to the clinical
histories of all patients from whom ovaries, or wedge biopsies,
peripheral blood samples and endometria were obtained. The
day of cycle is the number of days lapsed since the onset of
menses. The previous menstrual history indicates the
duration of menses in day3 (top line) and the time from the
onset of menses to the commencement of the next menses (bottom
line). Parity refers to the number of children born alive
plus the number of unsuccessful pregnancies. The term
ovary indicates the number of whole ovaries or the number of
wedge biopsies (W or 2 X W) received. The sise of the wedge
varied from a thin slice of cortex to at least one half of the
ovary. M-EP, EP, MP, IP, VIP or PP refer to early proliferative -
patient still menstruating, early, mid-, late, very late or
persistently proliferative phase respectively, whilst E3, MS and
L3 refer to early, mid- or late follicular phase whilst V-EL, EL,
ML and LL refer to very early-, early, mid- and late luteal
phase of the menstrual cycle. The stage of the m. nstrual cycle
was assessed from the date since last menstrual period,
endometrial biopsy, presence or absence of a corpus luteum, and
the concentrations in plasma of LH, F3H, oe3tradiol and
progesterone. - = no specimen obtained and ? = information not
recorded. All patients suffered from menorrhagia with the
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summary
The concentrations of FSH, LH, prolactin, oestradiol and progesterone
were measured in peripheral plasma and follicular fluid of women through¬
out the menstrual cycle. With the exception of prolactin, concentrations of
pituitary and steroid hormones in follicular fluid correlated with those in
peripheral plasma.
Follicle-stimulating hormone was present in a greater number of small
follicles (< 8 mm) during or just after the peaks of ESH in peripheral
plasma. During the mid-follicular phase the concentration of both FSH and
oestradiol in fluid from large follicles (^ 8 mm) was high. During the late
follicular phase the large follicles (^ 8 mm) contained high amounts of
progesterone in addition to oestradiol, low physiological levels of pro¬
lactin, and concentrations of LH and FSH about 30 and 60 % respectively
of those found in plasma. By contrast no large 'active' follicles (^ 8 mm)
were found during the luteal phase although many contained both LH
and FSH. Luteinizing hormone was present in a proportion of small follicles
(< 8 mm) during the late follicular and early luteal but not at other stages of
the menstrual cycle.
It is suggested that a precise sequence of hormonal changes occur within
the microenvironment of the developing Graafian follicle; the order in
which they occur may be of considerable importance for the growth of that
follicle and secretory activity of the granulosa cells both before and after
ovulation.
introduction
There is considerable evidence to suggest that pituitary gonadotrophins are
responsible for the later stages of follicular growth, maturation of the oocyte and
ovulation (see reviews of Baker, 1972; Biggers & Scheutz, 1972; Greep, 1973).
Although it is possible to correlate changes in gonadotrophins in peripheral plasma
38 E N D 64
556 K. P. McNatty and others
with the production of steroids from the ovary, the actions of luteinizing hormone
(LH) and follicle-stimulating hormone (FSH) on the follicle remain obscure. It has
been suggested that gonadotrophins within the follicular fluid itself may have
important consequences for follicular steroidogenesis (Channing, 1970, 1972;
Edwards, 1974; McNatty, Sawers & McNeilly, 1974). growth of the follicle, oocyte
maturation and evolution (Edwards, 1974).
The changing concentration of peripheral plasma oestradiol during the follicular
phase of the human menstrual cycle provides an index of follicle growth (Baird,
1971). Oestradiol in the peripheral plasma during this phase of the cycle is derived
almost solely from the actively growing follicles (Baird & Fraser, 1974) which also
contain high concentrations of oestradiol (Smith, 1960; Short & London, 1961;
Giorgi, 1965; Edwards, Steptoe, Abraham, Walters, Purdy & Fotherby, 1972;
Baird & Fraser, 1975 ; Sanyal, Berger, Thompson, Taymor & Home, 1974). Further¬
more, during the immediate preovulatory phase there is an increase in the concentra¬
tion of progesterone in follicular fluid (Edwards et al. 1972; McNatty et al. 1974;
Sanyal et al. 1974) which is also reflected in peripheral plasma (Johansson & Wide,
1969; Yussman & Taymor, 1970).
In the present study the concentrations of LH, FSH, prolactin, oestradiol and
progesterone were measured in samples of peripheral plasma and follicular fluid
collected from women at varying stages of the menstrual cycle. It was hoped in this
way to investigate the relationships between the concentrations of pituitary and
steroid hormones in follicular fluid and to relate them to concentrations in plasma,
follicle size, and the stage of the menstrual cycle.
MATERIALS AND METHODS
Subjects
Ninety-seven subjects (aged 21-48 years) who were at varying stages of the men¬
strual cycle were undergoing hysterectomy for various gynaecological conditions.
The indications for surgery were stage 0 carcinoma of the cervix (17), menorrhagia
due to fibroids (35), dysfunctional uterine bleeding (10), endometriosis (9), or chronic
pelvic pains or dysmenorrhoea (26). Those with stage 0 carcinoma of the cervix had
regular menstrual cycles (21-32 days) and were considered to be endocrinologically
normal (Baird & Fraser, 1974). The previous menstrual cycles of the group with
menorrhagia varied in length from 21-34 days and about 50 % of these subjects had
ovulated in the cycle under study, as indicated by the presence of a secretory
endometrium and of at least one corpus luteum at the time of the operation. The
remaining subjects were in the proliferative phase as assessed by their endometrial
histology and date of the last menstrual period.
Dating the menstrual cycle
An endometrial biopsy and a peripheral blood sample (collected before oophorec¬
tomy) were obtained during the operation. The endometrium was examined histo¬
logically and dated according to the criteria of Noyes, Hertig & Rock (1950). The
stage of the menstrual cycle was assessed in all subjects from the date of the last
menstrual period, the concentrations in plasma of LH, FSH, oestradiol and pro-
Hormones in follicular fluid 557
gesterone, endometrial histology and the presence or absence of a corpus luteum.
The menstrual cycle was divided into six phases: early follicular, still menstruating
(EF); mid-follicular (MF); late follicidar (LF); early luteal (EL); mid-luteal (ML)
and late luteal (LL).
Ovarian morphology
Ovaries were examined in situ to assess gross morphology and to record the
presence or absence of a corpus luteum. In some cases excised ovarian specimens
were examined by light microscopy after removal of the Graafian follicles to ascertain
that no major ovarian pathology existed.
Collection of follicular fluid
The follicular fluid analysed in this study was obtained from ovaries of the 97
subjects described above. Two different methods for the collection of the fluid were
used.
In 23 subjects antral fluid was aspirated from 36 Graafian follicles through a 23G
needle into a syringe during surgery. It was technically not possible to measure
these follicles accurately, consequently they were classified as large (^ 8 mm) or
small (< 8 mm).
In 74 subjects ovarian specimens (whole ovaries or wedge biopsies) were collected
into chilled Medium 199 containing Hanks' salts and HEPES buffer (20 mM) (Flow
Laboratories) and all follicles which were ^ 4 mm diameter (153) were dissected out
within 2 h of surgery. The diameter of each isolated follicle was measured and the
antral fluid aspirated through a 27G needle into a 500 /d Hamilton syringe.
Fluid collected by either method was frozen at — 20 °C until assayed. No attempt
was made to recover the oocyte.
Follicles without a lining of granulosa cells, irrespective of size, were defined as
'cystic'. Subsequent data reported for the cystic follicles are considered separately
from those obtained for normal follicles.
Radioimmunoassay of pituitary and steroid hormones
Luteinizing hormone and follicle-stimulating hormones
The radioimmunoassays for LH and FSH in plasma and follicular fluid were based
upon those previously described (Hunter, Edmond, Watson & McLean, 1974) with
modifications for the antral fluid in order to accommodate the small volumes. The
original concentrations of standards, tracer and antiserum were retained but the
incubation volume was reduced to 150 /A of which 50 y\ were neat (or diluted)
follicular fluid or standard. The counting time was increased proportionately so that
in this respect assay precision was undiminished. The following standards were used:
LH, MRC 68/40 assumed 77 units/ampoule; FSH, MRC 68/39 assumed 32-8 units/
ampoule (MRC National Institute for Biological Standards and Control). The con¬
centrations of LH and FSH are expressed as mu./ml, where 1 mu. LH = 11-6 ng
LER 907 and 1 mu. FSH = 44-6 ng LER 907. The assays would normally measure
LH and FSH respectively over the ranges 0-8-12-8 and 0-4-6-4 mu./ml in undiluted
follicular fluid. With large follicles, ^ 8 mm diameter, assays were in general carried
38-2
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out in duplicate, whilst those for follicles < 8 mm diameter were single determina¬
tions. A number of LH assays were also carried out on larger volumes of pooled fluid
from small follicles.
Prolactin
Prolactin in peripheral plasma and follicular fluid was measured using a specific
double antibody radioimmunoassay (RIA) previously described (McNeilly, 1973;
McNeilly & Hagen, 1974). Purified human prolactin for standards and labelling with
125I was generously supplied by Dr H. G. Friesen, University of Manitoba, Winnipeg,
Canada. The concentration of prolactin is expressed as ng Friesen prolactin/ml of
which 1 ng = 20 /tu. MRC 71/222. The minimum detectable level of prolactin was
1-5 ng/ml for both follicular fluid and plasma. Assays were carried out in duplicate
in both specimens of plasma and fluid.
Progesterone
Progesterone was measured in peripheral plasma using a radioimmunoassay similar
to that described by Thorneycroft & Stone (1972), and in follicular fluid by the
method of Neal, Baker, McNatty & Scaramuzzi (1975). Follicular fluid (2-10 /d) was
diluted 100- to 1000-fold in phosphate-buffered saline (0-1 mol/1, pH 7-0) and 0-1 ml
samples were assayed directly without extraction. The precision and accuracy of the
assay was similar to that described by Neal et al. (1974). The progesterone antiserum
(RI-4) was raised in a rabbit against progesterone-lla-hemisuccinate conjugated to
bovine serum albumin and the specificity was similar to that previously reported
(Dighe & Hunter, 1974). The assays were conducted in duplicate and the minimum
detectable level of progesterone was 300 pg/ml in plasma and 10 ng/ml in follicular
fluid.
Oestradiol
Antiserum for the assay of oestradiol was raised in a rabbit to a conjugate of
oestradiol 6-carboxymethyl-oxime and bovine serum albumin. Cross-reactions of
other steroids using the routine assay conditions were: oestrone, 3 %; oestriol,
0-4%; 6-oxo-oestradiol, 100%; testosterone, 0-003%; progesterone, 0-0002%.
For estimations of oestradiol in plasma an ether extract was evaporated to dry¬
ness, equal volumes of 0-05 M-NaOH and carbon tetrachloride were added and shaken
together with the residue. Samples of the aqueous phase were then neutralized in a
slightly acid diluent for incubation in the RIA system as described by A. Bolton and
F. Rutherford (personal communication). Oestradiol in follicular fluid was assayed
without prior extraction. The assays were carried out in duplicate and the minimum
detectable level of oestradiol was 8 ng/ml in follicular fluid and 20 pg/ml in plasma.
RESULTS
Concentrations of hormones in plasma and follicular fluid in subjects with stage 0
carcinoma of the cervix were compared with those of patients with menorrhagia and
were not found to be significantly different. The results from all patients have
therefore been pooled.
Concentrations of FSH, LH, oestradiol and progesterone in the antral fluid of
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Stage of menstrual cycle
Fig. 1. Mean concentrations of (a) LH, (6), FSH (c) prolactin, (d) progesterone and (e) oestradiol
in peripheral plasma during the menstrual cycle. Vertical lines represent + s.e.m. EF, MF and LF
refer to early (still menstruating), mid- and late follicular phases respectively, while EL, ML
and LL refer to early, mid- and late luteal phases respectively. Numbers of observations are
given at the top of the figure.
follicles aspirated in situ were not significantly different from those aspirated in vitro
(P > 0-2). The results obtained for each hormone from the two methods of collection
have therefore been pooled. Concentrations of prolactin in the antral fluid of follicles
aspirated in situ are not reported. These samples were stored at — 20 °C for at least
12 months before being assayed. The immunological and biological activity of
prolactin in physiological fluids declines with prolonged storage (H. G. Friesen,
personal communication).
Concentration of luteinizing hormone, follicle-stimulating hormone, prolactin,
progesterone and oestradiol in peripheral plasma
Mean values (± s.e.m.) obtained for the concentrations of LH, FSH, prolactin,
progesterone and oestradiol in peripheral plasma with respect to the stage of the
menstrual cycle are shown in Fig. 1.
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Distribution of the size of excised follicles in relation to the stage
of the menstrual cycle
A scatter plot of follicle size in relation to the stage of the menstrual cycle is
shown in Fig. 2. The greatest range of follicle sizes (4—20 mm) was found in the late
follicular and late luteal phases. The greatest number of 'cystic' follicles (4:5%) was
found in the early follicular phase whereas none was found during the late follicular
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Fig. 2. Distribution of size of excised follicles in relation to the stage of the menstrual cycle.
Follicles < 4 mm were not collected; #, 'cystic' follicles; x , 'non-cystic' follicles. See Fig. 1
for abbreviations.
The concentrations of pituitary and steroid hormones in the follicular
fluid of individual Graafian follicles
Follicle-stimulating hormone
There were no significant differences in the concentration of FSH in follicular fluid
from follicles aspirated in situ when compared with those aspirated in vitro (P > 0-2).
The mean concentration of FSH in all antral fluids in relation to size and the stage of
the menstrual cycle is shown in Fig. 3 a. The minimum detectable level of FSH in the
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Stage of menstrual cycle
Fig. 3. Concentrations of {a) FSH and (6) LH in antral fluid in relation to follicle size and phase
of the menstrual cycle. The vertical lines represent+ s.e.m. White bars, mean concentration in
follicles ^ 8 mm; black bars, mean concentration in follicles < 8 mm. Broken line = minimum
detectable level of (a) FSH (1-3 mu./ml), (6) LH (2-8 mu./ml). See Fig. 1 for abbreviations.
Number of observations in parentheses.
smallest follicles (4 mm) was 1-3 mu./ml, which was therefore chosen as the limit of
detection for all follicles. The percentage of follicles with detectable FSH at each
stage of the cycle is shown in Table 1. In general, the greatest proportion of small
follicles with detectable FSH are found either during or immediately after the
increase in levels in the plasma (Fig. 1 and Table 1). In contrast, the concentration of
FSH in some large follicles was high when the plasma concentrations were low (Fig. 1
and Fig. 3). Follicle-stimulating hormone was detectable in a proportion of the
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smallest follicles examined (see Tables 1 and 2). However, at no time during the
cycle was the concentration of FSH in follicular fluid more than 60 % of the levels
found in plasma.
Table 1. Percentage of follicles with detectable levels of LH, FSH or LH + FSH in
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EF, MF and LF refer to early (still menstruating), mid- and late follicular phase, respectively, while
EL, ML and LL refer to early, mid- and late luteal phase respectively.
Table 2. Concentration of FSH in fluid from different sized follicles at each phase of
the human menstrual cycle
(Values are means+ s.e.m. in mu./ml. Samples less than the detection limit were assumed to
have a concentration of 1-3 mu./ml for the purposes of the group mean.)
Stage of Follicle diameter (mm)
menstrual , *
cycle* 6 6-8 9-12 12
EF 1-50+ 0-09 2-30 — —
(6) (3)
MF 1-30 1-40 + 0-05 2-30 + 0-40 —
(3) (18) (13)
LF 1-76 + 0-26 1-68 2-20 + 0-26 3-20
(8) (3) (10) (3)
EL 1-66 + 0-23 2-10 + 0-50 2-10 —
(8) (9) (3) —
ML 1-30 1-30 1-30 —
(H (11) (3)
LL 1-46 + 0-13 1-30 3-00+1-10 3-28
(20) (12) (8) (2)
* For abbreviations see Table 1. Number of observations in parentheses.
Luteinizing hormone
The concentration of LH in the antral fluid of follicles aspirated in situ was not
significantly different from those aspirated in vitro (P > 0-2). The mean concentra¬
tion of LH in all antral fluids examined with respect to follicle size and the stage of
the menstrual cycle is shown in Fig. 3b. The percentage of follicles containing
detectable concentrations of LH at various stages of the cycle is shown in Table 1;
the lowest detectable level in the smallest follicles examined (4 mm) was 2-8 mu./ml,
which was therefore chosen as the limit of sensitivity. There was a greater proportion
of large follicles with detectable LH during the late follicular phase (Table 1), when the
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concentrations were higher than at any other stage of the cycle (Fig. 3 b). Luteinizing
hormone was not detectable in any follicle of < 8 mm during the early and mid-
follicular and mid- and late luteal phases. Fluids from 20 early and mid-follicular
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Fig. 4. Concentrations of (a) prolactin, (b) oestradiol and (c) progesterone in follicular fluid in
relation to follicle size and stage of the cycle. Vertical lines represent+1 s.e.m. White bars,
mean concentration in follicles ^ 8 mm; black bars, mean concentration in follicles < 8 mm.
Minimum detectable level of prolactin (1-5 ng/ml) is indicated by the broken line. See Fig. 1 for
abbreviations. Numbers of observations in parentheses.
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LH was 0-96 mu./ml (detection limit 0-8 niu./ml). Throughout all stages of the cycle
the fluid concentration of LH was < 30 % of that found in peripheral plasma.
Furthermore, LH was only found in those follicles that also contained FSH (Table 1).
Prolactin
Unlike LH and FSH, prolactin was detectable in almost all the follicles examined.
The minimum detectable concentration was 1-5 ng/ml. The concentration of prolactin
was significantly lower in the large follicles during the late follicular phase than in any
other stage of the menstrual cycle (P < 0-05) (Fig. 4a), with the exception of the
large follicles during the early luteal phase. The general pattern of prolactin in antral
fluid indicates a progressive fall in concentration during the follicular phase followed
by a rise in concentration during the luteal phase.
Oestradiol
The concentration of oestradiol in the antral fluid of follicles aspirated in situ was
not significantly different from those aspirated in vitro (P > 0-2). This finding is
similar to that reported by Sanyal et al. (1974). The concentration of oestradiol with
respect to size of follicle and stage of the cycle is shown in Fig. 4b. The levels of
oestradiol in follicles at all stages of the cycle are between 40 and 40000 times higher
than those in peripheral plasma. During the mid- and late follicular phases the large
follicles contained a significantly higher concentration than that in small follicles at
the same phase (P < 0-001). During the luteal phase there were no significant
differences in the concentration of oestradiol between small and large follicles
(P > 0-05) and the levels did not exceed those foimd in follicles during the early
follicular phase.
Progesterone
The concentration of progesterone in the antral fluid of follicles aspirated in situ
was not significantly different from those aspirated in vitro (P > 0-2). The concentra¬
tion of progesterone with respect to size of follicle and stage of menstrual cycle is
shown in Fig. 4c. Levels of progesterone in large follicles during the proliferative
phase were significantly higher than those found in the corresponding small follicles
(P < 0-001). The most dramatic increase was found in the large follicles during the
late follicular phase, where the levels were up to 20 times higher than in any other
follicle throughout the cycle. By contrast, the small follicles (< 8 mm) during the
early luteal phase had a significantly higher concentration of progesterone than any
other follicle during the luteal phase (P < 0-001).
Hormones in the fluid of recently ruptured and ' cystic' follicles
Haemorrhagic fluid was aspirated in vitro from two recently ruptured follicles in
subjects whose endometria still showed very late proliferative changes. The con¬
centrations of hormones in the fluids were: progesterone, 8600-10800 ng/ml;
oestradiol, 335-210 ng/ml; LH, 9-6-7-6 mu./ml; FSH 7-9-6-8 mu./ml; prolactin,
14-6-12-1 ng/ml. The levels of LH and FSH were similar to those in peripheral
plasma whereas the concentrations of prolactin in follicular fluid were about half the
peripheral plasma concentrations. The steroid concentrations were 100- to 1000-fold
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higher than the concentrations of oestradiol and progesterone in peripheral plasma.
The concentration of progesterone in the fluid was also four to eight times higher than
in late follicular phase fluid, but the concentration of oestradiol was at least ten times
lower.
Table 3. Hormone levels in human cystic follicles
(Samples less than the detection limit were assumed to have a concentration of 1*3 mu./ml,
2-8 mu./ml, 1-5 ng/ml for FSH, LH and prolactin respectively for the purposes of the group
means.)
Stage Follicle
of size LH FSH Prolactin Oestradiol Progesterone
cycle* (mm) (mu./ml) (mu./ml) (ng/ml) (ng/ml) (ng/ml)
EF 20 2-8 2-9 13-8 9 55
16 60 1-7 390 205 20
14 2-8 1-4 25-2 17 20
20 2-8 1-2 47-0 40 15
MF 20 2-8 6-6 19-9 18 90
15 120 1-3 230 230 17
25 2-8 2-2 28-2 36 58
ML 10 2-8 1-3 230 150 90
13 100 1-3 210 104 70
10 2-8 1-3 210 30 80
LL 10 140 2-4 30 19 48
* For abbreviations see Table 1.
Table 4. Concentrations (a) of oestradiol in the follicular fluid with or without FSH and
(b) of progesterone in follicular fluid with or without LH (values are means + s.e.m. in
ng/ml)
Stage of menstrual cycle*
EF MF LF EL ML LL
(a) Oestradiol concentrations
FSH ( > 1-3 mu./ml) 300 + 34 2120 + 410 2180 + 310 135 + 40 33 + 26 211+200
(4) (13) (22) (12) (5) (5)
FSH (<1-3 mu./ml) 103 + 22 196 + 60 140 + 55 102 + 58 24+11 60 + 38
(8) (29) (13) (14) (23) (41)
(b) Progesterone concentrations
LH ( > 2-8 mu./ml) t 760 (2) 1720 + 280 715 + 60 196 (2) 320 + 40
(18) (4) (4)
LH (< 2-8 mu./ml) 110 + 31 96 + 33 352 + 84 66 + 11 111 + 15 100 + 20
(12) (40) (17) (22) (26) (42)
* For abbreviations see Table 1. Number of observations in parentheses. Limit of detection for FSH
is 1-3 mu./ml and for LH is 2-8 mu./ml.
t No follicles containing LH.
Data relating to the hormone levels in cystic follicles are shown in Table 3. All
these follicles contained low levels of oestradiol and progesterone irrespective of the
stage of the cycle, suggesting that they were 'inactive' (Baird & Fraser, 1975).
Relationship between follicular concentrations of hormones
Those follicles which had detectable levels of FSH during the follicular phase
without exception contained significantly higher concentrations of oestradiol than
those with undetectable FSH (Table 4a) (EF, MF, LF; P < 0-01, P < 0-001,
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P < 0-001, respectively). Conversely, follicles with undetectable FSH contained low
levels of oestradiol irrespective of the stage of the cycle. During the luteal phase
these correlations no longer held, since follicles with or without FSH had consistently
low levels of oestradiol.
A significantly higher concentration of progesterone was found in follicles con¬
taining LH (Table 46) (MF, LF, EL, ML, LL; P < 0-001, P < 0-001, P < 0-001,
P < 0-05, P < 0-01 respectively). All the follicles containing LH and a high con¬
centration of progesterone were > 8 mm diameter and also contained FSH.
During the mid-follicular, late follicular and late luteal phase of the cycle the
concentration of oestradiol in follicular fluid was correlated with that of progesterone
(r = 0-44, n = 43, P < 0-01; r — 0-88, n = 33, P < 0-001; and r = 0-49, n = 37,
P < 0-01, respectively).
DISCUSSION
There was no difference in the concentration of hormones in fluid collected from
follicles in vitro from those collected in vivo suggesting that there was little if any
production or metabolism of hormones in the time between ovariectomy and aspira¬
tion of fluid (cf. Giorgi, Addis & Colombo, 1969; Sanyal et al. 1974). Although
patients were undergoing surgery for a variety of reasons, the general pattern of
hormones in peripheral plasma (Fig. 1) was similar to that described in normal
women during the menstrual cycle (e.g. Robyn, Delvoye, Nokin, Vekemans, Badawi,
Perez-Lopez & L'Hermite, 1973). However, the concentration of prolactin in
peripheral plasma was up to sixfold higher than that in normal women (McNeilly,
Evans & Chard, 1973 ; McNeilly & Chard, 1974). This is probably because the samples
were collected under the stress of surgery which is known to stimulate the release of
prolactin (Robyn et al. 1973). The overall mean concentration of prolactin in follicu¬
lar fluid (20 ± 5 ng/ml, n = 189) was much lower than that in peripheral plasma. In
the absence of information about the rate of exchange of prolactin between plasma
and follicular fluid in vivo it is impossible to determine whether this difference is of
physiological importance or whether it is an artifact due to the elevated prolactin
concentration in peripheral plasma as a result of stress. Since all the samples were
collected under similar conditions, the striking change in follicular fluid concentration
at different stages of the cycle (Fig. 4a) is probably not an artifact.
The distribution of follicle size in relation to the stage of the cycle is similar to that
previously described in women (Block, 1951) and rhesus monkeys (Koering, 1969).
Large follicles (> 8 mm) were much commoner during the mid- and late follicular and
late luteal phases than at any other stage of the cycle. Although it is difficult to draw
conclusions about the dynamics of follicle growth from these cross-sectional observa¬
tions, it is tempting to speculate that these large follicles represent the end result of
two waves of follicular development initiated by the peaks of secretion of FSH
occurring at the onset of menses and again at mid-cycle. The minimum time necessary
to develop a follicle from the antral to the mature preovulatory stage in women is
probably 6-10 days (Gemzell & Johansson, 1971; Bertrand, Coleman, Crooke,
Macnaughton & Mills, 1972). The concentration of FSH in small follicles reaches a
maximum during the early follicular, late follicular or early luteal phases of the cycle
(Table 2) which is either during or just after the peak FSH concentration in peri-
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pheral blood. Furthermore, the concentration of FSH in these follicles apparently
increases as they develop into mature preovulatory follicles in spite of the falling
levels of FSH in peripheral blood (cf. Table 2 and Fig. 1). Some factor may increase
the affinity of these follicles for FSH. Oestradiol, the concentration of which is
extremely high in the mid- and late proliferative phase follicles, is known to
increase the sensitivity of the ovary to FSH (Goldenberg, Vaitukaitis & Ross, 1972).
The high levels of oestradiol in the large follicles during the mid- and late follicular
phase are similar to those previously reported by other workers in normal (Smith,
1960; Short & London, 1961; Sanyal et al. 1974; Baird & Fraser, 1975) and
gonadotrophin-stimulated ovaries (Short, 1964a; Edwards et al. 1972). Follicles
which have detectable levels of FSH during the follicular phase also have a high
concentration of oestradiol whereas those follicles with undetectable levels of FSH
have significantly lower levels of oestradiol (see Fig. 3a and Table 4a).
When the concentration of FSH in peripheral plasma was high (early follicular
phase and at mid-cycle) FSH was detectable in only a minority of small follicles
(diameter < 8 mm) (Tables 1 and 2). Presumably follicles in which the concentration
of FSH is high are those which are stimulated to further development (Table 4 a). It
is not known how this minority of small antral follicles are selected although it has
been suggested that oocytes are 'programmed' for development in the order in
which they are formed during foetal life (Henderson & Edwards, 1968).
About 17 % of the small follicles (diameter < 8 mm) in the early luteal phase of
the cycle had measurable amounts of FSH and LH (Table 1), presumably as a result
of the preovulatory peaks of the gonadotrophins. In contrast to the follicular phase
of the cycle, none of the follicles in the luteal phase were functionally 'active', as
indicated by the persistently low concentrations of oestradiol. From the time of the
LH 'surge' there is an abrupt fall in the mitotic activity of granulosa cells (Delforge,
Thomas, Roux, Caneiro de Siqueiro & Ferin, 1972). Thus the presence of LH in some
of these small follicles (Table 1) may interfere with their normal orderly development
and consequently their steroidogenic potential (Tables 4a and b). The marked
increase in cystic follicles (Fig. 2) from the mid-luteal phase is probably a conse¬
quence of this. It may be that an ordered sequence of gonadotrophins, e.g. FSH
alone followed by FSH and LH, is necessary for normal follicular development.
Luteinization of the granulosa cells of the preovulatory follicle begins some 24-36 li
before ovulation in response to the mid-cycle LH surge (Hertig, 1967 ; Delforge et al.
1972). After exposure to LH, the preovulatory follicle secretes increasing amounts of
progesterone as indicated by the rise in concentration in ovarian (Mikhail, 1970;
Lloyd, Lobotsky, Baird, McCracken, Weisz, Pupkin, Zanartu & Puga, 1971) and
peripheral plasma (Johansson & Wide, 1969; Yussman & Taymor, 1970). The rela¬
tively high concentration of progesterone in follicular fluid of preovulatory follicles is
similar to that found by other workers in normal (Sanyal et al. 1974) and gonado¬
trophin-stimulated ovaries (Short, 1964a; Edwards et al. 1972), and it is likely that
the luteinizing granulosa cells are the source of this steroid (Channing, 1969, 1970;
Edwards et al. 1972).
The large preovulatory follicles were characterized by a highly vascular appear¬
ance (Short, 19646). The granulosa cells were very loosely attached to one another;
the walls were slimy and mucoid, and the follicular fluid was bright yellow and
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viscous. When the granulosa cells from large follicles collected during the pre¬
ovulatory phase were cultured in vitro they secreted maximal amounts of progester¬
one in response to minimal physiological concentrations of gonadotrophins in the
medium (Channing, 1970 ; K. P. McNatty & R. S. Sawers, unpublished observations).
The granulosa cells are stimulated in vivo by the relatively high concentrations of
LH in blood and follicular fluid. Presumably the metabolic requirement of these
actively secreting cells is high and may account for the relatively low oxygen tension
within the follicle (Fraser, Baird & Cockburn, 1973). The relatively low concentration
of prolactin may also reflect utilization or metabolism of the hormone by the follicle.
It may also play a key role in controlling steroid synthesis, for the production of
progesterone by human granulosa cells in vitro is inhibited when the concentration of
prolactin in the medium exceeds 30 ng/ml (McNatty et al. 1974).
It is apparent that despite the presence of FSH in antral fluid the granulosa cells
do not secrete progesterone in the absence of LH. Furthermore, the concentration of
progesterone in follicular fluid of small follicles during the luteal phase is significantly
lower than in preovulatory follicles, even though they contain both FSH and LH.
The failure of the granulosa cells in small follicles to secrete substantial amounts of
progesterone when exposed to LH suggests that these cells require time before they
are capable of responding fully. The latter finding is consistent with the observa¬
tion that granulosa cells harvested from preovulatory follicles in the pig have a
significantly greater number of receptors for LH when compared with the cells
harvested at other stages of the oestrous cycle (Channing & Kammerman, 1973;
C. P. Channing, personal communication).
The concentration of oestradiol in the haemorrhagic fluid of recently ruptured
follicles was very much lower than that found in the large preovulatory follicles.
Although most of the fluid is lost at ovulation the low concentration of oestradiol in
the haemorrhagic fluid is consistent with the low plasma levels during the immediate
post-ovulatory period (Fig. 1) (Moor, 1974). In contrast, however, the levels of
progesterone were higher than those found in the preovulatory follicle and this is
consistent with the increased plasma levels indicating the growing secretory capacity
of the luteinizing granulosa cells.
Steroid levels in the cystic follicles were low irrespective of the stage of the cycle
and in many the pituitary gonadotrophin concentrations were high and similar to
those found in plasma. These findings suggest that cystic follicles are functionally
inactive and are incapable of secreting oestradiol or progesterone even in the presence
of gonadotrophins.
These data suggest that a precise sequence of hormonal changes occurs within the
microenvironment of the developing Graafian follicle; the order in which the changes
occur may well be of considerable importance for the growth of that follicle and the
secretory activity of the granulosa cells both before and after ovulation. Figure 5
shows the possible inter-relationships between the concentrations of pituitary hor¬
mones in plasma and follicular fluid with respect to the steroidogenic activity and
growth of a follicle during the follicular and luteal phase of the menstrual cycle. The
changes in the concentrations of pituitary hormones in follicular fluid throughout the
menstrual cycle are related to those which occur in peripheral plasma. The presence
of FSH in the smallest follicles appears to be important for their development. The
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presence of FSH and oestradiol in the follicular phase follicles prepares them for the
preovulatory production of progesterone under the influence of LH. The very low
concentrations of prolactin in these follicles may be related to the upsurge in meta¬
bolic activity within the follicle during this time. The antral fluid of the preovulatory
follicle contains relatively large amounts of oestradiol and progesterone, low physio¬
logical levels of prolactin, and concentrations of LH and FSH approaching 30 and
32 -i Follicular phase PLASMA
Luteal phase
24 -

























1 1 1 r
LL EF MF LF EL
i 1 1 1~
LF EL ML LL EF
Stage of menstrual cycle
Fig. 5. The postulated relationships between the concentrations of pituitary and steroid
hormones in peripheral plasma and in the follicular fluid of a developing follicle during either
the follicular or luteal phase of the menstrual cycle (see text). Oa = oestradiol, P4 = proges¬
terone. See Fig. 1 for abbreviations.
60 % respectively of those found in plasma. These changes in the growth of a follicle
destined to ovulate are different from those proposed for the pig (Channing, 1972).
Such differences that exist will possibly depend on the permeability of a Graafian
follicle in different species to protein hormones (see Edwards, 1974, for review).
Furthermore, it is suggested that the large inactive follicles found during the
luteal phase are a consequence of LH interference during the growth of these follicles
under the influence of FSH. The consequence of these findings may prove to be
important in the treatment of amenorrhoeic or anovulatory patients with exogenous
gonadotrophins.
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